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Summary
A b r ie f  review o f na rco tic  analgesics, w ith p a r t ic u la r  reference to 
the 4 -p h e n y lp ip e r id in e  c la s s , is  presented in  Chapter 1. The 
chem ical and s te reochem ica l fe a tu re s  o f the 4-phenylp iperid ines 
tha t ensure high le v e ls  o f a c t iv i t y  are discussed, w ith emphasis on 
the co n fo rm a tio n a l and c o n f ig u ra t io n a l aspects o f C -m ethyl 
de riva tives  o f the reversed ester o f pe th id ine.
One aspect o f the chem is try  o f the 4-phenylp iperid ine analgesics 
tha t is  h ig h lig h ted  is  the e ffe c t o f meta-hydroxy s u b s titu tio n  in  
the aromatic r in g . In 4-phenylp iperid ine analgesics w ith C«*-carbon 
substituen ts, such a chemical change enhances a c t iv i ty .  However, 
studies o f the phenolic analogues o f the prodines and a lly lp ro d in e s  
(w ith  C*f-oxygen s u b s t itu e n ts ) ,  in d ic a te  th a t a com plete lo s s  o f 
a c t i v i t y  o c c u rs . Hence, i t  has been sug ges ted  th a t  4 - 
phenylp iperid ines w ith O-carbon substituents associate w ith  opiate 
receptors in  a mode c lo s e ly  analogous to  tha t o f morphine (a x ia l-4 -  
a ry l conformer), w h ile  those w ith O-oxygen substituents in te ra c t 
w ith opiate receptors in  a manner in v o lv in g  an e q u a to r ia l-4 -a ry l 
p ipe rid ine  cha ir conformer.
The bas is  fo r  the syn th e s is  o f the compounds described  in  th is  
thesis is  to  challenge the proposals on receptor in te ra c tio n  o f the 
4-phenylp iperid ines. To th is  end, the synthesis o f a novel series 
o f p o te n tia l analgesics based on the 3a-phenolic tropane analogue 
o f peth id ine and the preparation o f the phenolic a- and 3-2-methyl 
analogues o f the reversed ester o f peth id ine are reported (Chapter
-  V -
2). The p a r t ic u la r  in te re s t  in  these d e r iv a t iv e s  a r is e s  as a 
re s u lt  o f the nature o f the 4 -a ry l group. In both the 3a-phenolic 
tropane analogues o f peth id ine (considered as a r ig id  p ip e rid in e  as 
a re s u lt  o f the fused p y rro lid in e  r in g ) and the phenolic a-2-methyl 
analogue o f the reversed  e s te r o f p e th id in e , the 4 - a r y l  group is  
a x ia l in  i t s  p re fe rre d  o r ie n ta t io n  and hence can be used to  
e lu c id a te  fu r th e r  in fo rm a tio n  o f re ce p to r in te ra c t io n  o f these 
types o f compounds.
Chapter 2 a lso describes lim ite d  work on the attempted synthesis o f 
the 3a- and 3&-phenolic tropane analogues o f the reversed acetyloxy 
e s te r o f p e th id in e . Of p a r t ic u la r  in te re s t was the 3a-analogue, 
w ith an a x ia l ly  o rien ta ted a ry l moiety.
The re s o lu t io n  o f ( t ) - a - l ,2 - d im e th y l- 4 - p h e n y lp ip e r id in -4 - o l  is  
re p o rte d , so as to  p ro v id e  fu r th e r  in fo rm a tio n  on the a n a lg e s ic  
potency o f o p t ic a l ly  a c tive  forms o f c h ira l diastereoisomers in  the 
4-phenylp iperid ine class o f analgesics.
F in a lly ,  the pharmacological re s u lts  o f these compounds, a v a ila b le  
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INTRODUCTION
-  1 -
1.1 Historical Introduction
P rio r to  the advent o f modern syn the tic  chemistry, na tu ra l products 
p ro v id e d  the o n ly  means o f drug tre a tm e n t. Of a l l  the h e rb a l 
remedies tha t were a v a ila b le , opium was probably the most e ffe c t iv e  
drug o f them a l l .
Opium has been used as a drug a t le a s t  s ince  the c la s s ic a l  tim es, 
not o n ly  because i t  deadens pa in  bu t because i t  a ls o  produces a 
sense o f  w e ll-b e in g  in  the use r. In  1803, morphine (1) was 
iso la te d  from opium by a German pharmacist and by the middle o f the 
19th cen tu ry  the use o f pure morphine, ra th e r  than crude opium 
preparations, had spread w idely.
Apart from i t s  pa in  r e l ie v in g  p ro p e r t ie s , morphine a ls o  a f fe c ts
many o f the v i t a l  centres in  the b ra in . One notable feature is  the
0
development o f to le rance w ith repeated use, re s u lt in g  in  the user 
becoming e m o tio n a lly  and p h y s ic a l ly  dependent on the  drug. The 
widespread use o f  morphine re s u lte d  in  a d ram atic  inc re ase  in  
addiction , and hence the drug was the cause o f a s ig n if ic a n t s o c ia l 
problem. This resu lted  in  the search fo r non-addictive syn the tic  
(and sem i-synthetic) op ia tes , la c k in g  the u n d e s ira b le  e f fe c ts  o f 
morphine.
-  2  -
1.2 Morphine and its Derivatives
Morphine (1 ), the c h ie f  a lk a lo id  ob ta ined  from opium, Papaver 
som niferum, was is o la te d  by the  German pharmacist Sertuner. I ts  
s tru c tu re , o r ig in a l ly  proposed by Gulland and Robinson in  1923^»^, 
was not confirm ed u n t i l  i t s  t o t a l  syn th e s is  in  1952 by Gates and 
TschudP.
Used as an agent a g a in s t severe and ch ro n ic  pa in , morphine may be 
regarded as the prototype among the analgesic drugs. However, i t s  
m u lt ip le  s id e  e f fe c ts ,  such as re s p ira to ry  depress ion , g a s tro ­
in te s t in a l disturbances and the development o f to lerance leading to  
add ic tion , have led to  much m odifica tion  o f the morphine molecule 
in  an e f fo r t  to  produce the idea l c e n tra lly -a c tin g  analgesic.
Me
Cl)
E arly m odifica tion  o f morphine, in  an attempt to  produce analgesics 
superior to  the na tu ra l product, in vo lve d  d e r iv a tis a tio n  o f the 3- 
and 6- hydroxy groups. A ce ty la tion  o f both hydroxy groups y ie lded
- 3 -
the a n a lg e t ic a l ly  p o ten t and h ig h ly  a d d ic tin g  d ia ce ty lm o rp h in e  
(Heroin, ?), whereas e th e r if ic a t io n  o f the phenolic hydroxy group 
lowered the a n a lg e t ic  potency, as i l l u s t r a t e d  by codeine (£) and 
pholcodine (A).
N^ M e
(2) r=r ‘ =coch3
(2) R=Me, R‘ =H
(A) r=ch2ch2- i/ V  r‘ =h
Other m odifications in vo lve d  chemical transformations w ith in  r in g  C 
o f morphine which generated s e v e ra l drugs having m o rp h in e - lik e  
a c t iv i t ie s ,  although these d e riv a tiv e s  o ffe r  no re a l advantage over 




A lte ra tio n  o f groups on the n itrogen o f the morphine nucleus has a 
major e ffe c t on both the q u a n tita tiv e  and q u a li ta t iv e  a c t iv i t y  o f 
morphine. The j^ -phene thy l analogue (£ ), is  more po ten t than 
morphine, but w ith q u a l i ta t iv e ly  s im ila r  a c t iv i t y 4. S ubs titu tion  
by groups such as a l l y l ,  d im e th y la lly l and cyclopropylm ethyl impart 
antagonist a c t iv i t y  to  morphine. The N - a l ly l  compound (Nalorphine, 
7) was one o f the f i r s t  compounds recogn ised as a morphine 
a n ta g o n is t5, and has been used as an a n tid o te  in  morphine 
poisoning^. A lthough n a lo rp h in e  la c k s  a n a lg e s ic  p ro p e r t ie s  in  
la b o ra to ry  an im a ls , in  humans i t  shows p o te n t, e s s e n t ia l ly  non­
a d d ic tin g  a n a lg e s ic  e f fe c ts .  Th is o b s e rv a tio n  has le d  to  the  
development o f s e v e ra l c l i n i c a l l y  u s e fu l a n a lg e s ics  based on 
morphine antagonists7. One morphine antagonist th a t has a ttrac te d  
much in te re s t is  the N - a l ly l  analogue o f oxymorphone (Naloxone, 8), 
which is  considered to  be an almost pure antagonist as i t  does not 




B en tle y  and co-w orkers u t i l i z e d  the m e d ic a lly  use less  a lk a lo id  
thebaine (2) to  produce a series o f morphine analogues c a lle d  the 
oripavines^. Thus, e x p lo ita tio n  o f the diene component o f thebaine 
v ia  D ie ls  A lder condensations w ith a v a r ie ty  o f d ienophiles, gave 
r is e  to  k e to n ic  adducts w ith  a c t i v i t i e s  comparable to  those o f 
morphine, w h ile  c e r ta in  t e r t ia r y  a lc o h o ls  d e riv e d  from G rignard  
re a c tio n s  on these k e to n ic  adducts were shown to  have ve ry  h igh  
le v e ls  o f a c t i v i t y .  One such compound, e to rp h in e  (10), has an 









1.3 Synthetic Centrally-Acting Analgesics
Research in  the f ie ld  o f syn the tic , c e n tra lly -a c tin g  analgesics has 
concen tra ted  on m o d if ic a t io n  o f the morphine s tru c tu re  in  an 
attem pt to  e x tra c t  the pharmacophore necessary fo r  a c t i v i t y .  
Although not in  chrono log ica l order o f development, the fo llo w in g
se c tio n s  a ttem pt to  i l l u s t r a t e  how a c o n tin u a l re d u c tio n  in  the
size o f the morphine molecule has generated various groups o f drugs 
w ith  a n a lg e s ic  p ro p e r t ie s . Though these a n a lg e s ics  va ry  in  
s t r u c tu r a l  c h a ra c te r is t ic s ,  they can a l l  be re la te d  to  the 
prototype, morphine (see F ig . l) .
1.3.1 The Morphinans
The morphinans, inves tiga ted  by Grewe11’ 12 in  h is  to ta l  synthesis 
o f morphine, bear the c loses t s tru c tu ra l s im ila r it y  to  the na tu ra l 
product, as they contain the complete carbon-nitrogen skeleton (see 
F ig . l ,a ) .  Among the v a r io u s  d e r iv a t iv e s  w ith in  th is  group, 
racemorphan (11) was the f i r s t  c l i n i c a l l y  v a lu a b le  agent, w ith  
tw ice the a c t iv i t y  o f morphine-^. Resolution o f racemorphan, and 
subsequent pharmacological te s t in g  o f each enantiom er, re v e a le d  
th a t a n a lg e s ic  potency res id ed  a lm ost c o m p le te ly  in  the la e vo  
isomer, levo rphano l1^.
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Figure 1
S tru c tu ra l elements o f (a) the morphinans, (b) the benzomorphans,
(c) the phenylpiperidines and (d) the diphenylpropylamines as they 
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S t r u c tu r e - a c t iv i t y  re la t io n s h ip s  among the morphinans c lo s e ly  
m ir ro r  those o f morphine, a lthough  few changes have re s u lte d  in  
u s e fu l drugs. Two c l i n i c a l l y  u s e fu l agents are worthy o f no te : 
le v a llo rp h a n  (12), the  N - a l l y l  analogue o f le v o rp h a n o l, is  an 
analgesic antagonist w ith  f iv e  times the potency o f na lorph ine15, 
w h i ls t  dextrom ethorphan ( ]J ) ,  the ^ -m e th y l e th e r o f the d e x tro  
isomer o f racemorphan, has found extensive use as a non-addictive 




S im p lif ic a tio n  o f the morphine s tru c tu re  was ca rried  a step fu rth e r 
by May and asso c ia tes  in  1954 w ith  the advent o f the 6 ,7 - 
benzomorphans1^. In th is  se t o f compounds r in g  C o f  morphine has 
been replaced by methyl or other a lk y l substituents at C-5 and C-9, 
a chemical change which confers an a d d itio n a l geometrical isomerism 
across r in g  B (see F ig . l ,b ) .  Termed a lpha (a - , c is  5 ,9 - d ia lk y l ,  
14) and beta ($ -, tra n s  5 ,9 - d ia lk y l ,  15) benzomorphans, g re a te r
RO
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analgesic a c t iv i t y ,  dependence l i a b i l i t y  and to x ic i ty  is  associated 
w ith  the ^ -s e r ie s ,  and, a d d i t io n a l ly ,  a g o n is t a c t i v i t y  re s id e s  
mainly in  the laevo isomers17.
(14) a- : X=H, Y=RX 
C13 3 0- : X=R1, Y=H
C l in i c a l l y  im po rta n t 6,7-benzom orphan d e r iv a t iv e s  in c lu d e  
phenazocine (16; N-phenethylnorbenzomorphan), w ith  3-5 times the 
a c t iv i t y  o f morphine in  man but a lower dependence l i a b i l i t y 18, and 
p e n ta z o c in e  (1 7 ), th e  N -d im e th y  l a l  1 y 1 n o rb e n z o m o rp h a n  
d e riv a tiv e 19*20. A lthough a fe e b le  a n ta g o n is t o f morphine, 
pentazocine is  an e ffe c t iv e  analgesic in  man. I t  was marketed as 
an a n a lg e s ic  w ith  low a d d ic i t iv e  l i a b i l i t y  (as ’ F o r t r a lO ,  bu t 
c l in ic a l  experience has disproved th is  la t te r  aspect, so th a t i t  is  






( ]J )  R=CH2CH=CMe2
1.3.3 The 4- Phenylpiperidines
The s e re n d ip ito u s  d is c o v e ry  o f p e th id in e , in  1939 by E is le b  and 
Schaumann21, rep resen ts  fu r th e r  s im p l i f ic a t io n  o f the morphine 
molecule. P e th id in e  (1 8 ), th e  p a re n t compound o f  th e  4 - 
p h e n y lp ip e r id in e  a n a lg e s ic s , was o r ig in a l l y  syn thes ised  as a 
p o te n t ia l  an tispasm odic agent. I t s  a n a lg e s ic  p ro p e r t ie s  were 
observed in  the course o f  c l i n i c a l  t r i a l s ,  and, w ith  h in d -s ig h t ,  
i t s  s tru c tu re  can be assigned to  a po rtion  o f the morphine molecule 
(see F ig . l , c ) .  A f u l l  c o n s id e r a t io n  o f  th e  c h e m is try  and 
stereochemistry o f the 4-phenylp iperid ines and re la te d  compounds is  





The d is c o v e ry  o f such a s im p le  n a rc o tic  agent as p e th id in e  
in fluenced the d ire c tio n  o f research and resu lted  in  the u ltim a te  
s im p lif ic a t io n  o f the morphine s tru c tu re  in  the preparation o f the 
a cyc lic  analgesic, methadone (19)22’ 2-5. This a c y c lic  analgesic, a 
3,3-diphenylpropylam ine d e r iv a tiv e , was one o f the e a rly  non-fused 
r in g  analgesics recognised. A possib le  conform ational re la tio n s h ip  
o f methadone to  morphine has been postu lated (see F ig .l,d ) .
Ph
i




C lin ic a l ly  s im ila r  to  morphine, methadone has the advantage tha t i t  
su s ta in s  a d d ic tio n  a t one q u a rte r the dose o f morphine, and 
withdrawal e ffe c ts , both physical and emotional, are less severe.
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Hence, i t s  major use is  in  the maintenance o f n a rc o tic  dependent 
s u b je c ts 24. S t ru c tu ra l analogues o f methadone g e n e ra lly  show 
reduced a c t iv i t y  or are i n a c t i v e ^ .  Varia tions about the n itrogen 
atom o f methadone th a t have produced c l i n i c a l l y  u s e fu l drugs 
include use o f the morpholino group, as in  phenadoxone (20)2^, and 
the p ipe rid ino  group, as in  dipipanone (21)27.
Ph (20) R= -N 0
c 2h - c - c - c h - c h - r  
O Ph Me
( 2 1 )  R
*  - O
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1.4 4-Phenylpiperidine Analgesics and Related Compounds
1.4.1 Introduction
The 4 -p h e n y lp ip e r id in e  type o f a n a lg e s ic s  are h i s t o r i c a l l y  the  
o ld e s t s y n th e t ic  group. P e th id in e  (18), the  paren t compound o f 
th is  group, is  one o f the  most w id e ly  accepted s u b s t itu te s  fo r  
morphine, and was f i r s t  introduced in to  c l in ic a l  p rac tice  by E is leb  
and Schaumann in  193921.
Me
(18)
Pethidine has about one f i f t h  to  one eighth the potency o f morphine 
in  man28y and is  u s e fu l in  the c o n tro l o f  m ild  to  moderate p a in . 
However, i t  shows l i t t l e  advantage over the na tu ra l product, except 
th a t i t  has a low er le v e l  o f t o x ic i t y  and s h o rte r d u ra tio n  o f 
action. C l in ic a l ly ,  peth id ine has many uses, although i t s  major 
use is  in  the c o n tro l o f la b o u r p a in 29, a c l i n i c a l  a p p lic a t io n  
which has a t t ra c te d  some c r i t ic is m -50. E x te n s ive  research in to  
syn the tic  m odifications o f peth id ine has been undertaken w ith the 
aim o f producing an id e a l a n a lg e s ic , and a ls o  to  in v e s t ig a te  the 
s t r u c t u r e - a c t i v i t y  r e la t io n s h ip s  th a t  a p p ly  among th e  4 - 
phenylp iperid ines.
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1.4.2 Synthetic Modifications of Pethidine
1.4 .2.1  V aria tion  o f the Nitrogen Substituent
F o llo w in g  the o b se rva tio n  made by P e rr in e  and Eddy in  1956 th a t 
N-phenethylnorpethidine (P h e n e r id in e ,  22) had a potency tw ice tha t 
o f p e th id in e  in  mice51, a f u l l  in v e s t ig a t io n  in to  o th e r N- 
s u b s t itu te d  n o rp e th id in e s  was undertaken. I t  has become apparent 
th a t the  potency o f analogues in  the 4 -p h e n y lp ip e r id in e  s e r ie s  
depends h e a v ily  upon the na tu re  o f the  n itro g e n  s u b s t itu e n t.  
S ubs titu tion  on the phenyl o f pheneridine w ith groups such as amino 
and methoxy is  consistent w ith  good potency, as is  hydroxy la tion  in  
the side chain. Varying the length o f the side chain a lk y l a lso  
d ra m a tica lly  e ffe c ts  potency. A c t iv ity  r ise s  from N-benzyl- (0.25 
tim es as p o ten t as p e th id in e ) to  N -p h e n y lp ro p y ln o rp e th id in e  (13 
tim es as p o ten t as p e th id in e ) ,  and then decreases on fu r th e r  
extension o f the a lk y l c h a in 5^ .  Replacement o f the side chain a ry l 
by p y r id y l enhances a c t iv i t y 55, w h ils t the dioxolane group in  th a t 
p o s it io n  g ive s  a compound w ith  the  same potency as the  pa ren t 
este r54.
^ -s u b s t itu te d  analogues o f p e th id in e  in  c l i n i c a l  use in c lu d e  
phenoperid ine50 (O pe rid in e , 23), the  secondary a lc o h o l ob ta ined  
from the reduction o f the Mannich base derived from norpethid ine 
and acetophenone, w ith  a potency o f 150 tim es p e th id in e 55*56; 
a n ile r id in e  (L e r it in e , 24), the N-para aminophenethyl analogue o f 
p e th id in e , w ith  2-3 tim es the potency o f  the p a re n t57*58; and 
piminodine (A lvodine, 25), possessing an N -substituent contain ing a 
secondary amino group between the a lk y l and a ry l func tion , a drug 





(24) R=CH2CH2- ^ N H 2 
(2£) R=CH2CH2CH2-NH-Ph
Research aimed a t producing a n a rc o t ic  a n ta g o n is t based on 4 - 
phenylp iperid ines, in v o lv in g  a change o f the N -subs titu ten t, has 
not produced an e f fe c t iv e  agent. L in k in g  the n itro g e n  atom to  
groups such as a l l y l  or c y c lo p ro p y lm e th y l,  m o d if ic a t io n s  which 
produce antagonists in  the morphine and benzomorphan series , have 
le d  to  agents hav ing  no power to  b lo c k  o p ia te  re c e p to rs 40. 
However, p a r t i a l  success in  p ro d u c in g  4 - p h e n y lp ip e r id in e  
antagonists has been achieved: compound (26), based on bemidone,




C H -C H
(26)
1.4 .2 .2  The C-4 Oxygen Function
In v e s t ig a t io n s  in to  the v a r ia t io n  o f the C-4 oxygen fu n c tio n  o f 
p e th id in e , and i t s  e f fe c t  on a n a lg e s ic  potency, were c a r r ie d  out 
soon a f te r  the drug was in tro du ced  in to  c l i n i c a l  p ra c t ic e .  The 
carbethoxy group (C02E t) is  considered to  be o f o p tim a l s iz e  fo r  
a n a lg e s ic  a c t i v i t y ^ 2 , and i t s  replacem ent by carbomethoxy^-5, or 
higher a lk y l esters, decreases a c t iv i t y ^ 5* ^ .  However, in  1943 i t  
was reported tha t the replacement o f 4-carbethoxy by 4-propionyloxy 
(OCOEt) enhanced potency by a fa c to r  o f 204-5>44. Th is group o f 
analgesics, the so -ca lle d  reversed esters o f pe th id ine, showed high 
le v e ls  o f potency ir re s p e c t iv e  o f the  na tu re  o f the n itro g e n  
s u b s t itu e n t.  F u rthe r increases in  potency were observed w ith in  
th is  series when nitrogen substituents known to confer high le v e ls  
o f a c t iv i ty  in  the pethid ines were introduced. The reduced Mannich 
p ro d u c t (27) is  one o f  th e  most p o te n t p h e n y lp ip e r id in e s ,  





The ease o f th e ir  s y n th e t ic  a c c e s s ib i l i t y ,  to g e th e r w ith  th e i r  
enhanced le v e ls  o f a c t iv i t y ,  have resu lted  in  much o f the research 
o f the 4 -p h e n y lp ip e r id in e  type o f a n a lg e s ics  being based on the 
reversed esters. Studies on the e ffe c t o f v a r ia tio n  o f the 4 -a ry l 
group, and in ve s tig a tio n s  in to  the s tru c tu re -a c t iv ity  re la tio n s h ip  
o f various C -a lk y l analogues, are considered in  se c tio n s  1 .4 .2 .3  
and 1 .4 .2 .4  respec tive ly .
Other changes at the C-4 oxygen p o s itio n  inc lude the replacement o f 
the ester by ketonic functions and a lk y l ethers. Ketobemidone (28) 
possesses a 4 -p ro p io n y l group to g e th e r w ith  a 4-m-hydroxypheny 1 
g rou p , and has 10 tim e s  th e  p o te n cy  o f  p e th id in e 4^ . The 
4-ethoxy-4-(2,- fu r y l )  analogue (29) o f pe thid ine has 2.5 times the 








1.4 .2.3 V aria tion  o f the 4 -A ry l Group
Much o f the work in v e s tig a tin g  a change in  the nature o f the 4 -a ry l 
group o f the  4 -p h e n y lp ip e r id in e s , and i t s  e f fe c t  on a n a lg e s ic  
potency, has u t i l iz e d  the s y n th e tic a lly  accessible reversed esters. 
Complete rem oval o f the 4 -pheny l r e s u lts  in  a d ram atic  f a l l  in  
potency (see 3Jp)^ 8»^9, w h ils t i t s  replacement by la rg e r groups such 
as n a p h th y l^ 0,. or non-arom atic groups capable o f dona ting  it 
e le c tro n s , such as e th y n y l51, a b o lish e s  a c t i v i t y  c o m p le te ly . 
Iso s te ric  replacement o f phenyl by groups such as fu r y l ,  p y r id y l 
and th ie n y l are a ls o  d isadvantageous in  terms o f potency (see
3^47,50,52
^OCOEt
(30): EDso : 20.2 mg/Kg SC (mice HP) 




X A c t iv ity ^7 »^0







The in tro d u c t io n  o f s u b s titu e n ts  in to  the arom atic  r in g ,  such as 
m ethyl (3%)  and methoxy (j53) has been re p o rte d , a lth ou g h  in  most 
cases these analogues are le s s  po ten t than the  paren t compounds. 
No c o rre la tio n  between potency and po s ition  o f s u b s titu tio n  can be 
observed, a lth o ug h  para s u b s t i tu t io n  u s u a lly  r e s u lts  in  the 
greatest, and ortho the le a s t, f a l l  in  a c t iv i ty .
R
A c t iv ity 5-5 
R = H 4.3
OCOEt
v / M g
R = o-Me 2.6
R = m-Me 0.4






A c t iv ity 54’ 55 
R = H 5.7OCOMe
R = o-OMe 3.0




S tud ies on the e f fe c t  o f o th e r a rom atic  s u b s titu e n ts  are la c k in g  
although the in fluence  o f hydroxyla tion  in  the a ry l r in g  has been 
investiga ted . H y d ro x y la tio n  o f the 4 -pheny l group, a s i tu a t io n  
which increases a n a lg e s ic  potency in  the fused r in g  systems, 
genera lly  leads to  a marked reduction or complete loss o f a c t iv i t y  
in  many 4 -p h e n y lp ip e r id in e  a n a lg e s ic s . Thus, meta-p h e n o lic  
analogues (34), (35) and (36) o f the  reversed  e s te r o f p e th id in e , 
a- and B.- p rod ine  and a -  and £ -  a l ly lp r o d in e  re s p e c tiv e ly , have 









However, the in tro d u c t io n  o f a meta-p h e n o lic  h y d ro x y l in to  
p e th id in e , as in  bemidone (37), e le v a te s  potency by a fa c to r  o f 
1.5, w h ile  ketobemidone (2§), is  approximately 20 times more potent 






(57) (29) (5 9 )
1.4 .2 .4  A lky la tio n  o f the P iperid ine Ring
In v e s t ig a t io n  in to  the  e f fe c t  o f a lk y la t io n  o f the h e te ro c y c lic  
r in g  o f the 4 -p h e n y lp ip e r id in e s  has m a in ly  been con fined  to  the 
reversed esters. This can be a ttr ib u te d  to the v e r s a t i l i t y  o f the 
4 - a r y l - 4 - p ip e r id in o l  s y n th e s is , and the high le v e ls  o f a c t iv i t y  
associated w ith the reversed esters. Fo llow ing the reports in  the 
la te  1940s on the 3 -m e thy l analogues o f the reve rsed  e s te rs  o f 
pe th id ine5^, many 3 -a lk y l d e riv a tiv e s , and a l l  possib le  mono- and 
d i-C -m e th y l d e r iv a t iv e s ,  o f the reversed  e s te rs  have been 
described.
A. The Isomeric 3 -A lk y l Analogues o f the Reversed Ester o f
Pethidine
The isom e ric  na tu re  o f the 3 -m ethy l d e r iv a t iv e s  o f the reversed  
ester o f pethid ine were f i r s t  studied by Z ie ring  et a l . in  194760.
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They r e p o r te d  a p o te n c y  d i f f e r e n c e  b e tw ee n  th e  tw o 
d ia s te re o iso m e rs , examined as racemates. A lpha-prodine (39), the 
major component, was re p o rte d  to  have a potency e q u iv a le n t to  
morphine, whereas the minor component, be ta-prodine (40), was f iv e  
times as a c tive  as the standard agent59. Many reports since 1947 
have confirm ed these o r ig in a l  f in d in g s  and, in  a d d it io n ,  b e ta - 
prod ine  has been shown to  be f iv e  tim es as po ten t as the  paren t 












The o r ig in a l c o n fig u ra tio n s  assigned to  a lp h a -  and b e ta -p ro d in e  
remained c o n tro v e rs ia l u n t i l  they were e s ta b lis h e d  by X -ray 
c ry s ta l lo g ra p h ic  a n a ly s e s ^ ,  and s u b s ta n tia te d  by 1H- and 13C- 
n .m .r. s tu d ie s ^  >64,65,66 ^  The assignments are trans 3 -m e th y l/ 4- 
phenyl fo r  a-prodine (39a) and c is  3-m ethyl/4-phenyl fo r  8-prodine 
(40a). The corresponding IUPAC nomenclature is  a: £-3-Me, r -4 -  
OCOEt; £ : t >-3 -M e , r -4 -0 C 0 E t.  Both d ia s te re o iso m e rs  are




{These s tru c tu re s  
r e l a t i v e  s te reochem  
D e ta i ls  o f  a b s o lu te  





meant o n ly  to  express 
L s try  a t t h i s  s ta g e , 
s te re o c h e m is try  a re
However, i t  is  now accepted th a t the  case o f the 3 -m ethy l 
substituent is  unique, and w ith la rg e r a lk y l  groups those compounds 
w ith  a tra n s  3 - a lk y l/4 -p h e n y l c o n f ig u ra t io n  (the  a -iso m ers ) are 
more po ten t than th e i r  c o rre s p o n d in g  c is  3 - a lk y  1 /4 -p h e n y  1 
analogues67 (see Table 1). From th is  data i t  appears th a t d rug- 
re ce p to r in te ra c t io n  is  enhanced by a - e th y l and impeded by a -n -  
propyl and a -n -b u ty l, w h ile  a l l  3 -substituen ts except methyl have a 
detrim enta l in fluence .
Receptor a f f in i t i e s  measured by determ ining the concentration o f 
the 3 -a lky la te d  ester to  d isp lace 50% o f s p e c if ic a l ly  bound Ph] 
dihydrom orphine from r a t  b ra in  homogenates have con firm ed the 
h ighe r a f f i n i t y  o f 3.- ove r a - (42, R=Me, Table 1) and a - ove r 3.- 
(42, R=Et and £ -h e x y l,  Table 1), and the r e s u lts  were found to  
co rre la te  w e ll w ith  analgesic potency6^.
Table 1
A nalgesic  A c t iv i t y  (Hot P la te  EDso mg/Kg SC in  mice) o f Some 










C6Hi 3n inac tive  at 80 54.4
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The in f lu e n c e  o f a j3 -3 -m ethy l group may be ach ieved d i r e c t ly  
through in te ra c t io n  w ith  a b in d in g  s i te  on the re ce p to r s p e c if ic  
fo r a x ia l methyl. However, longer hydrocarbon groups o f the same 
a x ia l  o r ie n t a t io n  a re  n o t accommodated a t t h i s  s i t e .  An 
a lte rn a tiv e  explanation, however, is  tha t a 3-3-methyl group has an 
in d ire c t in fluence  on ligand-recep tor association by f a c i l i t a t in g  a 
r is e  in  the population o f reversed ester conformations tha t bind 
more e f fe c t iv e ly  than the equa to ria l 4-phenyl chairs favoured fo r 
unsubstituted and 3a-substitu ted d e riv a tiv e s . Thus, the a x ia l 4- 
phenyl c h a ir  (43) may have g re a te r re ce p to r a f f i n i t y  than the 







N - M e
(43)
F o llo w in g  the e s ta b lish m e n t o f  the  con fo rm ation  and r e la t iv e  
con figu ra tion  o f alpha- and beta-prodine, an in v e s tig a tio n  in to  the 
a n a lg e s ic  potency o f the two o p t ic a l  forms o f each c h i r a l  
diastereoisomer was necessary to  complete a comprehensive study o f 
the s tru c tu re -a c t iv ity  re la tio n sh ip s  o f the prodine-type reversed 
e s te rs .  T h is  in v o lv e d  s e p a ra t io n  o f  the  two c h i r a l
diastereoisomers in to  antipoda l forms, e lu c id a tio n  o f the absolute 
c o n f ig u ra t io n  o f each enantiom er, and the assessment o f each
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anan^or'fiers* a n a lg e s ic  potency. Portoghese and co -w orkers69 
succeeded in  achieving these aims, the find ings o f which are given 
below. For th is  ana lys is , they considered the 4-phenylp iperid ine  
reversed esters to e x is t in  favourable equa to ria l 4-phenyl cha ir 
c o n fo rm a tio n s , and by u s in g  b io c h e m ic a l n o m e n c la tu re 7^, 
d i f fe r e n t ia te d  between the two s ides o f the p ip e rid in e  molecule. 
One s id e  was term ed p r o - c h ir a l - 4 S  (P ro -4 S ) and th e  o th e r  
p ro -ch ira l-4R  (Pro-4R*, see 44). In the unsubstituted parent ester 








group on the Pro-4S s ide  g ive s  C-4 an S c o n f ig u ra t io n  (us ing  the 
Cahn-Ingold-Prelog convention71), w h ils t s u b s titu tio n  on the Pro-4R 
side gives C-4 an R con figu ra tion .
Considering the two antipodal forms o f a lpha-prodine (39), w ith  an 
equa to ria l 3-methyl substituen t, more a c t iv i t y  was found to  reside 


















These f in d in g s  seem to  sug g es t th a t  th e  o p ia te  re c e p to r  
d is c r im in a te s  a g a in s t the Pro-4S s ide  o f the molecule. Thus, i f  
the Pro-4R s ide  o f the m o lecu le  is  presented to  the  o p ia te  
re c e p to r, e q u a to r ia l 3 -m ethy l s u b s titu e n ts  lo ca te d  on th is  s ide  
h in de r drug re ce p to r in te ra c t io n ,  whereas e q u a to r ia l 3 -m e thy l 
groups on the Pro-4S s id e  do not a f fe c t  th is  in te ra c t io n .  This 
a n a ly s is  is  fu r th e r  s u b s ta n tia te d  by s tu d ie s  on o th e r a n tip o d a l 
forms o f 3 -a -a lk y l analogues. One example to  i l lu s t r a t e  th is  is  
the 3-a-n-propyl d e riv a tiv e s  o f the reversed ester o f pe th id ine: 
the  3R,4S enantiom er (EDso = l.Omg/Kg) has a h ig h e r le v e l  o f 
po ten cy  tha n  th e  c o rre s p o n d in g  3S,4R p o d a l fo rm  (EDso = 
25.2mgAg)72’ 73.
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A s im i la r  study o f the two a n tip o d a l forms o f 0_-prodine (AO), in  
which the 3-methyl substituen t has an a x ia l o r ie n ta tio n , revealed 
th a t  g re a te r a n a lg e s ic  potency re s id ed  w ith  the 3S,4S an tipode  













Hence, w ith  an e q u a to r ia l A -phenyl c h a ir  con fo rm a tion , a x ia l 3 - 
m ethyl s u b s t itu t io n  on the Pro-AS s ide  is  p r e fe r e n t ia l  fo r  h igh  
le v e ls  o f a c t i v i t y  and, in  a d d it io n ,  such a x ia l 3 -m e thy l 
s u b s t itu t io n  has an a c t iv e  r o le  to  p la y  in  o p ia te - re c e p to r  
in te ra c tio n . This is  i l lu s t r a te d  by comparison o f the analgesic 
a c t i v i t i e s  o f 3R ,4S -a-3-m ethyl and 3S,A5-Br 3-methyl analogues o f 
reversed ester o f pe th id ine .
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B. Conform ation, R e la t iv e  C o n fig u ra tio n  and A na lg es ic
Potency o f Other C-Methyl Analogues o f Reversed Esters o f 
Pethidine
Follow ing the o r ig in a l in ve s tig a tio n s  o f the 3-methyl analogues o f 
the reversed ester o f peth id ine (a lpha- and beta- prodine), studies 
o f other mono- and di-C-methyl analogues have been reported. These 
include 2-m ethyl, 2 ,6-, 2 ,5-, 2,3- and 3,5- dim ethyl d e r iv a tiv e s . 
As p a rt o f the comprehensive study on the s t r u c tu r e - a c t iv i t y  
re la tio n s h ip  o f the 4-phenylp iperid ine  analgesics, i t  was necessary 
to  deduce the preferred conformation and re la t iv e  con figu ra tion  o f 
the members o f each isom eric  s e t. The f in d in g s  o f these s tu d ie s  
are given in  th is  section. An ana lys is  o f the two o p tic a l forms o f 
each d ia s te re o iso m e r, which in c lu d e s  the e lu c id a t io n  o f the  
ab so lu te  c o n f ig u ra t io n  o f  each enantiomer, and the assessment o f 
the analgesic potency o f each podal form, is  discussed in  section 
1 .4 .2 .4 (C ).
{To s im p l i fy  the  subsequent formulae representing 
re la t iv e  or absolute con figu ra tion , methyl groups 
are denoted by a s ing le  l in e  de fin ing  p o s itio n  and 
o rie n ta tio n  (a x ia l or eq ua to ria l) o f s u b s titu t io n .}
a) The 2 -m ethy l and the 2 ,6 -d im e th y l analogues o f the
reversed este r o f pethid ine
Studies on the 2-methyl (43) and the 2,6-dim ethyl (46) analogues o f











The s te reochem ica l fe a tu re s  o f the  two 2-m ethy l isomers were 
assigned by a n a ly s is  o f th e i r  correspond ing p recu rso r a lc o h o ls .  
The o r ig in a l  assignments o f a -(£ -2 -M e , r-4 -0 H ; 45a, R=H) and
£-C t-2 -M e, r-4 -0H ; 45b, R=H) based on chem ical r e a c t iv i t y  and





I t  should be noted tha t w h ils t the 3-isomer ex is ts  in  an equa to ria l 
4-phenyl cha ir conformation, an a x ia l 4-phenyl cha ir is  preferred 
fo r  the a -iso m er. Assessment o f the a n a lg e s ic  potency o f  the 
propionate esters o f the two racemic diastereoisomers revealed th a t
- 31 -
both isomers showed the same le v e l  o f potency and, in  a d d it io n ,  
were more potent than the standard agent peth id ine but less  a c tive  
than the desmethyl parent ester (see 47)75.
R EDso mg/Kg mice HP
H 0.85
a: c-2-Me, r-4-0C0Et 1.32
8: t-2-Me, r-4-0C0Et 1.37




S im ila r  s tu d ie s  on the  1 ,2 ,6 - tr im e th y l d e r iv a tiv e s  (46) revealed 
tha t three possib le  diastereoisomers existed, one c h ira l (4£a, R=H) 
and two a c h ira l (46b and 4£c, R=H). The preferred conformation and 
r e la t iv e  c o n f ig u ra t io n  o f each isomer was e s ta b lis h e d  by X -ray 
c ry s ta llo g ra p h ic  ana lys is o f the precursor p ip e r id in o l76 (46a, 4£b, 
4£c, R=H). The r e s u lts  were fu r th e r  s u b s ta n tia te d  by ^ - n .m . r .  






Studies o f analgesic potency o f the three diastereoisomers w ith in  
the set revealed tha t the two a c h ira l molecules were in a c tiv e  (4£b, 
R=C0Me; 46c, R=C0Me) w h ils t the c h ira l species (4£a, R=C0Me) was
a c tive . The EDso o f 4&a (R=C0Me) was found to  be 2.0 mg/Kg
compared w ith  peth id ine a t 4.7 mgAg (mice, hot p la te  te s t ) 77.
b) The 2 ,5 -d im e th y l analogues o f  the  reve rse d  e s te r o f
peth id ine (The promedols)
The 2,5-dim ethyl analogues o f the reversed esters o f pe th id ine  (48)
were f i r s t  in v e s t ig a te d  by Nazarov e t a l . 78 in  1948. They
succeeded in  is o la t in g  three (a-, fr- and o f the four possib le
diastereoisomers, and assessed each fo r  a n a lg e s ic  a c t i v i t y .  The
fou rth  isomer, 6-, was la te r  reported by Russian workers in  195979.







The s te reochem ica l c h a ra c te r is t ic s  o f each d ia s te re o isom e r were 
e s ta b lis h e d  by Casy e t £ l . , 81’ 82. S tud ies o f the  p re cu rso r 
p ip e r id in o ls  by chem ica l r e a c t iv i t y  and l H -n.m .r. spectroscopy 
enabled the re la t iv e  con figu ra tion  and p re fe rre d  con fo rm a tion  o f  
the a - ,  £ -  and x -  promedols to  be deduced. These r e s u lts  were 
fu r th e r  s u b s ta n tia te d  by 13C -n .m .r.8^ and X-ray c ry s ta llo g ra p h ic  
stud ies8^. j-C t-2-M e, £ -5 -Me, r-4-OCOEt*, 48a) and &-(£-2-Me, £ -5 - 
Me, r-4 -0C 0 E t; 48b) promedols were shown to  e x is t  in  fa v o u ra b le  
eq ua to ria l 4-phenyl ch a ir conformations, w h ils t the a-isomer (£-2- 
Me, t_-5-Me, r-4 -0C 0 E t) e x is ts  as an a x ia l 4 -pheny l c h a ir  (48c). 
The con figu ra tion  o f the 6-isomer has not been estab lished but by 


















c) The 2 ,3 -d im e th y l analogues o f the reve rse d  e s te rs  o f
pethid ine
F irs t  reported in  196185, the four possib le  diastereoisomers o f the 
isomeric l,2 ,3 -tr im e th y l-4 -p h e n y l-4 -p ip e r id in o ls  were is o la te d  by 
M astryukov e t a l . 8^. They analysed each racemic diastereoisomer 
fo r  a n a lg e s ic  potency (as the p rop iona te  e s te r)  and showed th a t ,  
w h ils t the a- and isomers were a n a lg e t ic a lly  potent, the 3- and 
6- diastereoisomers were in a c tiv e  (see 49).
The s te reochem ica l p ro p e r t ie s  o f these fo u r d ia s te re o iso m e rs , 
inves tiga ted  as the precursor a lco ho ls , was undertaken by Casy et 
a l . 87 on the basis o f 1H- and 13C-n.m .r. s tud ies.
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a-
A c t iv ity
1
Ph OCOEt
v-M e in a c tive
X - 30Me
6 - ina c tive
Me Morphine: 1
A l l  fo u r d ias te reo isom ers  were shown to  e x is t  in  a fa v o u ra b le  
4-phenyl cha ir conformation and the re la t iv e  con figu ra tion  o f each 
isomer was established as a- (c-2-Me, £ -3 -Me, r-4-0H; 49a), £- (£-
2-Me, c-3-Me, r-4-0H*, 49b), (£ -2 -Me, £ -3 -Me, r-4-0H*, 4£c) and










Further studies o f the potency o f the a- and ^-diastereoisom ers has 
been undertaken and compared w ith  th a t o f the pa ren t desmethyl 
es te r. The isomer was shown to  have four times the a c t iv i t y  o f 
the parent, w h ils t the a-isomer was only 0.25 times as active®8.
d) The 3 ,5 -d im e th y l analogues o f the  reve rse d  e s te rs  o f
peth id ine
S tudying the e f fe c t  o f 3 ,5 -d im e th y l s u b s titu tio n  on the reversed 
es te rs  o f p e th id in e , S o rok in89 re po rted  th a t th re e  p o s s ib le  
diastereoisomers o f 50 could e x is t.
Stereochemical consideration o f the three possib le  diastereoisomers 





o th e r two meso (5Qb and 5Qc). The c h i r a l  isomer (des ignated 
has been shown to  be tw ice  as a c t iv e  as morphine in  mice, w h i ls t  
the  two meso forms (w ith  a c is  -  3 ,5 -d im e th y l)  were shown to  be 




The s te re o ch e m is try  o f  the  a c t iv e  d ia s te re o iso m e r (x» ) has been 
con firm ed by Portoghese e t a l . ^ .  where an e q u a to r ia l 4 -phe ny l 
c h a ir  con fo rm a tion  a p p lie s ,  w ith  a c-3-M e, t-5 -M e , r-4 -0C 0E t 
co n figu ra tion .
A summary o f the stereochemical data re le v a n t to  the 2-methyl and 
the 2 ,6 - , 2 ,5 - , 2 ,3 - and 3 ,5 - d im e th y l analogues o f  the  reve rse d  
esters o f peth id ine  is  given in  Table 2.
C. Absolute con figu ra tion  and analgesic potency o f C-methyl
analogues o f Reversed E s te rs  o f  P e th id in e  re p o rte d  to  
date
To complete the ana lys is  o f the s t ru c tu re -a c t iv ity  re la tio n s h ip  o f 
the reversed  e s te rs  o f p e th id in e , and so enab le  a p ic tu re  to  be 
b u i l t  up o f the stereochemical features o f the 4-phenylp iperid ines 
th a t fa v o u r o p ia te  re c e p to r in te ra c t io n s ,  s tu d ie s  on the two
38
Taole 2 Summary o f  ste reochem ica l oa ts  re le v a n t to  the  2-m ethyl and the 2 ,6 - ,  
analogues o f  Reversed E ste rs  o f P e th id in e
C o n fig u ra tio n 3S u o s titu e n t S tru c tu re
2-m ethyl
2 ,6 -d im e tn y i
2 .5 -r iim e th v i
2 ,3 -d im e th v l
3 ,3 -d im e th v l
P H . .O C O E t
P h . .O C O M e




P h . .O C O E t
N '^ ^ 'M eI
Me
P h . .O C O E t






C h ira l
A c h ira l
N-Me





























In a c t iv e
In a c t iv e
— 6 “
In a c t iv e
In a c t iv e
In a c t iv e
In a c t iv e
Depicted as the p re fe rre d  c h a ir  con fo rm a tion ; o n ly  one enantiom orph ic form is  shown fo r  
c h ir a l m olecules.
EDso in  mg/ka (paren t oesmethyl e s te r  = 0.83 mg/Kgj 
A c t iv ic v  r e la t iv e  to  morDhine = i
d im ethy l
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o p t ic a l  fo rm s o f  each C -m e th y l d ia s te re o is o m e r  have been 
undertaken. Inves tiga tions  o f the two o p tic a l forms o f a lpha- and 
beta- p rod ine  (see page 26) re v e a le d  th a t when the 3 -m e thy l 
s u b s t itu e n t was e q u a to r ia l in  o r ie n ta t io n ,  as in  a lp h a -p ro d in e  
(22), s u b s t i tu t io n  on the  Pro-4R s ide  (39b) was d e tr im e n ta l to  
potency, w h ils t an equa to ria l 3-methyl substituen t on the Pro-4S 
side (39a) had l i t t l e  in fluence  on analgesic potency (the EDso o f 
3£a is  o f the  same o rde r o f magnitude as the paren t desm ethyl 
e s te r). In  the case o f  be ta -p ro d in e , (40), w ith  an a x ia l l y  
orien ta ted 3-methyl subs tituen t, the potency o f the enantiomer in  
which the s u b s t itu e n t was p laced on the Pro-4S s id e  (40a) was 
enhanced, hence in d ica tin g  an a c tive  ro le  o f th is  a x ia l 3-m ethyl. 
Table 3 summarises th is  work.
To in v e s t ig a te  the e f fe c t  o f the a b so lu te  o r ie n ta t io n  o f m ethyl 
s u b s titu tio n  on analgesic potency, analogues w ith eq ua to ria l methyl 
substituents on ly , a x ia l methyl substituents on ly , and those w ith 
m ixed a x ia l  and e q u a to r ia l  m e th y l s u b s t i tu e n ts  w i l l  be 
considered separately.
{W ith in th is  section , acyloxy functions (OCOEt) in  
the formulae are denoted by 0}
a) Equatoria l Methyl Substituents
Analogues o f the re ve rse d  e s te rs  o f p e th id in e  w ith  e q u a to r ia l 
methyl substituents inc lude the 0-2-methyl, 2-2 ,5-d im ethyl and the 
0 -2 ,3-dimethyl d e riva tive s .
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Table 3 Analgesic A c t iv ity  o f the podal forms o f g- and 6- 
prodine69
Structure Absolute EDso (mg/kg) 
C onfiguration
P hv

















i .  The fJ-2-methyl de riva tives
The jS-2-methyl d e r iv a tiv e  (31) o f the reversed este r o f peth id ine 
is  known to  e x is t  in  a p re fe rre d  e q u a to r ia l 4 -phe ny l c h a ir  
c o n fo rm a tio n  and th e  p o s i t io n  2 -m e th y l has an e q u a to r ia l  
o r ie n ta tio n . Analgesic te s tin g  o f the racemic ester 51 (p a r t ia l 
formula) showed tha t i t s  potency was s l ig h t ly  less than the parent 
desmethyl compound. However, separation o f the two enantiomers and 
subsequent analgesic te s tin g  revealed tha t the laevo isomer (5,1a*, 
w ith  a 2S,4R a b so lu te  c o n f ig u ra t io n )  had a potency e q u iv a le n t to  
the pa ren t e s te r , w h ile  the d e x tro  isomer (51b; w ith  a 2R,4S 













Hence, s u b s t itu t io n  o f a m ethyl ad jacen t to  the  n itro g e n  on the 
Pro-4R side o f the p ip e rid ine  molecule has a passive ro le  to  p lay 
in  drug receptor in te ra c tio n . The fa c t th a t the 2R,4S enantiomer 
was le s s  a c t iv e  than the paren t e s te r in d ic a te s  th a t Pro-4S s ide  
s u b s t itu t io n  a t p o s it io n  2 h inde rs  drug in te ra c t io n  w ith  the 
receptor.
i i .  The x~2,5-dim ethyl de riva tives  
In  the 5-dim ethyl analogue o f the reversed este r o f peth id ine 
(52), both methyl groups have an eq ua to ria l o r ie n ta tio n . Fo llow ing 
the  p r in c ip le s  e s ta b lis h e d  by exam ination o f  the 2 - and 3- 
monomethyl d e r iv a t iv e s  w ith  e q u a to r ia l s u b s t itu e n ts , s im i la r  
c o n s id e r a t io n  o f  th e  two e n a n tio m e rs  o f (52) re v e a le d  the 
s u p e r io r i ty  in  potency o f  one an tipode over the  o th e r92. The 
de x tro  isomer (52a; 2S,4S,5R) was found to  be the  more p o ten t
antipode as both methyl groups are favourably placed. The laevo 
isomer (52b; 2R,4R,5S) w ith  both m ethyl groups in  u n fa vo u ra b le















The fa c t  th a t the dex tro  isomer had a potency e q u iv a le n t to  the 
parent desmethyl compound is  fu rth e r evidence o f a passive ro le  o f 
equa to ria l methyl substituen ts .
i i i .  The 8-2,3-dim ethyl de riva tives  
The £ -2 ,3-dim ethyl d e r iv a tiv e  (3^) has two eq ua to ria l methyl groups 
on the same s ide  o f the p ip e r id in e  m o le cu le . I t  is  th e re fo re  
im p o s s ib le  to  p la c e  b o th  m e th y ls  in  fa v o u ra b le  a b s o lu te  
o r ie n ta tio n s . Hence, i f  the 2-methyl is  in  a favourable  po s ition  
(on the Pro-4R s id e ) then the 3 -m ethy l is  a ls o  on the Pro-4R s ide  
and is  u n fa vo u ra b le . S im i la r ly ,  su b s titu tio n  on the Pro-4S side 
contains one favourable and one unfavoured element (see 3^a). This 
observation expla ins why the potency o f the racemic 8.-2,3-dim ethyl 
analogue is  low (EDso=30.7 mg/Kg, mice HP)87.











In  c o n c lu s io n , e q u a to r ia l m ethyl s u b s titu e n ts  g e n e ra lly  have a 
passive ro le  to  p lay in  opiate receptor in te ra c tio n s . This can be 
ju s t i f ie d  by the fa c t tha t the more ac tive  an tipoda l forms o f each 
diastereoisom eric set have potencies close to  th a t o f the parent 
es te r. The arguments g ive n  above are fu r th e r  s u b s ta n tia te d  by 
ana lys is  o f the stereochemical p roperties o f the in a c tiv e  c is -2 ,6 - 
d im e th y l (54)77 and c is -3 ,5 -d im e th y l (55)®9 analogues. In  these 
two d e r iv a t iv e s ,  m ethyl s u b s titu e n ts  o f un favoured a b s o lu te  







Table 4 summarises the data on equatoria l methyl substituen ts .
b) A xia l Methyl Substituents
D eriva tives  o f the reversed ester o f peth id ine th a t i l lu s t r a t e  the 
ro le  o f a x ia l methyl groups in  opiate receptor in te ra c tio n s  inc lude 
the a-2,5-d im ethyl analogue and the j-2 ,3 -d im e th y l analogue.
i .  The a -2 ,5- dimethyl d e riva tive  (a-promedol)
S epara tion  o f the two o p t ic a l  forms o f a-prom edol ( 56 ) and 
subsequent analgesic te s tin g  ind ica ted tha t the dextro isomer (56a) 
was approximately 20 times more a c tive  than the parent es te r, and 
a lso  tha t the laevo isomer (56b) was in a c tiv e ^ 5.
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Table 4 A summary o f the e f fe c t  o f e q u a to r ia l C -methyl s u c s t itu t io n  on a n a lg es ic  potency in  
d e r iv a t iv e s  o f Reversed E s te rs  o f P e th id in e
S u o s titu e n t
3-m ethvl
Isomer D es icna tion
3R,4S-a-
Abso lu te  C o n fia u ra tio n
Ph
N—Me
A c t iv i t y  
EDso ( mg/Kg)a


























2 .6 -d im e thv j
Ph
N—Me
In a c t iv e
3 .5 -d im e th y l
a. S.C. m ice, hot p la te  te s t .
b. ED>o o f oa ren t desmethyl e s te r  =. 1.3 mg/Kg
c . ED50  o f pa ren t oesmetnyl e s te r  = C.4 -  CLg mg/Kg















EDso (mg/kg) 0 .0 6  in a c tive  a t 50
a-Promedol is  considered to  e x is t  in  an a x ia l 4 -pheny l c h a ir  
con form ation  w ith  both m e th y l g roups h a v in g  an e q u a t o r ia l  
o r ie n ta tio n . However, inve rs ion  o f th is  a x ia l 4-phenyl cha ir to  
the correspond ing e q u a to r ia l 4 -pheny l c h a ir  g iv e s  both m ethyl 




In  th is  con fo rm a tion , a s im i la r i t y  to ]3 -p ro d in e  (40) can be seen. 
Studies on 3-prodine revealed tha t an a x ia l 3-methyl on the Pro-4S 
s ide  enhanced a c t i v i t y  by a fa c to r  o f 4 ove r th a t o f the  paren t 
desmethyl este r. This is  a lso the case in  (+)-a-promedol, as the. 
a x ia l 3 -m ethy l group is  on the Pro-4S s id e . However, the 
s u p e rio r ity  o f potency o f (+)-a-promedol over (+)-0-prodine must be 
due to  the in fluence  o f an a x ia l 2-methyl group on the Pro-4R side. 
Therefore, both methyl groups in  (+)-a-promedol appear to  p lay an 
a c tive  ro le  in  opiate receptor in te ra c tio n .
i i .  The 2-2 ,3-d im ethyl d e riva tive  
The 2 ~ 2 ,3 -  d im e th y l d e r i v a t i v e  (58) possesses two a x ia l l y  
o r ie n ta te d  m e th y l s u b s t i tu e n ts .  The two e n a n tio m e rs  a re  
represented by (58a; Pro-4S s ide  s u b s t itu t io n )  and (5<gb#, Pro-4R 










Separation o f the two antipoda l forms has not been undertaken, but 
i t  would be expected th a t the 4S enantiom er (5&a) would be more 
a c tive , as the 3-methyl is  in  a favourable o r ie n ta tio n . In the 4R 
enantiomer (58b), the a x ia l 3-methyl is  o f unfavourable o r ie n ta tio n  
(see (-)-J3- prodine, page 28)9^.
The 2-methyl substituen t, w ith  an a x ia l o r ie n ta tio n , a lso  plays an 
a c tive  ro le  in  receptor in te ra c tio n . An a x ia l methyl adjacent to  
the  n itro g e n  on the Pro-4R s ide  is  known to  enhance a c t i v i t y  (see 
a-prom edol; page 45). However, in v e s t ig a t io n s  o f  the  tropane 
analogue (59) o f peth id ine reversed acetoxy ester revealed th a t i t  
e xh ib its  enhanced a c t iv i t y  over the parent reversed acetoxy ester 







EDso mg/Kg 3.4 4.7
The f in d in g  suggests th a t an a x ia l l y  o r ie n ta te d  C -2-m ethy l on
e ith e r  the Pro-4R or Pro-4S s ide  is  not d e tr im e n ta l to  a n a lg e s ic
a c t iv i ty .
In conclusion, a x ia l ly  o rien ta ted methyl substituents o f ce rta in  
absolute o r ie n ta tio n  have a profound e ffe c t on analgesic a c t iv i t y .  
An a x ia l l y  p laced m ethyl ad jacen t to  the  4 -pheny l on the  Pro-4S 
edge ra is e s  potency w h ile  a s im i la r ly  o r ie n ta te d  m ethyl on the 
Pro-4R edge causes a d ram atic  decrease in  potency. An a x ia l l y  
o r ie n ta te d  m ethyl ad jacen t to  n itro g e n  on e ith e r  the Pro-4R or 
Pro-4S edge is  a ls o  b e n e f ic ia l  to  potency le v e ls .  Table  5 
summarises the data on a x ia l methyl substituen ts .
c) A x ia l/E qua to ria l Substituents
With the exception o f the ^ -3 ,5-dim ethyl analogue o f the reversed 
e s te r o f p e th id in e , s tu d ie s  on the two o p t ic a l  forms o f o th e r 
C -m ethyl d ia s te re o isom ers  w ith  a x ia l and equa to ria l substituen ts 
are la c k in g . Given below is  a c o n s id e ra tio n  o f the r e s u lts
51
Fable 5 A summary o f  the e f fe c t  o f a x ia l C-methyl s u o s t itu t io n  on ana lges ic  potency in  
a e r iv a t iv e s  o f Reversed E s te rs  o f P e th id in e










2 ,3 -d im e th y l
A S -g r-
A R - v -
Ph
> c
2 .5 -d im e th v l









N In a c tive *3 
a t 30
Tropane analogue o f  
tne  reverseo acetoxy 




5 . A '
a. S.C. m ice, hot p la te  te s t .
b . EDso o f parent desmethyl e s te r  = 1 .3  mg/Kg.
c . Racemic m ix tu re , fo u r tim es as po ten t as the reversed e s te r o f p e th id in e
d. EDso o f reversed acetoxy e s te r  o f  p e th id in e  = A .7 mgAg.
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ob ta ined from s tu d ie s  on the 5 -d im e th y l analogue. A b r ie f  
assessment o f the an tic ipa ted  re s u lts  fo r other C-methyl analogues 
is  given in  Table 6.
In the j-3 ,5 -d im e th y l analogue o f the reversed este r o f pe th id ine
(61), one m ethyl group has an a x ia l and the o th e r an e q u a to r ia l 
o r ie n ta tio n . Separation and subsequent analgesic te s tin g  o f the 
two enantiomers o f 61 revealed the su p e rio r ity  o f potency o f the 






EDso mg/Kg 4.91 





-a o ie  6 A SUi^ARV QR ~H£ ANTICIPATED E r O F  MIXED AXIAL AND EQUATORIAL C-ME Thy1.  SUBSTITUTION ON ANA.GESIC 3C-TEnCv 
IN DERIVATIVES OF REVERSES ESTERS OF PETHIDINE94
S u o s titu e n t S tru c tu re A csciu te
C o n fig u ra tio n
A nalgesic  A c t iv i t y  
fo r  Racemic M ix ture  
(EDso mg/Kg)a
Notes
! 3 -2 ,5 -d im e th y l
P h .  yO
N ""'M e  
Me
o. 0
X ' ' 3 7 ' " '
0
0 .6b
One e o u a to r ia l 5- anc 
one a x ia l 2 - m ethyl 
s u o s t itu e n t.
A c tiv e  form expectec 
to  be (a), w ith  
e o u a to r ia l 5- metnyl 
w ith in  tne rea r eoge.
1
a -2 .3 -o im e rn y l
P h .  y '0
....Me




One e o u a to r ia l 3- and
one a x ia l 2 - m ethyl
s u b s t itu e n t.
A c tiv e  form expected
to  be (c ) w ith
e o u a to r ia l 3- m etnyl




- X y ' " '
0
6 -2 ,5 -d im e th y l
1
I
PI .  * ' °
^ ^ ^ M e
Me




Reoortea as tw ice  
a c t iv e  as i t s  
corresponding 
y-isom er.
One e o u a to r ia l 2 - and 
one a x ia l 5- m ethyl 
s u o s t itu e n t.
A c tiv e  form 
a n tic iD a te d  as (e) 
w ith  both m etnyl 
s u b s t itu t io n s  in  
fa v o u ra b le  
o r ie n ta t io n s .
I 6 -2 ,3 -d im e th y l
1i
P h .  o- 0
N /  X Me
1
M e




In a c tiv e
In a c t iv e ,  as expectec 
due to  ootn  m ethyl 
groups in  u n favo u ra b le  
p o s it io n s .
a. 5 .C . m ice, hot p la te  te s t .
b . ED*® o f  pa ren t desmethyi e s te r = 0.85 mg/Kg.
c . EDso o f  pa ren t desmethyi e s te r = 0 .4  -  0 .6  mg/Kg.
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The d e x tro  isomer possesses a fa v o u ra b ly  p laced a x ia l  3 -m e th y l 
group (on the Pro-AS side) and an equa to ria l 5-methyl group which 
is  unfavourable fo r drug receptor in te ra c tio n s . These observations 
exp la in  why th is  antipode is  less ac tive  than the desmethyi parent 
es te r. In  the case o f the la e vo  isom er, n e ith e r  the  e q u a to r ia l 
3 -m ethy l or the a x ia l 5 -m ethy l enhance potency le v e ls  and hence 
exp la ins the low le v e l o f a c t iv i t y  associated w ith  th is  podal form.
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1.5 Concluding Remarks
The fe a tu re s  th a t ensure h igh le v e ls  o f potency in  the 4- 
phenylp iperid ine c lass o f analgesics have been discussed both from 
the chem ical and s te reochem ica l p o in t o f v iew . However, some 
ambiguity arises in  in te rp re tin g  the e ffe c t on analgesic a c t iv i t y  
o f meta hydroxyl s u b s titu tio n  in  the aromatic moiety (see section 
2 .1 ). The work described in  th is  th e s is  was undertaken to  
in v e s t ig a te  f u r t h e r  exam ples o f  p h e n o lic  analogues o f 4- 
p h e n y lp ip e r id in e  type and tropane type a n a lg e s ic s , the tropanes 
representing re s tr ic te d  p iperid ines as a consequence o f the fused 
p y rro lid in e  r in g .
DISCUSSION
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2.1 Alms and Objectives of the Present Work
During the 1950s i t  was noted tha t a meta-placed phenolic group as 
in  bemidone (62; R=C02E t) and ketobemidone58 (6 2 R=C0Et) enhanced 




This observation encouraged the suggestion tha t the ax ia l-4 -p heny l 
conformation o f the p ipe rid ines  is  the a c tive  one since i t  mimics 
the 4 -a ry l p ip e rid in e  moiety o f the morphine skele ton (see 63)96.
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OH
Morphine -  P a rtia l 4 -A ry lp ip e rid in e
Formula -  P a r t ia l Formula
(63)
However, s tu d ie s  on the reve rsed  e s te rs  o f p e th id in e  w ith  one or 
two C-methyl substituents placed at various pos itions  around the 
a l ic y c l ic  r in g , has y ie lded  data consistent w ith the e q u a to ria l-4 - 
phenyl c h a ir  as the p re fe rre d  con fo rm a tion  (64; see s e c tio n  
1 .4 .2 .4 ). Furtherm ore, as o u t l in e d  in  s e c tio n  1 .4 .2 .2 , the  
in trod u c tion  o f a meta-placed hydroxy in to  the phenyl substituen t 
o f the reversed ester o f peth id ine (65*, R=H), a-prodine (65; R=Me, 
w ith  c-3-M e, r-4 -0 C 0 E t), j3 -p rod ine  (65, R=Me, w ith  t.-3-M e, r - 4 -  
OCOEt), and the two a lly lp ro d in e s  (65; R=CH2-CH=CH2), a l l  potent 










Esters -  P a rtia l Formula IVIe
(64) (63)
I t  would seem, th e re fo re , th a t a n a lg e s ics  based on 4 - a r y l -  
p ip e r id in e  w ith  C^-carbon s u b s titu e n ts  a sso c ia te  w ith  o p ia te  
receptors in  the a x ia l-4 -a ry l cha ir conformation, which is  a mode 
c lo s e ly  analogous to  th a t  o f morphine. I t  is  c o n s is te n t th a t  
in tro du c tio n  o f a meta-OH function  in to  such C,,-carbon p ipe rid ines  
should enhance analgesic potency. The peth id ine reversed esters, 
on the o th e r hand, which possess -oxygen fu n c tio n s , seem to  
associate w ith opiate receptors in  a d if fe re n t manner, in v o lv in g  an 
equa to ria l 4-phenyl cha ir conformation which w i l l  not to le ra te  a 
phenolic substituen t.
The aim o f  t h is  work is  to  se cu re  compounds o f  s p e c i f i c  
con figura tion  tha t w i l l  challenge these proposals. The compounds 
required are those which are phenolic analogues o f both C ,,-carbon 
and C,,-oxygen 4 -p h e n y lp ip e r id in e s , w ith  fe a tu re s  ensuring  h igh  
preference fo r a x ia l-4 -a ry l conformers. Included in  th is  group o f 
compounds are the p h e n o lic  analogues o f a -2 -m e th y l p e th id in e  
reversed e s te r (66)75 and the p h e n o lic  analogue o f  tropane (67) 





( « ) (6J)
One o th e r aim o f the  p resen t th e s is  is  to  o b ta in  fu r th e r  data on 
the  o p t ic a l  enantiom ers o f the reversed  e s te r o f p e th id in e . To 
th is  end, re so lu tio n  o f a - l,2 -d im e th y l-4 -p h e n y lp ip e rid in -4 -o l was 
undertaken.
The work in  th is  thes is  therefore en ta ile d :
1. The synthesis o f required compounds;
2. Separation o f isomers;
3. C on figura tiona l and conform ational assignments using 
spectroscopic techniques; and
4. Pharmacological eva luation.
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2.2 The Tropanes
2.2.1 Attempted synthesis of ethyl 3a-(3-hydroxyphenyl 3-307 
tropane carboxyl ate and ethyl 3&7(3-hydroxyphenyl)-3o7 
tropane carboxylate.
2 .2 .1 .1  In troduction
In  1961, C ig n a re lla  e t a l .^S re p o rte d  th a t c is -N - to s y l-2 ,5 -  
b is (ch lo ro m e th y l)p y rro lid in e  (68*, R=tosyl) and p h e n y la c e to n it r i le  
in  the presence o f NaNH2 afforded a s in g le  compound (£?; R=tosyl, 
R*=CN, R” =Ph) in  28% y ie ld .  Th is in  tu rn  was conve rted  to  the 
e s te r (69; R=Me, R’ =C02E t, R” =Ph). F u rthe r s tu d ie s  in  1974 by 
Daum e t a l . "  re p o rte d  th a t c is -N -b e n z y l- 2 ,5 - b is  (ch i oromethy 13- 
p y rro lid in e  (68; R=CH^h) and p h e n y la c e to n itr ile  in  the presence o f 
NaH in  D.M.F. y ie ld e d  a 3s l m ix tu re  o f the compounds (69; R=CH2Ph, 
R’ =CN, R,J=Ph) and (69; R=CH2Ph, R*=Ph, R” =CN). They succeeded in  
separating th is  epimeric m ixture and converted each epimer to  the 
correspond ing tropane analogue (69; R=Me, R*=C02E t, R” =Ph) and 





As part o f th is  present work, m od ifica tion  o f the method described 
by Daum e t a l .^9 u t i l iz in g  m -m ethoxyphenylacetonitrile and c is -N- 
be nzy l-2 ,5 -b is (ch lo rom e thy l)p y rro lid ine  was employed.
2 .2 .1 .2  Synthesis and Chemistry
The proposed ro u te  o f  syn th e s is  fo r  the  two p h e n o lic  tropane 
analogues (70) and (71) o f peth id ine is  o u tlin e d  in  Scheme 1.
A. The syn th e s is  o f  c is -N -b e n z y l-2 ,5 -b is (c h lo ro m e th y l )-
p y rro lid in e
The f i r s t  s tep le a d in g  to  the in te rm e d ia te  c is -N -b e n z y l-2 ,5 -  
b is (c h lo ro m e th y l)p y r ro lid in e  (72; Scheme 1) in  the syn th e s is  o f 
the  ta rg e t compounds (70 and 71) in v o lv e d  the condensation o f 
methyl meso-aa’-dibromoadipate (7?) and benzylamine.
CH30 2C -B rC H -(C H 2)2-C H B r -C 0 aCH3
<73)
PhCH2NH2












































M ethyl meso- qg ’ -d ib rom oad ipa te  was prepared by the procedure 
described  by Blackman and B a l t z l y 100. T h is  in v o lv e d  th e  
b rom ina tion  o f a d ip o y l c h lo r id e  (74; prepared by the a c tio n  o f 
th io n y l ch lo rid e  on ad ip ic  acid) fo llow ed by reaction  w ith methanol 
(Scheme 2). The bromination o f ad ipoyl ch lo rid e  proved p ra c t ic a l ly
HOOC-(CHj)4-CO O H
| s o c i2





C H P jC—BrHC — (C H2)2—CHBr—C 02C H3
(7.3)
Scheme 2
d i f f i c u l t ,  o ften re s u lt in g  in  charring o f the product. To overcome 
th is  problem  i t  was necessary to  perform  the re a c tio n  on s m a ll 
a l iq u o ts  o f a d ip o y l c h lo r id e  w ith  c a r e fu l  c o n t r o l  o f  th e  
temperature o f the reaction  medium.
T h is  b r o m in a t io n ,  a ty p e  o f  He 11 -  V o 1 h a r d - Z e 1 in s k y  
re a c t io n 101-1^  is  p o s i t io n a l ly  s e le c t iv e  and r e s u lts  in  a - 
bromination on ly . Although explanations o f the mechanism o f the
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H e ll-V o lh a rd -Z e lin s k y  re a c tio n  have been num erous*^ , 105 j the  
mechanism is  u su a lly  regarded as proceeding through the enol (7£), 








R—C H =C —Cl +  Br2









C yc liza tion  o f methyl meso-aa’-dibromoadipate w ith benzylamine led  
to  an is o m e r ic  m ix tu re  o f  c i s -  and t r a n s -N -b e n z y 1 - 2 ,3 -  
d ic a rb o m e th o x y p y r ro l id in e  (76 and 77; Scheme 1 ), in  th e  
approxim ate r a t io  2:1 (as jud ged  by ^ - n . m . r .  O-CHj s ig n a l  
in t e n s i t y  and s u b s ta n t ia te d  by 13C -n .m .r. r e la t i v e  s ig n a l 
in te n s i t ie s ) .  S epara tion  o f these two isomers was ach ieved by 
fra c tio n a l c r y s ta l l is a t io n  o f th e ir  hydrochloride s a lts .
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The stereochemistry o f the two products was established from th e ir  
^ - n .m . r .  s p e c tra l c h a ra c te r is t ic s  (a t 400MHz), n o ta b ly  the  
m u l t ip l i c i t y  o f the N-CH2 s ig n a l.  The ^ - n .m . r .  spectrum o f the 
major isomer (Tab le  10, N o .l) e x h ib ite d  a sharp s in g le t  a t 53.90 
fo r the N-CH2 s ig n a l, in d ic a t iv e  o f two m a g n e tic a lly  e q u iv a le n t 
p ro to n s . However, the  spectrum o f the m inor isomer (Table  10, 
No.2) showed a two p ro ton  AB q u a rte t p a tte rn  cen tred  a t 63.95 fo r  
one p ro ton  and 3.78 fo r  the o th e r (J=13Hz), a fe a tu re  assoc ia ted  
w ith two non-equiva lent, m utua lly  coupled protons (see F ig .2).
An AB quarte t pa ttern arises when two non-equivalent protons couple 
w ith each other, th a t is ,  the protons e x h ib it a geminal coupling o f 
the order 12-18Hz, w h ile  the chemical s h i f t  d iffe ren ce  between them 
is  sm a ll. As an example to  i l lu s t r a te  the nature o f an AB quarte t, 
the hypothe tica l case o f two non-equivalent methylene protons H  ^
and Hq w i l l  be cons idered . The n o n -e qu iva le nce  o f these two 
protons can be caused by one o f three s itu a tio n s :
1. the methylene group is  part o f a r in g  system,
2. the  m ethylene group is  ad jacen t to  an asymmetric 
centre ,
3. the methylene group is  part o f an a lip h a t ic  chain in  
which there is  re s tr ic te d  ro ta tio n .
The two protons Hft and Hq have a chemical s h i f t  d iffe rence  o f A6AB 
and a gem inal c o u p lin g  cons tan t JA0, where JA0 >> A5AB. This 
s i tu a t io n  g ive s  r is e  to  a p a tte rn  o f fo u r pe rtu rbe d  l in e s  









Partial ^ -n .m .r .  spectrum (at 400 MHz) to il lustrate ab 
quartet pattern of non-equivalent methylene protons in 
trans-N-benzyl-2,5-dicarbomethoxypyrrolidine.
Figure 3
Exam ination o f D re id ing  models o f  the two iso m e ric  forms o f N- 
b e n z y l-2 ,5 -d ic a rb o m e th o x y p y rro lid in e  (76 and 77) suggests th a t 
w h ile  the c is  isomer possesses two equ iva len t protons, in  the trans 
form the two protons are not equ iva len t due to  re s tr ic te d  ro ta tio n  
about the N-CH2 bond. T h ere fo re , the ^ - n .m . r .  da ta o f the major 
isomer is  c o n s is te n t w ith  a c is  s te re o ch e m is try  and th a t o f the  
m inor isomer c o n s is te n t w ith  a tra n s  s te re o ch e m is try . In  accord 
w ith  th is  f in d in g ,  the  ^ - n .m . r .  spectrum o f the  minor isomer 
(trans form) showed fa r greater s igna l com plexity, as expected fo r 
th is  non-symmetrical molecule.
The l3C -n.m .r. and IR spe c tra  fo r  the  c is -isom er were c o n s is te n t 
w ith  the assigned s truc tu re  (76).
Having iso la te d  and characterised cis-N-benzyl-2,5-dicarbom ethoxy- 
p y r ro lid in e , n u c le o p h ilic  reduction o f th is  ester w ith LiA lH^ in  
te tra h y d ro fu ra n  proceeded sm ooth ly y ie ld in g  the a lc o h o l (78; 
Scheme l ) 1^9. L iA lH  ,, is  a po w erfu l reducing agent, capab le  o f  
reduc ing  the  C=0 group in  a ldehydes, ketones, a c id s , e s te rs  and 
amides1*-17. The e f fe c t iv e  reducing agent is  AlH^ which ac ts  as a 
powerful hydride ion, H“ , donor. M echan is tica lly  th is  reduction 
proceeds as shown in  Scheme 4.
69
C -O -C H
H -A IH H -A IH
C H ,O jC
H
C t ° c h
CHjPh ^







The 13C -n.m .r. and IR spe c tra  o f  the reduced p roduct in d ic a te d  
absence o f the ca rb on y l group (no s ig n a ls  a t 6175.9ppm and 1740 
cm-1 re s p e c t iv e ly ) ,  and were c o n s is te n t  w ith  th e  a ss ig n e d  
s tru c tu re .
The ^ -n .m .r . spectrum was consistent w ith a c is  stereochemistry as 
ind ica ted  by a sharp s in g le t at 63.86 fo r  the N-CH2 protons.
This a lcoho l on reaction w ith  th io n y l ch lo rid e  in  toluene gave c is -  
N -b e n z y l-b is (c h lo ro m e th y l)p y r ro lid in e  (7£; Scheme 1) as the  
h y d ro c h lo r id e  s a l t  which separated on a d d it io n  o f  e th e r. Data 
c o l la te d  on th is  compound ( 13C -n .m .r., ^ - n .m . r .  and IR) were 
c o n s is te n t w ith  the assigned s tru c tu re  and s te re o c h e m is try . In  
ad d ition , the m e lting  po in t and s o lu b i l i t y  ch a ra c te r is tic s  o f th is  
c is - is o m e r  c o r r e la te d  w e l l  w ith  re p o r ts  in  th e  p a te n t 
l i te r a tu r e 1^ »1(19.
B. Attempted c y c l iz a t io n  o f c i s - N -b e n z y l-2 ,5 -b is (ch lo ro -
m e th y l)p y rro lid in e  and m -m ethoxyphenylacetonitrile
As o u t l in e d  in  Scheme 1, c y c l i z a t io n  o f  c is -N -b e n z y l-2 ,5 -
b is (ch lo rom e th y l)py rro lid ine  (72) w ith  m -m ethoxyphenylacetonitrile
was expected to  y ie ld  an ep im eric  m ix tu re  o f the  two tropane









However, in  the course o f these studies numerous attempts to e ffe c t 
t h i s  c y c l i z a t io n  f a i l e d  to  g e n e ra te  th e  re q u ire d  tro p a n e  
de riva tive s .
The re a c tio n  was expected to  proceed as o u t l in e d  in  Scheme 5, 
in v o lv in g  the fo rm a tio n  o f the carban ion (81) due to  p ro ton  
e x tra c t io n  by bases such as NaH, NaNH2 or Na m e ta l. Ring 
c y c liz a t io n  by n u c le o p h ilic  a lk y la t io n  would then occur.
Table 7 l i s t s  the c o n d it io n s  and bases used in  th is  attem pted 
unsuccessful c y c liz a tio n . In a l l  cases the reactions y ie lded  dark 
viscous o i ls ,  the t . l . c .  and 13C-n.m.r. spectra o f which showed the 
products  to  be complex m ix tu res  which proved in t r a c t ib le .  The 
p o s s ib i l i t y  th a t a meta p laced  methoxy group h indered carban ion 
formation was inves tiga ted  by u t i l iz in g  p h e n y la c e to n itr ile  in  the 
c y c l iz a t io n .  In  c o n tra s t to  the re p o r ts  by Daum e t a l . , 99 th is  
c y c liz a t io n  (using NaH in  D.M.F.) a lso fa ile d .
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(m ixture o f 79 + $0)
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Table 7 CONDITIONS AND BASES USED IN THE ATTEMPTED UNSUCCESSFUL 
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b: at re flu x  temperature
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F in k le s te in  re a c tion )11^ to  g ive c is -N-benzyl-2,5-b is (iodom ethyl)- 
p y r ro lid in e  (§£), a compound w ith a leav ing  group tha t can be more 
r e a d i ly  d is p la c e d  than c h lo r in e ^ ^ - ,  a ls o  f a i le d  to  e f fe c t  
c y c liz a tio n  w ith p h e n y la c e to n itr ile .
At th is  stage in  the work the s y n th e t ic  approach expressed in  
Scheme 1 was abandoned.
2.2.2 The synthesis of ethyl 3a-(3-hydroxyphenyl)-3£-tropane 
carboxylate and corresponding N-alkylated nortropanes
2.2 .2 .1  In troduction
Fo llow ing the unsuccessful attempt o f the synthesis o f the epimeric 
tropane d e riv a tiv e s  (70) and (71*, Scheme 1), a tte n tio n  was given 
to  the s y n th e t ic  procedure described  by B e l l  and A rc h e r^  on the 





M o d if ic a t io n  o f th is  approach u t i l i z i n g  3-brom oaniso le  was 
undertaken, w ith  the aim o f producing the s in g le  tropane d e r iv a tiv e
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(83*, R=Me). O-Demethyl at ion o f th is  d e r iv a tiv e  would thus y ie ld  




Before considering the synthesis and stereochemistry o f th is  group 
o f compounds, a t te n t io n  w i l l  be g ive n  to  the  co n fo rm a tio n a l and 
con figu ra tion a l analysis o f 3 ,3 -d isu bs titu ted  tropanes.
2 .2 .2 .2  C on fo rm ationa l and c o n f ig u ra t io n a l a n a ly s is  o f 3 ,3 -
d isu bs titu te d  tropanes
The conform ational preference o f the tropane d e r iv a tiv e s  produced
in  th is  work was provided by ana lys is o f the ^ -n .m .r . data.
Assignment o f the a p p ro p ria te  con fo rm ation  to  each tropane 
d e r iv a t iv e  was made by a n a ly s is  o f the w id th  o f h a l f  the maximum 
h e ig h t (W^) o f the  1(5)-H s ig n a l Throughout th is  tropane
s e r ie s  the c o u p lin g  between the 6 (7 )-m ethy lene p ro tons  and the 
1(5)-H is  considered to  be constant. However, the magnitude o f the 
coupling constant (3J) between the 1(5)-H and the 2(4)-H protons in  
the boat and cha ir conformation d if fe rs  considerably.
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The magnitude o f 3J in  th is  tropane series la rg e ly  depends on the 
d ih e d ra l angle (0 ) between the 1(5)-H and the 2(4)-H p ro tons, as 
described by K a rp lu s11^. The re la t io n s h ip  between the co u p lin g  
constant (3J) and the d ihedral angle (00 is  given by:
J =
8.5 cos2 0 -  0.28 0° « 0 « 90°
9.5 C O S2 0 -  0.28 90° 4 0  4 180°
Thus, the coupling constant (3J) depends upon the carbon-hydrogen 
bond angle (see F ig .4).
3J
Figure 4: Relationship between the d ihedra l angle 0, and
v ic in a l coupling constants
In the cha ir conformation (84), the couplings are sm all (F ig .5) and 
hence the 1(5)-H resonance signal is  na rro w -^ .
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NEWMAN PROJECTION 





However, in  the  boat con fo rm a tion  (85), the 1(5)-H and 2(4)-H  
protons are eclipsed and so the coupling is  la rge , g iv in g  r is e  to  a 
broad 1(5)-H resonance s igna l (F ig .6)116.
NEWMAN PROJECTION 






To i l lu s t r a t e  the a p p lica tio n  o f these p r in c ip le s , model boat and 
cha ir tropanes are presented below.
Tropine (86), pseudotropine (87) and 38-phenyltropan-3a-ol (88) are 
considered  to  e x is t  in  a p re fe rre d  c h a ir  co n fo rm a tio n 117” 121. 
Examination o f the respective  l H-n.m.r. spectra revealed tha t the 
v a lu e  o f the 1(5)-H resonance was in  the  range 9 -  10Hz, and 
th e re fo re  is  taken to  be d ia g n o s tic  o f  a tropane d e r iv a t iv e  
e x is tin g  in  a cha ir (or fla tte n e d  cha ir) conformation122.







3 a -P h en y l-3 8 .-tro pa n y lp he n y lke to n e  (89) is  considered to  be a
tropane d e r iv a tiv e  th a t e x is ts  in  a boat conformation (U.V. and IR 
ev id e n ce )12-5. The ^ - n .m . r .  spectrum d is p la y e d  a 1(5)-H s ig n a l 





With the a v a i la b i l i t y  o f 400MHz l H-n.m.r., fu r th e r in form ation to  
substan tia te  the assigned conformation was achieved by ana lys is  o f 
the  resonance appearance o f  the  a x ia l  2(4)-H s ig n a l.  V ic in a l  
coupling in  the boat is  la rge  w h ile  in  the cha ir i t  is  sm a ll.
^ - n .m . r .  and 13C -n.m .r. spectroscopy a ls o  p ro v id e s  evidence in  
r e la t io n  to  the  c o n f ig u ra t io n  a t C-3, th a t is ,  the  na tu re  o f  the  
a x ia l ly  o rien ta ted  group. This ana lys is  is  based on the chemical 
s h i f t  d if fe re n c e  (A) between the  exo and endo 6 (7 )-m e thy lene  
p ro tons  in  the  ^ - n .m . r . ,  and the  chem ica l s h i f t s  o f  the C6C7 
carbon resonance in  the l3C-n.m.r.
The f o l lo w in g  exam ples i l l u s t r a t e  how e s ta b l is h in g  th e  
c o n f ig u ra t io n  was undertaken us ing  ^ - n .m . r .  spectroscopy. The 
a p p lic a t io n  o f  13C -n.m .r. in  c o n f ig u ra t io n a l assignments is  
discussed on pages 93 and 100.
The in fluence  o f an a x ia l ly  o rien ta ted  hydroxy group at 
C-3 on the 6 (7)-m ethy lene  p ro tons can be d iscerned by 
examination o f the ^ -n .m .r . data (notab ly the resonance 
p o s it io n  o f the  6(7)-hydrogens) fo r  t ro p in e  (86) and 
pseudotropine (87). In trop ine  (86), w ith  an a x ia l 3-OH, 
the endo 6 (7 )-p ro to n s  are desh ie ld ed  and hence are 
separated from the exo 6 (7 )-p ro to n s . In  pseudotrop ine
(87), w ith an equa to ria l 3-OH, th is  separation o f s igna ls  
is  not seen*-^’ *2^
S im ila r  c o n s id e ra tio n  o f the  resonance p o s it io n  o f the 
6(7)-methylene hydrogens in  3 -s u b s t itu te d  tropanes w ith  
an a x ia l C-3 carbonyl group (as in  a ketone or an ester) 
a llo w s  i t s  o r ie n ta t io n  to  be con firm ed . In  the a x ia l 
o r ie n ta tio n  i t  exerts a deshie ld ing in f lu e n c e *^  on the 
endo 6 (7 )-p ro to n s  as a r e s u l t  o f  magnetic a n is o tro p ic  
e f f e c t s  th a t  a re  induced^-2^ . in  th e  e q u a to r ia l  
o r ie n ta t io n ,  the ca rbo n y l group would no t e x e rt th is  
deshie ld ing in flu ence . A pp lica tion  o f th is  fin d in g , as 
in  a-ecgonine ester (90), is  considered on page 88.
Examination o f the ^ -n .m .r . data to  e lu c id a te  the e ffe c t 
o f  an a x i a l l y  o r ie n ta te d  a ro m a tic  -r in g  in  3 ,3 -  
d is u b s t itu te d  tropanes in d ic a te s  a s h ie ld in g  e ffe c t on 
the endo 6(7)-protons127. j n th is  a x ia l o r ie n ta tio n , the 
plane o f the aromatic r in g  is  a t r ig h t  angles to  a plane 
passing through n itro g e n  and C-3 o f the  p ip e r id in e  






Using these p r in c ip le s , i t  was poss ib le  to  e lu c id a te  the nature o f 
the a x ia l group at C-3 in  the tropane series synthesised.
2 .2 .2 .3  Synthesis and stereochem istry
The proposed route o f synthesis fo r e th y l 3a-(3-hydroxyphenyl)-3$- 
tropane ca rboxy la te  (7JD) and some o f i t s  d e r iv a tiv e s  is  o u tlin e d  in  
Scheme 6.
A. E thy l 3a-(3-methoxyphenyl)-36-tropane carboxyla te
As a s t a r t i n g  p o in t  f o r  th e  s y n th e s is  o f  e t h y l  3 a - (3 -  
m e th o xyph e n y l)-3 £ -tro p a n e  carboxyla te  i t  was necessary to  prepare 
a -ecgon ine  m ethy l e s te r  (9 0 )129. The s y n th e t ic  ro u te  which 
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Scheme 7
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An a c id ic  s o lu t io n  o f  tropan -3 -one  was tre a te d  w ith  potassium  
cyanide to  g ive  tropinone cyanohydrin (91). Acid ic hyd ro lys is  o f 
th is  cyanohydrin afforded a-ecgonine (9?), which on treatment w ith 
m e than o lic  hydrogen c h lo r id e  fu rn is h e d  the d e s ire d  a-ecgonine 
m ethyl e s te r (90). S y n th e tic  problems were encountered in  the 
h y d ro ly s is  o f tro p in o n e  cyanohydrin . Procedures recorded in  the 
l i te r a tu r e 129 suggested tha t hyd ro lys is  could be achieved by the 
a c tio n  o f concen tra ted  HC1 fo r  18 hours a t room tem pera tu re . 
However, th is  proved most u n s a t is fa c to ry , g e n e ra ting  m ix tu res  o f 
s ta r t in g  cyanohydrin  and a-ecgon ine amide ( ^ ;  t h is  amide is  
interm ediate in  the hyd ro lys is  o f the cyanohydrin to  the acid -  see 
Scheme 8). To overcome th is ,  an IR study o f the products obtained 
under varying conditions o f temperature and time was performed, the 





From th is  da ta , i t  was e s ta b lis h e d  th a t h y d ro ly s is  o f  tro p in o n e  
cyanohydrin w ith concentrated HC1 proceeded smoothly a t 80°C fo r a 
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Scheme 8
- 87 -
Table 8 The e f fe c t  o f  tem perature and tim e on the 
h y d r o ly s is  o f  t ro p in o n e  c y a n o h y d r in  (by 
concentrated HC1) to  a-ecgonine









25 “C 24 hrs 1690 cm-1 
1730 cm’ 1
Mixture o f 
amide (93) 
and acid- (92)
40°C 30 hrs 1690 cm '1 
1750 cm’ 1
Acid (92) and 
Amide (93)
80°C 6 hrs 1690-1700 cm’ 1 
1750 cm’ 1
Acid (92) and 
Amide (93)
80°C 12 hrs 1700 cm-1 
1750 cm’ 1
Acid (92) and 
Amide [93)
80°C 24 hrs 1690 cm” 1 (weak) 
1760 cm’ 1
Acid (92) w ith 
small quantity  
o f Amide (Sg)
80°C 48 hrs 1750-1760 cm” 1 Acid (92)
The l3C -n .m .r., l H -n.m .r. and IR sp e c tra  were c o n s is te n t w ith  the 
assigned s tru c tu re .  The 13C-n.m .r. spectrum (Tab le  14, N o .l) 
showed sharp peak s ig n a ls  fo r  the C ^ s ,  and C6C7 p a irs  o f
carbons, a c h a ra c te r is tic  tha t is  in d ic a tiv e  o f a plane o f symmetry 
in  th is  compound, and a feature tha t a l l  the tropane d e riv a tiv e s  
in  th is  syn the tic  sequence show. The ^ -n .m .r . spectrum (Table 13,
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N o .l) p e rm its  an a n a ly s is  o f the con fo rm a tion  o f th is  tropane 
d e r iv a tiv e  to  be made (the conform ational ana lys is  o f th is  tropane 
d e r iv a t iv e ,  and o th e r tropanes syn thes ised  in  the course o f th is  
work, was p ro v id e d  by a p p lic a t io n  o f the  p r in c ip le s  o u t l in e d  in  
S ection  2 .2 .2 .2 , page 75). The 1(5)-H resonance a t 53.22 w ith  
W^=16Hz suggests tha t the boat conformation (94) is  s ig n if ic a n t ly  
popu la ted  in  CDC13. Furtherm ore, the  0-H s ig n a l a t 55.50 is  in  
accord w ith  the proposed in tram o lecu la r hydrogen bonding1^ .  While
th is  evidence supports  a boat co n fo rm a tion ,, a fe a tu re  o f the 
xH-n.m .r. spectrum th a t is  d ia g n o s tic  o f c o n tr ib u t io n s  from the 
c h a ir  con fo rm a tion  is  seen by exam ina tion o f the s ig n a ls  fo r  the 
6(7)-methylene protons. The two 2-proton m u lt ip le ts  representing 
the  6 (7)-m ethy lene  pro tons are cen tred  near 51.55 and 1.95 
(A=0.4ppm). This la rge  chemical s h i f t  d iffe rence  (A) is  in d ic a tiv e  
o f a cha ir conformation as i t  suggests th a t the two endo 6(7)-H are 
de sh ie lded  by the ca rb on y l fu n c tio n  o f the  e s te r ( e f fe c t  through 
space -  ’an iso tro p ic ’ 12**) to  a greater extent than th a t experienced 
by the exo protons (see 95)125.










F in a lly ,  the IR spectrum showed strong in tram o lecu la r absorption at 
3300 cm“ l in d ica tin g  N • • • -H-0 bonding.
Reaction o f a-ecgon ine m ethyl e s te r w ith  the G rignard reagent 
d e riv e d  from 3 -b rom oan iso le  and magnesium a ffo rd e d  3 a -b is (3 - 
m ethoxypheny l)hyd roxym ethy l-3 j3 -tropano l (96, Scheme 6 ) in  h igh 
y ie ld .
Confirmation o f the s tru c tu ra l features o f th is  d io l was achieved 
using 1 3C-n.m.r. and ^ -n .m .r . spectra. The 1 3 C-n.m.r. spectrum in  
CDCI3 (Table 14, No.2) showed s ix  l in e s  in  the arom atic  re g ion  
(each re p re se n tin g  two carbons as judged by s ig n a l in te n s i ty )  
in d ica tin g  the symmetrical nature o f th is  molecule and o f the two 
a rom atic  r in g s . The spectrum d is p la y e d  one qua te rna ry  carbon 
s ig n a l in  the a l ip h a t ic  re g ion  in s te a d  o f  the expected two, a 
fe a tu re  a t t r ib u te d  to  s ig n a l o v e r la p , bu t the spectrum ob ta ined 
from a sample in  methanol (Table 14, No.3) revealed both quaternary 
carbon atoms.
90
The ^ -n .m .r . spectrum o f the d io l (96) as the hydrochloride in  D20 
(T a b le l3 , No.2), d is p la y e d  a 1(5)-H resonance a t 53.80 w ith  
W^=17Hz, evidence th a t th is  tropane d e r iv a t iv e  e x is ts  in  a boat 
con fo rm ation  (97). The a -2 (4 )-H  and 3.-2(4)-H s ig n a ls  ove rlapped
and were poorly  reso lved, although such a s im i la r it y  in  chemical 
s h i f t  is  ev idence in  fa vo u r o f both se ts  o f  p ro tons  being in  
s im ila r  environments. The 6(7)-methylene protons formed a pa ir o f
9
2-proton m u lt ip le ts  w ith A=0.24 ppm, evidence suggesting tha t the 
exo and endo pa irs  o f protons are in  s im ila r  chemical environments, 
an u n lik e ly  fin d in g  i f  the cha ir con tribu ted to  the conformational 
eq u ilib riu m .
Th is ev idence , su p po rtin g  the boat con fo rm a tion  o f the d io l  
hydrochloride (9J), is  in  accord w ith previous l3C-n.m.r. studies 
o f  3 a -d ip h e n y lh y d ro x y m e th y l-3 8 -tro p a n o l (£8) and the e f fe c ts  o f
protonation1^1.
o c h 3
(92)
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Treatment o f 3ot-b is  (3-me thoxypheny l)h y d ro x y  m e th y l-3 6 -tro p a n o l 
hydrochloride (97) w ith zinc ch lo rid e  and ace tic  anhydride y ie lded  
impure 3a -(3 -m ethoxypheny l)-33 -tropany l(3 -m ethoxypheny l)ke tone  
(99*, Scheme 6 ). M echan is tica lly , th is  rearrangement is  considered 
to  proceed as o u t l in e d  in  Scheme 91*5^ . The mechanism i n i t i a l l y  
in vo lve s  the c a ta ly t ic  formation o f the ^-epoxide ( 1 0 0 ) under the 
in f lu e n c e  o f z in c  c h lo r id e .  The rearrangem ent o f  the 8_-epoxide 
then proceeds w ith  an in v e rs io n  o f the s te re o ch e m is try  a t C-3 to  
g ive the ketone (£9). Evidence fo r the formation o f the 6 -epoxide 
in  th is  mechanism was reported by B e ll and Archer9 7  during studies 
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P u r i f ic a t io n  o f the ketone a t th is  stage was not undertaken as 
ra p id  darken ing and decom position o f the o i l  occu rred ; hence i t  
was used immediately in  the synthesis o f the oxime ( 1 0 1 ).
C h a ra c te r is a tio n  o f the ketone was based on 1 3 C -n.m .r. and IR 
ev idence , both o f which were c o n s is te n t w ith  s t ru c tu re .  One 
n o ta b le  fe a tu re  o f the l 3C -n.m .r. data (Tab le  14,' No.4 ), which 
enabled the c o n f ig u ra t io n  o f the ketone to  be con firm ed , was the 
re so n a tin g  p o s it io n  o f  the C6 C7 s ig n a l.  Daum e t a l . "  re p o rte d  
1 3 C -n.m .r. data fo r  the two ep im eric  tropane d e r iv a t iv e s  (89) and 
(102). The chem ical s h i f t  fo r  the C6 C7 carbons in  these two 






Ph C = 0
Ph
( 8 ?) (102)
In  the ketone (99), the C6 C 7 re so n a tin g  p o s it io n  was 29.04 ppm. 
Th is chem ical s h i f t  c o r re la te s  w e l l  w ith  the c o n f ig u ra t io n  
displayed by (89).
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Synthesis o f the oxime (1Q1):
The syn th e s is  o f  the oxime (101) was e ffe c te d  by tre a tm e n t o f 3a- 
(3 -m ethoxypheny l)-33 .-tropany l(3 -m e thoxypheny l)ke tone  (99) w ith  
hydroxylamine hydrochloride in  p ro p a n -l-o l and p y rid ine  (Scheme 6 ). 
P y r id in e  is  used in  th is  re a c tio n  to  l ib e r a te  the re a c t iv e  fre e  
hydroxylam ine by form ing p y r id in e  h y d ro c h lo r id e . The fo rc in g  
c o n d it io n s  o f th is  re a c tio n  th a t were necessary to  e f fe c t  oxime 
formation were associated w ith s te r ic  hindrance impeding access o f 
hydroxylamine to  the re a c tive  C=0.
The ^ - n .m . r . ,  1 3 C -n.m .r. and IR sp e c tra  o f  the  oxime were
c o n s is te n t w ith  s tru c tu re  (101). The ^ - n .m . r .  spectrum (base in  
CDC13 •, Table 13, No.3) provided c le a r evidence o f the preferred 
conformation o f th is  tropane d e r iv a tiv e . The 1(5)-H resonance a t
63.22 w ith  Wj5=1 1 Hz supports  the c h a ir  form as the  favoured 
conformation. The a- and 2(4)-H s ig n a ls  were w e ll reso lved and 
showed very sm all v ic in a l coupling, a fin d in g  a lso  in  accord w ith a 
cha ir conformation. Both s igna ls  were to  low f ie ld  o f the N-methyl 
resonance, a feature a ttr ib u te d  to  desh ie ld ing o f the a-2(4)-H by 
an a x ia l  a rom atic  r in g 1-5-5, and the 0_-2(4)-H by the  C=N. The 6 (7 )- 
methylene hydrogens formed two 2-proton m u lt ip le ts  centred a t 61.34 
and 1.65. The chemical s h i f t  d iffe rence  (A0.31 ppm) is  in d ic a tiv e  
o f a sh ie ld ing  e ffe c t experienced by the endo hydrogens due to  an 
a x ia l l y  o r ie n ta te d  arom atic  system127. This sh ie ld in g  e ffe c t is  
exerted when the plane o f the aromatic r in g  is  a t r ig h t  angles to a 
plane passing through n itrogen and C-3 o f the p ip e rid in e  r in g 12®. 
Th is s h ie ld in g  e f fe c t  would be absent i f  the oxime e x is te d  in  a 
boat conformation.
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One n o ta b le  c h a ra c te r is t ic  o f  the  1 3 C -n.m .r. spectrum (Tab le  14, 
No.5) was the presence o f a s igna l a t 5162.7 ppm, a ttr ib u te d  to  the 
oxime C=N. Th is was assigned w ith  the a id  o f the INEPT programme 
and chemical s h i f t  c o rre la tio n s  and compares w ith the C=0 s h i f t  at
6173.2 ppm in  the s ta r t in g  m a te ria l.
The IR spectrum o f (101) showed strong absorption at 3100-3500 cm” 1 
fo r  the  h y d ro x y l group and the com plete absence o f  a b so rp tio n  a t 
1780 cm” 1, th is  la t te r  being a feature associated w ith  the s ta r t in g  
ketone.
Beckmann rearrangement o f the oxime (101):
The Beckman rearrangem ent^-^ , a ge ne ra l re a c tio n  o f oximes, 
consists o f the conversion o f an oxime in to  an amide.
R R C = N -O H  -----► R-CONHR + R-CONHR
The re a c tio n  is  c a ta ly s e d  by a wide v a r ie ty  o f a c id ic  reagents 
in c lu d in g  H jSO,*, S0C1 2, PC15 , BF3 and H C l|C H 3 C00H. The 
rearrangem ent, o u t l in e d  m e c h a n is t ic a lly  in  Scheme 10, in v o lv e s  




h o n M
. X = N .
II
R
^ C -N H R
Scheme 10
water from the p ro tona ted  oxime. The i n i t i a l l y  formed c a tio n  
re a c ts  w ith  water to  g iv e  the eno l form o f an amide, which then 
re v e r ts  to  the amide p roper. The Beckmann rearrangem ent is  a 
s te re o s p e c if ic  re a c tio n , the  group th a t m ig ra tes be ing the one 
which is  tra n s  (a n t i ) to  the hydroxy group in  the oxime (R in  
Scheme 10)1-5-5.
When the oxime (1Q1) was sub jec ted  to  the a c tio n  o f  hydrogen 
c h lo r id e  in  hot a c e tic  ac id  i t  was converted  d i r e c t ly  to  3 a -(3 - 
m ethoxyphenyl)-3 jB -tropane c a rb o x y lic  acid hydroch loride (103) in  
good y ie ld .  The a n i l id e  (104), the expected p roduct o f the 
Beckmann rearrangem ent, was c lea ved  under these circumstances to 
















The ^ - n .m . r .  spectrum o f th is  ac id  (1Q3; Table 13, No.4) was 
consistent w ith  the s tru c tu re  assigned and allowed ana lys is  o f the 
conformation and re la t iv e  con figu ra tion  o f th is  tropane d e r iv a tiv e  
to  be made. The 1(5)-H resonance a t 53.93 w ith  W^=llHz supported 
the  c h a ir  as the p re fe rre d  con fo rm a tio n . The a -  and 0-2(4)-H  
p ro tons showed s m a ll v ic in a l  c o u p lin g  as expected fo r  th is  
co n fo rm a tion . A n a ly s is  o f  the resonance s ig n a ls  fo r  the  exo and 
endo 6 (7)-m ethy lene p ro tons a t 61.89 and 1.59 re s p e c t iv e ly  
(A=0.3 ppm) ind ica ted enhanced sh ie ld in g  o f the endo protons by an 
a x ia l ly  o rien ta ted  aromatic system1^
The IR and 1 3 C -n.m .r. were a ls o  c o n s is te n t w ith  s tru c tu re .  Thus, 
the IR spectrum showed carbonyl absorption at 1730 cm-1 , a feature 
assoc ia ted  w ith  c a rb o x y lic  a c id s , w h ile  com plete absence o f 
a b so rp tio n  in  the range 1630-1680 cm" 1 (a n t ic ip a te d  ca rbon y l 
a b so rp tio n  o f  a secondary amide) v e r i f ie d  th a t h y d ro ly s is  o f the 
in te rm e d ia te  amide had o c c u rre d . The 1 3 C -n .m .r . spe c trum  
(Table 14, No.6 ) d is p la y e d  o n ly  seven s ig n a ls  in  the a rom atic  
re g io n , which was in d ic a t iv e  o f one a rom a tic  r in g  (and C=0 ) and 
evidence o f hyd ro lys is  o f the amide occurring.
E s te r if ic a t io n  o f the ca rboxy lic  acid (103) w ith  e thano lic  hydrogen 
c h lo r id e  fu rn is h e d  e th y l  3 a -(3 -m e th o x y p h e n y 1 )-3 g -tro p a n e  
c a rb o x y la te  h y d ro c h lo r id e  (105; Scheme 6 ). The l H -n .m .r., 1 3 C- 
n.m.r. and IR spectra o f th is  ester were consistent w ith  s tru c tu re , 
and the 1 H- and 1 3 C-n.m .r. p ro v id e d  evidence r e la t in g  to  the 
stereochemical features o f (1Q5).
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As th is  e s te r is  a key compound in  the syn th e s is  o f the p h e n o lic  
tropane analogues, a tte n tio n  w i l l  be given to  the stereochemical 
and s tru c tu ra l features associated w ith i t .
The ^ -n .m .r. spectrum o f the ester as the base in  CDC13 (Table 13, 
No.5) suggested tha t the boat conformation '(106) was s ig n if ic a n t ly  
po pu la ted . The 1(5)-H resonance a t 63.19 and w ith  W^=16Hz 
supported th is  deduction. The resonance o f the 3-2(4)-H centred at 
53.06 displayed v ic in a l coupling in  the range 7-8Hz, in d ic a tiv e  o f 
a degree o f e c lip s in g  o f the 8-2(4)-H and the 1(5)-H protons. The 
a -2 (4 )-H , cen tred  a t 51.81, d isp la ye d  gem inal c o u p lin g  o n ly , as 
v ic in a l coupling was too sm all to measure, see F ig .8 .
CH3
\





[viewed along 1,2 bond]
Figure 8
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The la rg e  chem ical s h i f t  d if fe re n c e  between the a- and fr- 2(4)-H 
pro tons is  a t t r ib u te d  to  d e s h ie ld in g  o f the ^ -p ro to n s  by the 
ca rbo n y l o f the e s te r group1^ 5. The exo and endo 6(7)-H  s ig n a ls  
were separated a t 61.38 and 1.96 re s p e c t iv e ly  (A=0.58 ppm), a 
feature d iagnostic  o f some co n trib u tio n  o f the cha ir Conformation
(103)’, th a t is ,  endo protons are sh ie lded to a greater extent than 
exo protons as a re s u lt  o f an a x ia l aromatic system (see discussion 
on oxime; page 94)127. In  a d d it io n ,  th is  f in d in g  con firm s the 
re la t iv e  con figu ra tion  o f the ester (see l 3C-n.m.r. d iscussion).
At th is  p o in t ,  c o n firm a tio n  o f the s u b s t i tu t io n  p a tte rn  in  the  
a rom atic  r in g  is  p o s s ib le . The rearrangem ent o f  the d io l  
h y d ro c h lo r id e  (97) to  the ketone (^9; page 91) assumed th a t the 
t ra n s fe r  o f  the arom atic  r in g  from C-OH to  C-3 m a in ta in s  a meta 
s u b s titu tio n  pa tte rn . Figure 9 i l lu s t r a te s  the evidence in  support 
o f th is  meta s u b s t i tu t io n  p a tte rn  in  the arom atic  r in g  based on a 
c o n s id e ra tio n  o f the c o u p lin g  p a tte rn  experienced by the protons 
Ha , H0 , Hq and Hp.
1 3 C-n.m .r. evidence in  support o f the a x ia l  a rom a tic  system was 
p ro v id e d  by the C £ 7 carbon resonance (Tab le  14, No.7). Data on 
the two epimeric tropane analogues (67) and (107) o f pe th id ine has 
been re p o r te d " , and a s ig n if ic a n t d iffe rence  in  the C6C7 resonance 
noted. The e s te r (1Q5) d isp la ye d  a C6C7 resonance a t 627.63 ppm 
and hence the assigned con figu ra tion  in v o lv in g  an a x ia l aromatic 
r in g  is  substantia ted.
t r ip le t
Figure 9
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Jo = ortho coupling 
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B. S y n th e s is  o f  e th y l  3 a -(3 -h y d ro x y p h e n y l) -3 8 -tro p a n e
carboxylate (70) by O-demethylation 
The syn th e s is  o f  the p h e n o lic  t e r t ia r y  amine (70; Scheme 6 ), one 
o f  th e  main aims o f  t h i s  p re s e n t w ork , was a c h ie v e d  by 
O -d e m e th y la t io n  o f  e th y l  3 a -(3 -m e th o xyp h e n y  1 )-3 (3 -tropane  
carboxylate w ith  boron trib rom ide1-56.
Acid ha lides and anhydrides in  the presence o f m e ta llic  ha lides as 
c a ta ly s ts  have been used to  e f fe c t  e th e r c le a v a g e 1-57. Boron 
c h lo r id e ,  however, has been shown to  c le a v e  e th e rs  even in  the 
absence o f acid ha lides and anhydrides1-5®. The marked a b i l i t y  o f 
boron h a lid e s  to  form complexes w ith  e th e rs , and the  ease w ith  
which etherates w ith boron c h lo r id e  d is p ro p o r t io n a te , le d  to  the 
assumption tha t boron trib rom ide might prove a s u ita b le  reagent fo r 
c lea v ing  ethers. Studies have shown th is  to be the case1-56, w ith  
the re s u lts  in d ica tin g  th a t no mixtures o f products were produced 
in  the course o f the ether cleavage. The reaction  is  considered as
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proceeding in  two s te p s 1 ^ 9  as o u t l in e d  in  Scheme 12, and has been 
used in  the O-demethylation o f codeine to  morphine1^0.
3R—O—Me + BBr3  - (RCj)3 B+3MeBr
3R -O H  + H3BO3
Scheme 12
The O-demethylation o f the te r t ia ry  amine (105) proceeded smoothly 
y ie ld in g  e th y l 3a-(3-hydroxyphenyl)-38-tropane carboxyla te  (70) as 
a clean product in  poor y ie ld .
The spectra l data obtained fo r th is  phenolic tropane d e r iv a tiv e  was 
c o n s is te n t w ith  i t s  assigned s tru c tu re .  Thus, the  l 3C -n.m .r. 
showed absence o f an 0-CH3 s ig n a l,  and the  IR spectrum  showed 
strong absorption at 3300 cm _ 1  associated w ith  the presence o f the 
phenolic OH.
The ^ -n .m . r .  spectrum was con s is te n t w ith  s tru c tu re  and provided 
evidence o f the stereochemical features o f th is  tropane d e r iv a tiv e . 
The base in  CDC1 3 (Table  13, No.6 ) d is p la y e d  a 1(5)-H s ig n a l a t
63.23 w ith  Vfe=12Hz, evidence su p p o rtin g  the  c h a ir  as the most 
s ig n if ic a n t ly  populated conformer. The exo and endo 6(7)-methylene
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pro tons were w e l l  separated (A=0.44 ppm) in  accord w ith  an a x ia l 
aromatic r in g  exerting  a sh ie ld in g  e ffe c t on the endo protons1^7.
The ^ -n .m .r . spectrum o f th is  tropane d e r iv a tiv e  hydroch loride in  
D20 a ls o  confirm ed the c h a ir  as the favoured  con fo rm a tion . The 
1(5)-H resonance f e l l  near the h ig he r f i e l d  l in e s  o f the 0CH2CH3 
q u a rte t, but was s u f f ic ie n t ly  re s o lv e d  a t 400MHz to  pe rm it the 
measurement o f W^ =8 Hz. Examination o f the resonance s igna ls  fo r the 
a- and J3- 2(4)-H  in d ic a te d  th a t no la rg e  v ic in a l  c o u p lin g  was 
present, fu rth e r support o f the cha ir conformation.
C. S ynthes is  o f e th y l 3a-(3 -m ethoxyphenyl)-38r nortropane
carboxylate (1Q8 ) by h l-dea lky la tion
In  th is  work, the secondary amine (108; Scheme 6 ), a key compound
in  th e  s y n th e s is  o f  a w ho le  s e r ie s  o f  N - a lk y la te d  3 a - (3 -  
m ethoxyphenyl)-3 j5-nortropane carboxylates and th e ir  corresponding 
phenolic analogues, was obtained by N-demethylation o f the te r t ia r y
amine (105) w ith  2 , 2 , 2 -tr ich lo ro e th y lch lo ro fo rm a te 141.
Chloroformate esters, such as e th y l14^, phenyl1 4 -5 and v in y l144*145, 
have been used fo r N-demethylations and have been reported to g ive  
good y ie ld s  and clean products. However, the use o f these reagents
is  l im ite d  as the in te rm e d ia te  carbamates produced du rin g  the 
re a c tio n  are re s is ta n t  to  h y d ro ly s is  and demand long pe riods  o f 
r e f lu x  w ith  s tro n g  ac ids or bases to  y ie ld  the correspond ing  
secondary amine, conditions not to le ra te d  by acid or base la b i le  
compounds141. The use o f 2 ,2 ,2 - t r ic h lo ro e th y lc h lo ro fo rm a te  
overcomes th is  problem  as the in te rm e d ia te  carbamate formed
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undergoes fa c i le  hyd ro lys is  at room temperature in  the presence o f 
zinc and ace tic  acid. M echan is tica lly  the reaction  is  o u tlin e d  in  
Scheme 13.
The JN-dem ethvlation o f e th y l 3 a - ( 3 -m ethoxypheny l)-3 jJ -tropane 
carboxylate proceeded smoothly y ie ld in g  the corresponding secondary 
amine (108) in  good y ie ld .
The l H -n.m .r. and l 3C -n.m .r. spe c tra  o f  the  r e s u l t in g  secondary
amine were consistent w ith s tru c tu re , both showing absence o f an N-
m ethyl s ig n a l.  The l H -n.m .r. data (T ab le  15, N o .l)  d is p la y e d
c h a ra c te r is tic  features associa ted  w ith  the  c h a ir  form being the
most s ig n if ic a n t ly  populated in  th is  nortropane. Thus, the 1(5)-H
s ig n a l a t 64.21 w ith  W^=11.5Hz is  ev idence o f  s m a ll v ic in a l
c o u p lin g  w ith  the 2(4)-H p ro tons and, a d d i t io n a l ly ,  the  a -2 (4 )-H
and £-2(4)-H resonances a t 62.96 and 2.82 re s p e c tiv e ly  on ly showed
la rge  geminal coupling . The chemical s h i f t  d iffe rence  o f the a-and
&-2(4)-H was sm a ll, in d ic a tiv e  o f desh ie ld ing  being exerted on both
se ts  o f  p ro tons (a-H desh ie lded  by a x ia l  a rom atic  system*-55, £-H 
+ 125desh ie lded  by NH and COaEt ). Furtherm ore, the  exo and endo 
6(7)-methylene protons were w e ll separated (A=0.37 ppm), evidence
to  substantia te an a x ia l aromatic r in g  (as a re s u lt  o f an enhanced
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D. S ynthesis  o f e th y l fc J -a lly l-3 a -(3 -m e th o x y p h e n y l)-3 £ -
n o r t r o p a n e  c a r b o x y la t e  ( 1 L 3 ) ,  e t h y l  N- 
(cyclopropylmethyl)-3a-(3-methoxyphenyl)-33>-nortropane 
c a r b o x y la te  (1 L 0 ) , e th y l  3 a -(3 -m e th o x y p h e n y l)-N - 
ph e ne th y l-3 £ -n o rtro p a n e  c a rb o x y la te  (1Q9) and t h e i r  
phenolic analogues 
The syn th e s is  o f  the two tropane d e r iv a t iv e s  (109) and (1^,0; 
Scheme 6 ) was achieved by d ire c t a lk y la t io n  o f the secondary amine 
(108) w ith  the appropriate a lk y l h a lid e . This a lk y la t io n  is  o f the 
n u c le o p h ilic  category proceeding v ia  an SN2 mechanism as o u tlin e d  
in  Scheme lA 14^.
R = CH2Ph
or
(108) +  R_ C H 2- B r
Bi\ H |
- L h  


























I t  was f o r t u i t o u s  th a t  th e  use o f  p h e n e th y l b rom ide  and 
cyclopropylm ethyl bromide succeeded in  generating the two required 
t e r t ia r y  amines (1&9) and (110). The a l te r n a t iv e  method fo r  the 
in tro du c tio n  o f such N -a lky l groups in vo lve s  the synthesis o f the 
amides ( 1 1 1 ) and ( 1 1 2 ) by re a c tio n  w ith  phenacety l c h lo r id e  or 
cyc lop ropane c a rb o x y lic  ac id  re s p e c t iv e ly ,  fo llo w e d  by L iA lH ^ 
reduction to  the amine. Such an approach would not be to le ra te d  in  
t h is  s y n th e t ic  s e r ie s  as c o n c o m ita n t re d u c tio n  o f the 3jJ- 
carboethoxy group would occur (Scheme 15).
Reaction o f the secondary amine (108) w ith  a l l y l  bromide afforded 
(U 3 ) . Owing to  possib le a l l y l i c  rearrangements o f a l l y l  bromide, 
the nuc leoph ile  (108) may attack the ^-carbon instead o f the usual 
a-carbon v ia  a SN2’ mechanism1 ^ 7  (Scheme 16).








I t  is  suggested tha t th is  SN2’ mechanism is  more appropriate than 
the c o n v e n tio n a l SN 2  mechanism when b u lk y  n u c le o p h ile s  are 
em p loyed , s in c e  th e  s t e r i c  h in d ra n c e  a t  th e  ^ -c a rb o n  is  
considerably less than at the a-carbon.
C h a ra c te r is a tio n  o f these th ree  d e r iv a t iv e s  was based on the  
s p e c tra l data ob ta ined . The l 3C -n .m .r., ^ - n .m . r .  and IR sp e c tra  
were c o n s is te n t w ith  the assigned s tru c tu re s  and n o ta b ly  the 
l 3C-n.m.r. spectra displayed carbon s igna ls  fo r the appropriate N- 
a lk y l group (Table 16, Nos. 2, 4, 6 ).
The l H -n .m .r. d a ta  p ro v id e d  e v id e n c e  in  r e la t i o n  to  th e  
s te reochem ica l fe a tu re s  assoc ia ted  w ith  these th ree  tropane 
d e r iv a t iv e s  (Tab le  15, Nos. 2, 4, 6 ). Exam ination o f the 1(5)-H 
resonance s ig n a l in d ic a te d  th a t the th ree  tropane d e r iv a t iv e s  
e x is te d  in  the c h a ir  con fo rm a tion . The W^value was w ith in  the 
range 10 to  13Hz s ig n ify in g  tha t v ic in a l coupling w ith the 2(4)-H 
protons was sm a ll. Furthermore, the resonance o f the exo and endo 
6(7)-methylene protons in  a l l  three d e riv a tiv e s  were w e ll separated 
in  accord w ith a cha ir conformation.
0-Demethylation o f the three N -a lky la ted  nortropanes (109), (110) 
and (113) w ith  boron tr ib ro m id e 1 -5 6  y ie ld e d  the co rrespond ing  
phenolic analogues (1^4), (115) and (116*, Scheme 6 ). The y ie ld  o f 
these phenolic tropane d e riv a tiv e s  was poor, a fin d in g  experienced 
in  the O -dem ethy la tion  o f  the tropane (105; page 102). The 1 3 C- 
n.m.r. and ^ -n .m .r . o f these three d e riv a tiv e s  was consistent w ith  
s tru c tu re , the notable feature being absence o f the s ign a l fo r the
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0-CH3.
The cha ir conformation can be assigned to a l l  three d e r iv a tiv e s  on 
the ba s is  o f ^ - n .m . r . ,  w ith  Vfeof the  1(5)-H resonance being .in  
the range 10 to  12Hz. Other features o f the ^ -n .m .r . spectra were 
consistent w ith th is  conformation.
E. S ynthesis  o f e th y l J ]J -(2 -benzoy le thy l )-3a -(3 -m e tho xy -
p h e n y l)-3 £ -n o rtro p a n e  c a rb o x y la te  and i t s  p h e n o lic
analogue
The synthesis o f e th y l Nr (2-benzoylethyl)-3a-(3-m ethoxyphenyl)-38- 
nortropane carboxylate (li,7*, Scheme 6 ) was achieved by a Michael 
re a c t io n 1 ^ 8 " 1 5 0  o f  the secondary amine (108) w ith  phenyl v in y l  
ketone (118).
Phenyl v in y l  ketone was prepared by the  Mannich re a c t io n 1 5 1  o f  
dimethylamine hydroch loride , acetophenone and paraformaldehyde to  
form the base (119), fo llow ed by quate rn isa tion  w ith  methyl iod ide 
to  g ive  the quaternary s a l t  (1£0). Hofmann e lim in a tio n 1 5 2  o f (1£0) 
w ith K2 C03 so lu tion  afforded the required ketone (118; Scheme 17).
The Michael add ition  o f the secondary amine (108) and phenyl v in y l 
ke to ne  proceeded s m o o th ly  to  y ie ld  th e  ad d uc t (1 1 7 ) in  
reasonab le  y ie ld .  This M ichael a d d it io n  is  o f  the  n u c le o p h i l ic  
category, the mechanism o f which is  o u tlin e d  in  Scheme 18.
Confirmation o f the s tru c tu re  was based on 1 3 C-n.m.r. and ^ -n .m .r . 
ev idence . The 1 3 C -n.m .r. spectrum (Tab le  16, No.8 ) d is p la y e d  the
v  v - c - c h - c h 2- NMe,
(U 9 )
Mel
^ V c -C H ^ -C H 2-NMe3
\ = /  h  ( 1 ?0 )
k 2c o 3
CH$  c —CH=
W (118)












c o r re c t number o f carbon resonances and, n o ta b ly , two ca rb o n y l 
s ig n a ls  a t 6199.1 and 175.2 fo r  the  ketone and e s te r C=0 group 
re spec tive ly .
The l H -n.m .r. spectrum (Tab le  15, No.8 ) in  CDC13 was c o n s is te n t 
w ith  the assigned s tru c tu re  and provided evidence in  re la t io n  to  
the  c o n fo rm a tio n a l p re fe rence  o f  th is  tropane d e r iv a t iv e .  The 
1(5)-H resonance a t 63.35 w ith  Vife=16Hz is  in d ic a t iv e  o f a h igh  
popula tion o f the boat conformation (1£ 1 ), a find in g  substantiated 
by the sm all d iffe rence  in  the chemical s h if ts  o f the exo and endo 
6(7)-methylene protons (4^0.2 ppm).
OCH
(12D
An attempted synthesis o f Nk(2-benzoylethyl)-3o-(3-hydroxyphenyl)- 
38-nortropane carboxylate (122) by O-demethylation w ith BBr3^  a t 
room tem perature f a i le d ,  y ie ld in g  o n ly  an in t r a c t ib le  o i l .  The 
most p robab le  reason fo r  the  f a i lu r e  o f  th is  re a c tio n  is  due to  a 
re ve rse  M ichae l r e a c t io n ! ^  (re ve rse  o f the M ichae l a d d it io n )  
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2.2.3 Synthetic and stereochemical studies of other tropane 
derivatives
The syn th e s is  o f  the two e s te rs  (123) and (12,4) was a fu r th e r  








(1 2 3 ) (124)
2 .2 .3 .1  The attem pted syn th e s is  o f  3a-acetyloxy-3 jJ-(3-hydroxy- 
phenyl)tropane (123)
The proposed ro u te  o f s y n th e s is  fo r  t h is  tropane d e r iv a t iv e  is  
o u tlin e d  in  Scheme 20.
The a lco ho l (125) was synthesised by the condensation o f 3 -a n is y l 
l i th iu m  (d e r iv e d  from 3 -b rom oan iso le  and n -b u ty l l i th iu m )  w ith  
tropan-3-one. The re a c tio n  proceeded sm ooth ly y ie ld in g  an o i l ,  
which by t . l . c .  a n a ly s is  was shown to  be a m ix tu re  o f s ta r t in g  
ketone and the des ired  p ro d u c t. S epara tion  o f th is  m ix tu re  was 
ach ieved by t r i t u r a t io n  w ith  e th e r, the  a lc o h o l se p a ra tin g  as a 











Structural and stereochemical features of th is  tropan-3-o l (12.5) 
were deduced by analysis  of the 13C-n.m.r., ^ -n .m .r .  and IR
spectra.
The reaction is  considered to be stereospecific  with complete 
absence of production of the epimer (12,6). This is shown by l H- 






The stereochemical features o f th is  a lco ho l is  v e r if ie d  by ana lys is  
o f  the ^ - n .m . r .  spectrum (Tab le  18, No.6 ). The two 2 -p ro to n  
m u lt ip le ts  o f the exo and endo 6(7)-m ethy lene  p ro tons were w e l l  
separated. This is  a ttr ib u te d  to  desh ie ld ing  o f the endo protons 
by an a x ia l l y  o r ie n ta te d  h yd ro xy l group124. Evidence th a t th is  
tropane d e r iv a t iv e  e x is ts  in  a c h a ir  con fo rm ation  is  based on 
ana lys is  o f the 1(5)-H s ig n a l. Resonating a t 63.21 w ith  ^=9Hz, i t  
ind ica tes sm all v ic in a l coupling w ith the 2(4)-protons, as expected 
fo r such a conformation.
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The 1 3 C -n.m .r. (Tab le  19, No.6 ) was c o n s is te n t w ith  s tru c tu re ,  
notable features o f the spectrum being the disappearance o f the C=0 
resonance  ( c h a r a c t e r is t i c  o f  th e  s t a r t in g  ketone) and the 
appearance o f the appropriate aromatic s ign a ls .
Having succeeded in  the production o f the a lcoho l (1£5), a tte n tio n  
was then given to  the synthesis o f the ester (127). This te r t ia r y  
a lc o h o l  p ro ve d  r e s is t a n t  to  e s t e r i f i c a t i o n .  The use o f  
n u c le o p h ilic  c a ta ly s ts  such as p y r id in e 15 5^, t r ie th y la m in e 1 5 4  and 
£ - to lu e n e s u lp h o n ic  a c id 1 5 5  ( re a g e n ts  known to  promote the 
e s te r if ic a t io n  o f te r t ia r y  a lcoho ls ) fa i le d  to  generate the desired 
este r, and u su a lly  re su lte d  in  the formation o f o le f in ic  and other 
u n id e n tif ia b le  products.
A ttem pts to  e f fe c t  e s te r i f ic a t io n  us ing  the in  s i t u  method 
described  by Casy and B eckett^?  a ls o  f a i le d ,  and generated the  
a lc o h o l(1 2 5 ) o n ly .  This f a c i le  in  s i t u  method in v o lv e d  the 
a d d it io n  o f a c e t ic  anhydride d i r e c t ly  to  the l i th iu m  complex 
d e riv e d  from the re a c tio n  o f  tro pan -3 -one  and 3 -a n is y l l i th iu m .  







I t  was most p robab le  th a t s te r ic  h indrance a t the  C-3 induced by 
the bu lky a ry l moiety was an important fac to r in  the resistance o f 
the a lco h o l to  undergo e s te r if ic a t io n .
A f te r  numerous a ttem pts to  e f fe c t  th is  e s te r i f ic a t io n ,  i t  was 
decided to  abandon th is  s y n th e t ic  approach (as expressed in  
Scheme 20). A tte n t io n  was then d ire c te d  to  the syn th e s is  o f 33.- 
acetyloxy-3ot- (3-hydroxyphenyl )tropane (124).
2 .2 .3 .2  The attem pted syn th e s is  o f  3B.-acetyloxy-3a-(3-hydroxy- 
phenyl)tropane (124)
The proposed ro u te  o f syn th e s is  o f 3 j3 -a ce ty lo xy -3 a -(3 -h yd ro xy - 
phenyl)tropane is  o u tlined  in  Scheme 21 (R=0Me).
I t  was a n t ic ip a te d  th a t expe rim en ta l d i f f i c u l t i e s  would be 
encountered in  the p re p a ra tio n  o f th is  tropane d e r iv a t iv e  ( 1 2 / 0 . 
C onsequently , the v i a b i l i t y  o f th is  s y n th e t ic  procedure was 
inves tiga ted  by the synthesis o f the 3a-phenyl analogue (128*, R=H; 




















stereochemical features assoc ia ted  w ith  the tropane d e r iv a t iv e s  
produced were investiga ted  by ^ -n .m .r . spectroscopy.
The attempted synthesis o f 38-acetyloxy-3a-phenyltropane (128*, R=H) 
As a s ta r t in g  p o in t fo r  th is  s y n th e t ic  procedure, the  tro p a n o l 
(129; R=H) was produced by reaction  o f p h e n y l- lith iu m  w ith tropan-
3-one121. l H -n .m .r., 1 3 C-n.m .r. and IR spe c tra  o f th is  a lc o h o l 
were consistent w ith i t s  assigned s tru c tu re .  The s te reochem ica l 
fe a tu re s  o f  th is  a lc o h o l have been e s ta b lis h e d  by ^ - n .m . r .  
s tud ies122. I t  ex is ts  in  a preferred cha ir conformation (1(5)-H at 
63.23 w ith  VfelOHz), w ith the hydroxy group a x ia l ly  o rien ta ted .
Acid cata lysed dehydration o f th is  a lcoho l was accomplished using 
concen tra ted  HC1 and g la c ia l  a c e t ic  a c id 156, and fu rn ish e d  3 - 
p h e n y ltro p -2 -e n e  (1^0; R=H). Th is dehyd ra tion  is  considered to  













Confirmation o f th is  o le f in ic  product was provided by the detection 
o f a d d it io n a l resonances in  the 105-120 ppm re g ion  o f the  
1 3 C-n.m.r. spectrum , and the presence o f  an o le f in ic  d o u b le t a t
66.3 in  the ^ -n .m .r .  spectrum.
C a ta ly tic  hydrogenation o f 3-phenyltrop-2-ene y ie lded , e x c lu s iv e ly , 
3a-phenyltropane ( l ^ l ;  R=H) as judged by l H- and 1 3C-n.m.r. data.
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The mechanism o f c a ta ly t ic  hydrogena tion  is  complex and s t i l l  
c o n tro v e rs ia l. The ge ne ra lly  accepted current theory suggests the 
a d so rp tio n  o f  the  s u b s tra te  to  the m e ta l l ic  c a ta ly s t  su rface  
fo rm ing  a chem iso rp tion  com plex157” 159. W i l l s t a t t e r 16^ and 
In g o ld 1 6 1  envisaged th a t e lectrons are being transfe rred  from the 
surface o f the chemisorption complex to  the substrate.
S tereochem ically, the course o f c a ta ly t ic  hydrogenation is  complex. 
Evidence suggests th a t the  adsorbed hydrogen is  tt bonded to  the 
c a ta ly t ic  s i t e 16^, with  the hydrogen, ra d ic a ls  approaching from the 
le s s  h in d e re d  s id e  o f  th e  u n s a tu ra te d  s u b s tra te , y ie ld in g  
predominately c is -a d d itio n  products1 5 9  (see Scheme 23).
The hydrogenation o f 3-phenyltrop-2-ene in  th is  work was e ffected 
under hydrogen pressure o f 60 p . s . i . ,  ca ta ly s e d  by p a lla d iu m  
charcoal. The l H-n.m.r. spectrum o f the reduced product ind icated 
the disappearance o f the o le f in ic  d o u b le t. The c o n f ig u ra t io n  o f  
th e  3 -p h e n y l group o f  th e  reduced  p ro d u c t (1 3 1 ; R=H) is  
e s ta b lis h e d  as a - by ^ - n .m . r .  s tu d ie s  o f the t e r t ia r y  base. 
However, fo r comparative reasons i t  was des irab le  to analyse the 
spe c tra l features o f the epimeric congerer o f (1^1*, R=H)*, th a t is ,  
3j3-phenyl tropane (132)165.
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The synthesis o f ( 1 2 2 ) was achieved by the c a ta ly t ic  hydrogenolysis 
o f  the a lc o h o l (129; R=H) us ing  R aney-N icke l in  e th an o l (Scheme 
24).
CH 3  CH,





T . l.c .  ana lys is  o f the reaction  mixture revealed i t  to  be a m ixture 
o f s ta r t in g  a lc o h o l (129; R=H) and the des ired  tropane (122). 
S epara tion  o f these two tropane d e r iv a t iv e s  was ach ieved by 
d is t i l la t io n ,  although the y ie ld  o f (1 2 2 ) was poor.
C a ta ly tic  hydrogenolysis o f hydroxyl groups over Raney-Nickel is  
considered to  be s te r e o s p e c i f ic ^ ^ ^ ,  and the reaction  proceeds 
w ith  the re te n t io n  o f c o n f ig u ra t io n . The poor y ie ld  o f th is  
h yd ro g e n o lys is  can be a t t r ib u te d  to  the s te r ic  h indrance o f the 
a x ia l ly  o rien ta ted  hydroxyl group.
Spectral evidence fo r the preferred conformation and con figu ra tion  
o f these two tropane d e r iv a t iv e s  is  now presented (see Table 18, 
Nos. 4 and 5). A n a lys is  o f the 1(5)-H s ig n a l in  the ^ - n .m . r .  
spectrum suggests th a t both tropanes e x is t  in  a p re fe rre d  c h a ir  
con fo rm ation  (W^=9-10Hz). The tropane d e r iv a t iv e  (131; R=H) 
displayed two w e ll reso lved 6(7)-methylene resonances in  the XH- 
n.m.r. spectrum (A=0.16 ppm). This separation can be a ttr ib u te d  to
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the s h ie ld in g  in f lu e n c e  o f the endo p ro tons by an a x ia l arom atic 
system1^ .  However, the 6(7)-methylene resonance o f the d e r iv a tiv e  
( 1 2 2 ) overlapped, evidence suggesting s im ila r  environments o f the 
exo and endo p ro ton s , which is  in  accord w ith  the assigned 
co n fig u ra tion .
Exam ination o f  the resonance s ig n a l fo r  the C-3-H in  the two 
epimeric tropanes (12l> R=H) and (132) p ro v id e d  fu r th e r  evidence 
in  support o f  the assigned c o n f ig u ra t io n . In  3a -pheny ltropa ne  
(12,1; R=H), w ith  the C-3-H e q u a to r ia l,  the  resonance s ig n a l a t 
53.44 ppm appeared as a broad t r i p l e t  ( 3 J=7-8Hz), as a r e s u l t  o f 
two la rge  and two sm all v ic in a l couplings. In 38-phenyltropane 
(122), w ith  an a x ia l C-3-H, the resonance appeared as a seven l in e  
s ig n a l (ce n tre d  a t 62.83) in  accord w ith  a l l  v ic in a l  co u p lin g s  
being la rge . A pp lica tion  o f the Karplus re la t io n 1 1 4  to  these two 
epimers confirms these find in gs .
Having e s ta b lis h e d  the s te reoch em ica l fe a tu re s  o f  3 a -p h e n y l- 
tropane , the f in a l  step in  th is  re a c tio n  sequence in v o lv e d  the 
convers ion  o f (12i*> R=H) to  38.-acetyloxy-3a-phenyltropane (128*, 
R=H) by ace toxy la tion .
A ce toxy  1 a t  io n  is  a p ro c e d u re  th a t  has been used fo r  th e  
in tro du c tio n  o f an acetoxy group in to  a hydrocarbon substrate and 
is  a p p lie d  s y n th e t ic a l ly  as an in d ir e c t  way o f in tro d u c in g  an 
hydroxy subs titue n t. Typ ica l reagents u t i l i z e d  in  th is  re a c tio n  
are the tra n s it io n  metal s a lts  ( in  ace tic  or t r i f lu o ro a c e t ic  acid) 
such  as c o b a l t  a c e ta te  (C o (A c )3) 1^ 6 , ch ro m y l a c e ta te
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(Cr2 07 (0Ac)2) 167, p a lla d iu m  ace ta te  (Pd(0Ac)2 and stannous 
acetate1^9. As an example to  i l lu s t r a t e  th is  type o f reaction , i t  
has been reported tha t benzyl esters are produced c a ta ly t ic a l ly  at 
moderate temperatures from methylbenzenes in  a l iq u id  phase process 
em ploying a homogenous p a lla d iu m -s ta n n o u s  ace ta te  c a ta ly s t  and 
a i r 170 (sCheme 25).
0 2  -b HO Ac
Scheme 25
The mechanism o f such a pa llad ium  cata lysed oxidation is  not f u l l y  
understood. C o ( I I I )  and M n ( I I I )  o x id a tiv e  s u b s titu tio n  o f arenes
Ar—CH3  +
Ar—CH3  
Ar—CH 2  +
. . i n  _________________________ +• nM ir ^  A r-C H , + Mn
SLOW
--------------- Ar—CH, + H
■■I/ > nMn(OAc)  ~ A r-C H 2-O A c  + MrT
Scheme 26
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is  considered to  proceed v ia  the formation o f a ra d ic a l-c a tio n 1 7 1  
(Scheme 26). However, P d ( II )  is  no t a po ten t o x id a n t, and an 
a lte rn a t iv e  mechanistic explanation in v o lv e s  e le c tro p h il ic  aromatic 
s u b s t i tu t io n  fo llo w e d  by rearrangem ent (Scheme 27)17^. I t  is  
d i f f i c u l t  to  v is u a lis e  a s im p le  mechanism fo r  the proposed 
rearrangem ent o f a a - a r y l  to  a -b e n zy l species -^7 -5 and, the re fo re , 
more studies are c le a r ly  needed before any d e f in it iv e  conclusions 









In  the present work, numerous attempts to  e ffe c t th is  ace toxy la tion  
fa i le d  (u s ing  P d (II)-s ta n n o u s  a c e ta te ), and re tu rn ed  s ta r t in g  
m a te r ia l o n ly .  The attem pted synthesis o f the phenolic analogue 
(1^4) was the re fo re  not undertaken.
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The term ination o f th is  work was ju s t i f ie d  so as to  concentrate on 




In 1972, Casy and McErlane7 5  e luc idated the re la t iv e  con figu ra tion  
and conformation o f a- and 3 - l,2 -d im e th y l-4 -p h e n y lp ip e rid in -4 -o l by 
chemical means and ^ -n .m .r . spectroscopy (see s e c tio n  1 .4 .2 .4 .B ). 
Furthermore, Portoghese and co-w orkers^ succeeded in  re so lv ing  the
3 -isom er in to  i t s  two o p t ic a l  forms and determ ined the a b so lu te  
con figu ra tion  and analgesic potency o f each enantiomer (see section 
1 .4 .2 .4 .C ). As p a rt o f th is  p resen t work, the  s te reochem ica l 
assignments o f a -  and 3.- l,2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l are 
substantiated by a 270MHz ^ -n .m .r . study, and the a v a i la b i l i t y  o f 
the a-isomer prompted the re s o lu tio n  o f th is  diastereoisomer.
An assessment o f the expected potency r a t io  o f  the  two o p t ic a l  
forms o f the a -2 -methyl analogue ( 1£3 ) can be made by a p p lica tio n  
o f the p r in c ip le s  o u tlin e d  in  s e c tio n  I.4 .2 .4 .C . Th is 4 -p h e n y l-  
p ip e r id in e  d e r iv a t iv e  e x is t s  in  an a x ia l  4 -p h e n y l c h a ir  
con fo rm ation  w ith  an e q u a to r ia l 2 -m e th y l s u b s t itu e n t (see 1£4). 
However, fo r  th is  a n a ly s is  i t  is  necessary to  con s ide r th is  















In  th is  e q u a to r ia l 4 -pheny l c h a ir  con fo rm a tion , the 2-m ethy l 
substituen t has an a x ia l o r ie n ta tio n , and as i t  is  adjacent to the 
n it r o g e n  atom bo th  a n tip o d e s  possess fa v o u ra b ly  p la c e d  
substituen ts . As th is  is  the case, the  potency r a t io  o f  the two 
antipodal forms would be expected to  be u n ity .
A tte n t io n  was a ls o  g ive n  to  the  syn th e s is  and s te reochem ica l 
cha rac te riza tion  o f the two phenolic d e riv a tiv e s  ( 1^ 6 ) and ( 1 2 7)* 









described  by Portoghese e t a l^ . 5 6  w ith  phenolic-O H  p ro te c t io n  by 
methyl. Such an approach proved u n sa tis fa c to ry , and there fore  the 
s y n th e t ic  procedure described  by Casy and Ogungbamila5 7  was 
u t i l i z e d  w hich  s u c c e s s fu l ly  gave r i s e  to  th e  two d e s ire d  
d e r iv a t iv e s .  The s te re o c h e m ic a l fe a tu re s  o f  th e se  two 
diastereoisomers was determined by ^ -n .m .r . spectroscopy.
In  a six-membered r in g  c h a ir  system the order o f magnitude o f 
d ia x ia l  (Jaa), a x ia l- e q u a to r ia l  (Jae) and d ie q u a to r ia l (dee) 
coupling constants in  the ^ -n .m .r . spectrum can be predicted from 
the an gu la r re la t io n s h ip s  o f the  p ro tons  by a p p lic a t io n  o f the 
K arp lus  r e la t io n s h ip 1 1 4  (see page 76). 3J va lu es  are th e re fo re  
la rg e s t  when the v ic in a l  p ro tons are tra n s -c o p la n a r ( 0  = 180°), 
s l ig h t ly  less when they are c is -cop lana r ( 0  = 0 °), and almost zero 
when the protons are at r ig h t angles. Thus, Jaa values g e n e ra lly  
f a l l  w ith in  8-14Hz, while Jae and Jee values f a l l  w ith in  l - 6 Hz115.
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2.3.2 Synthesis and stereochemistry of the isomeric 1,2- 
dimethyl-4-phenylpiperidin-4-ols 
2 .3 .2 .1 . Synthesis
1,2-D im ethy 1 -4 -p ip e r id o n e  (138; Scheme 28), the key interm ediate 
in  the synthesis o f the diastereoisom eric a lcoho ls  (129) and (140), 







This synthesis invo lve d  the stepwise Michael condensation1 4 ® - 1 5 *1 o f 
e th y l crotonate and then e th y l a c ry la te  to  methylamine y ie ld in g  the 
d ie s te r  (141). This d ie s te r  in  the presence o f NaNH2 underwent 
Oieckmann c y c liz a t io n 1 7 4  to  g iv e  the 3 -ca rb o e th o xy -4 -p ip e rid o n e  
(1£2). Hydrolysis fo llow ed by decarboxylation o f (1&2) y ie lded  the 
required l,2 -d im ethy l-4 -p ipe ridone  (138).
The re a c tio n  o f p h e n y l- l i th iu m  w ith  the  p ip e rid o n e  (128) gave a 
m ixture composed o f almost equal amounts o f the two isomers (1^9) 
and (140) as judged by the 1- and 2 -m e th y l l H -n.m .r. s ig n a ls .  
S e p a ra t io n  o f  th e  two isom e rs  was a c h ie v e d  by f r a c t io n a l  
c ry s ta llis a t io n  o f the fre e  base. The f i r s t  crop was shown to  be
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the  8 -isom er (l&O ), w h ile  the second crop was the a -isom er (13,9). 
I t  was fo r tu i to u s  th a t the  se p a ra tio n  proceeded sm ooth ly , as 
procedures recorded in  the l i te ra tu re  demanded the use o f column 
chromatography75.
The a v a i l a b i l i t y  o f these two iso m e ric  a lc o h o ls  prompted a 
l H -n.m .r. study o f th e ir  stereochemical ch a ra c te ris tic s , and the 
re so lu tio n  o f the a-a lcohol (139) was also undertaken.
2 .3 .2 .2  S tereochem ica l s tu d ie s  o f the isom eric 1,2-dim ethyl-A- 
pheny lp ipe rid in -4 -o ls  
The s te re o ch e m is try  o f the  isom e ric  a lc o h o ls  (139) and (1&0) has 
been th e  s u b je c t  o f  p re v io u s  in v e s t ig a t io n s  and is  w e l l  
e s ta b lis h e d ^ *75. The present study, due to  the a v a i la b i l i t y  o f 
270MHz l H -n.m .r. spectroscopy, c o n f irm s  th e  s te re o c h e m ic a l 
assignments a lready made.
A. a -1 ,2 -D im ethy l-4 -pheny lp ipe rid in -4 -o l
P rev ious  s tu d ie s  o f the  chem ica l and s p e c tra l fe a tu re s  o f the 
a lc o h o l (1^9) supported the  c o n f ig u ra t io n  c-2-M e, r - 4 - 0 H ^ * 75. 
Evidence to  suggest th a t t h is  d e r iv a t iv e  e x is ts  as an a x ia l- 4 -  
phenyl c h a ir  (143) is  p ro v id e d  by a n a ly s is  o f the  ^ - n .m . r .  







Proof tha t the C-2-methyl group has an e q ua to ria l o r ie n ta tio n  and 
hence the 4 -pheny l group is  a x ia l l y  o r ie n ta te d  is  p ro v id e d  by 
examination o f the C-2-H resonance coupling pattern . The C-2-H is  
coupled to  two C-3-H protons (one a x ia l Ha and one eq ua to ria l He) 
and the C -2-m ethy l p ro ton s , g iv in g  r is e  to  a m u lt ip le  s ig n a l.  
Exam ination o f the spectrum re v e a le d  a tw e lv e  l in e  m u lt ip le t  
(ce n tre d  a t 62.4 ppm). D ecoupling experim ents were th e re fo re  
necessary to  reso lve  the C-2-H resonance in  order to  determine the 
v ic in a l 3J va lues. Spin decoupling o f the C-2-methyl doublet a t
61.1 ppm re s o lv e d  the C-2-H resonance in to  a d o u b le t o f d o u b le ts  
(see F ig .10) w ith  3 J=11.2 and 3.1Hz. These two 3J va lu e s  are 
ty p ic a l ly  those o f an a x ia l-a x ia l and an a x ia l-e q u a to r ia l coupled 
proton re sp e c tive ly . Therefore, the C-2-H has an a x ia l o r ie n ta tio n  
and hence the C-2-methyl must be e q u a to ria l. In order to  fu r th e r 
s u b s ta n tia te  th is  f in d in g ,  a n a ly s is  o f  the  l H -n.m .r. spectrum to  
e x tra c t  the c o u p lin g  data o f the two C-3-H was necessary. The 
resonance s ig n a ls  a t 62.8 ( 2 J=11.8Hz, 3 J=4.34Hz (Jee) and 2.48Hz 
(Jae)) and 62.62 ( 2 J=11.8Hz, 3 J=11.8Hz (Jaa) and 2.48Hz (Jae)) were 
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(at 270 MHz; (at 400 MHz)
decoupling at 61.1)
Figure 10 Partial ^-n.m.r .  spectrum and Spin Decoupled spectra of 
a-l,2-dimethyl-4-phenylpiperidin-4-ol (as base in CDC13).
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resonance s ig n a l a t 52.20 ( 2J=13.6Hz, 3J=13.6Hz (Jaa) and 5.00Hz 
(Jae)) was assigned as the a x ia l C-5-H (decoupling o f a x ia l C-2-H 
did not a ffe c t th is  s ig n a l). U nfortunate ly , the three other r ing  
p ro ton s , namely, the e q u a to r ia l C-5-H, e q u a to r ia l C-3-H and the 
a x ia l C-3-H were part o f a complex m u lt ip le t  centred at 61.75 ppm 
and hence no use fu l stereochemical in form ation could be gained from 
th is  s ig n a l.
B. 3 -l,2 -D im e thy l-4 -ph eny lp ip e rid in -4 -o l
The c o n f ig u ra t io n  o f the  3 ,-a lcoh o l (140) has been e s ta b lis h e d  as 
t-2-M e, r-4-0H based on chemical and spe c tra l evidence66*75. The 
^ - n .m . r .  (270MHz) spectrum p rov ide d  evidence in  support o f an 
eq ua to ria l C-2-methyl and hence an equa to ria l 4-phenyl as in  the 
con fo rm ation  (144*, base in  CDC13#, Table 21, No.2).
The C-2-H s ig n a l was not re s o lv e d  and was p a rt o f a complex 
m u lt ip le t  (62.1 to  62.4 ppm). However, one o f the C -3-m ethylene 
protons was resolved and the magnitude o f the 3J value shows a x ia l-  





th e re fo re  can be a t t r ib u te d  to  the a x ia l  C-3-H, c o u p lin g  w ith  an 
a x ia l  C-2-H. Hence, the 2 -m e thy l group must be e q u a to r ia l ly  
o rien ta ted .
W ith the excep tion  o f the e q u a to r ia l C-6 -H (52.8 ppm, 2 J=11.75Hz, 
3J=2.6Hz (Jea, Jee)), a l l  other r in g  protons were not resolved and 
so no fu rth e r inform ation on the conformation could be deduced from 
th is  data.
The stereochemical features o f the two a lcoho ls  (139) and (1&0) as 
described  above con firm  the p re fe rre d  con fo rm ation  o f each 
diastereoisomer. The p r in c ip le s  o u t l in e d  w i l l  be u t i l i z e d  in  
ana lys is  o f the stereochemistry o f the phenolic analogues (section 
2 .3 .4 ).
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2.3.3 Resolution of (±)-<&-l,2-dimethyl-4-phenylpiperidin-4-ol
As pa rt o f the continued in te re s t in  the analgesic a c t iv i t y  o f the 
two o p t ic a l  forms o f the d ia s te re o is o m e ric  p e th id in e  reversed  
e s te rs , re s o lu t io n  o f  ( - ) -a - l,2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l 
(139) was undertaken to  g iv e  (+ )- and ( - ) - a - l ,2 - d im e th y l- 4 -  
phenylp ip e r id in - 4 - o l .  E s te r i f ic a t io n  o f each enantiom er w ith  
a c e ty l c h lo r id e  a ffo rd e d  the corresponding acetate esters as the 
hydrochloride s a lts  (Scheme 29).
The term ’re s o lu t io n  or ’o p tic a l re s o lu tio n ’ is  gene ra lly  defined 
as a procedure through which both o p tic a l isomers (enantiomers) are 
separated in  the p u r i f ie d  s ta te  from a racem ic m ix tu re . Through 
years o f in v e s tig a tio n , Pasteur and h is  c o lle a g u e s 1 7 5  developed 
v a r io u s  methods which are the main means o f  re s o lu t io n  today. 
These methods includes
(a) reso lu tion  by entrainment17^,
(b) reso lu tion  v ia  d iastereoisom eric s a lt  form ation175,
(c) biochemical re so lu tio n 177.
The re s o lu t io n  o f  ( - ) -a - l,2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l was 
ach ieved by d ia s te re o is o m e ric  s a l t  fo rm a tio n . Th is procedure 
invo lve s  the in te ra c tio n  o f racemic bases (B) w ith o p t ic a l ly  a c tive  
ac ids  (A) or racemic ac ids  w ith  o p t ic a l l y  a c t iv e  bases. Thus, 
enantiom ers are transfo rm ed to  d iastereo isom eric s a lts  which may 
then be separated by d i f fe re n t ia l  s o lu b i l i t y  (Scheme 30).





(+ ) -a - l,2 -d im e th y l-
4 -p h e n y lp ip e rid in -4 -o l
( - ) -a - l,2 -d im e th y l-
4 -p h e n y lp ip e rid in -4 -o l
(+ )-a -4 -a ce ty lo xy -
1 ,2 -d im ethy l-4 -phenyl- 
p ip e r id in e  hydrochloride
( - )-a -4 -a ce ty lo xy -
1 ,2-d im ethyl-4-pheny1- 
p ip e rid in e  hydroch loride
Scheme 29
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ttA +  0B -► 0A0B + 0A0B
0B + 0A------- -► 0B0A +  0B0A
Scheme 30
The d ia s t e r e o is o m e r ic  s a l t s  cropped  a f t e r  f r a c t io n a l
c ry s ta llis a t io n  can then be hydrolyzed w ith inorganic a lk a l is  or 
ac ids  to  g iv e  the  enantiom ers. Th is procedure u su a lly  in vo lve s  
many re c ry s ta llis a t io n s , monitored by po larim etry.
Common o p t ic a l ly  a c tiv e  acids used fo r the re so lu tio n  o f racemic 
bases in c lu d e  t a r t a r ic  a c id , m andelic a c id , camphoric ac id  and 
c a m p h o r-1 0 -s u lp h o n ic  a c id . O p t ic a l ly  a c t iv e  bases such as 
morphine, ephedrine and menthylamine are used fo r re so lv in g  racemic 
a c id s . The c o n d it io n s  necessary to  e f fe c t  re s o lu t io n  cannot be 
g e n e ra lis e d , a lth o u g h  the cho ice  o f o p t ic a l ly  a c t iv e  re s o lv in g  
agent and the so lve n t are important considerations.
O p tic a l re s o lu t io n  o f ( - ) -a - l,2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l 
(139) was achieved through f r a c t io n a l  c r y s t a l l i s a t io n  o f the V ~  
n i t r o t a r t r a n i la t e  s a l t s .  (+ )-3 ,- n i t r o t a r t r a n i l i c  acid (145) was 
prepared by reacting  (+ ) - ta r ta r ic  acid w ith 3 -n itro a n ilin e  in  the 
presence o f dicyclohexylcarbodiim ide (146).
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O ic y c lo h e x y lc a rb o d iim id e  (DCC) is  an e f fe c t iv e  c a ta ly s t  fo r  the 
condensation o f c a rb o x y lic  ac ids  w ith  a lc o h o ls  and amines17®. 
Thus, an equ im o la r m ix tu re  o f the c a rb o x y lic  ac id  ( ( + ) - ta r ta r ic  
a c id ) ,  an amine ( 3 - n i t r o a n i1 in e )  and DCC r e s u l t  in  th e  
corresponding amide (145) and the h ig h ly  in s o lu b le  N ,N /-d ic y c lo - 
hexylurea (147; Scheme 31).
The n it r o ta r t ra n ila te  o f (+ )-a -l,2 -d im e th y l-4 -p h e n y lp ip e rid in -4 -o l 
has a sp e c ific  ro ta tio n  o f -60.0° and the n it r o ta r t ra n i la te  o f i t s  
enantiomer has an sp e c ific  ro ta tio n  o f +60.0°. B a s ifica tio n  o f the 
two s a lts  generated (+ )-o -l,2 -d im e th y l-4 -p h e n y lp ip e rid in -4 -o l w ith  
a sp e c ific  ro ta tio n  +1.0° and (-)-a - l,2 -d im e th y l-4 -p h e n y lp ip e rid in -
4 -o l w ith a sp e c ific  ro ta tio n  -1 .0°, (a lso  see Experimental, page 
219).
E s t e r i f i c a t i o n  o f  th e  ( + ) -  and ( - ) - a _ - l , 2 -d im e th y 1 -4 -  
phenylp ip e r id in - 4 - o l  w ith  a c e ty l c h lo r id e  in  to lu e n e  a ffo rd e d , 
re sp e c tive ly , (+ )-a -4-ace ty loxy-l,2 -d im ethy1-4 -pheny lp iperid ine  and 
( - ) - a - 4 - a c e t y lo x y - l , 2 - d im e th y 1 - 4 - p h e n y lp ip e r id in e  as th e  
hydrochloride s a lts .
- 145 -
HO—CH—COOH 
H O -C H -C O O -H
(146)
HO—CH-COOH
h o - c h - c - o - c = n - c 6h13 




H O - C H - C - ^ - C  = lj l -C  6 H„ 




h o - c h - c - o - c = n - c 6h ,3
I INH NHC6H13











2.3.4 The synthesis of a- and B- lf2-dimethyl-4-(3-hydroxy- 
phenyl)-4-propionyloxypiperidine
2.3 .4 .1  Unsuccessful synthesis
I n i t i a l  attempts to  secure the two phenolic esters (136) and (1J7) 
in v o lv e d  a p p lic a t io n  o f the  s y n th e t ic  procedure used in  the 
syn th e s is  o f the 3 -m e thy l (33) and 3 - a l l y l  (36) analogues o f the 
reversed esters o f pe th id ine , as described by Portoghese e t a l . 5^ .
a: c-3-R, r-4-0C0Et 
B: t-3 -R , r-4-0C0Et
(35) R=Me
(36) R=CH2 CH=CH2
A pre lim ina ry  in v e s tig a tio n  in to  the s u i ta b i l i t y  o f th is  procedure 
was undertaken using l-m ethy l-4 -p iperidone (148; Scheme 32).
Reaction o f l-m ethy l-4 -p ipe ridone  (148) w ith  the G rignard reagent 
d e riv e d  from 3-brom oan iso le  and magnesium furnished the a lcoho l 
(149). Characterisation o f th is  a lcoho l was achieved by ^ -n .m .r .,  
1 3 C-n.m.r. and IR spectra, one notable fea ture being the absence o f 
ca rbo n y l a b so rp tio n  (a c h a ra c te r is t ic  o f s ta r t in g  ketone) in  the 




















E s te r i f ic a t io n  o f (1&9) w ith  a c e ty l c h lo r id e  a ffo rd e d  (1£0) as 
i l l u s t r a t e d  in  Scheme 32. The IR spectrum o f th is  compound 
displayed strong absorption at 1750 cm"1, c h a ra c te r is tic  o f ester 
carbonyl. A ce ty lo xy  ca rbo n y l was observed a t 169.4 ppm in  the
1 3 C-n.m .r. Another important feature confirm ing e s te r if ic a t io n  was 
the d o w n fie ld  chem ica l s h i f t  (a p p ro x im a te ly  9-10 ppm) o f the C-4 
quaternary carbon in  the 1 3 C-n.m.r. due to  a stronger deshield ing 
e f fe c t  o f  0C0 group ove r the OH group o f  the a lc o h o l (C-4 in  
a lco ho l (149) a t 69.97 ppm; C-4 in  este r (150) at 79.70 ppm).
F o llo w in g  the success o f t h i s  p ro c e d u re  u s in g  l - m e th y l - 4 -  
p ip e rid o n e , the attem pted syn th e s is  o f the two isomeric a lcoho ls 
(151) and (1£2) was undertaken.
R eaction o f l,2 -d im e th y l-4 -p ip e r id o n e  (138) w ith  the G rignard 
reagent derived from 3-bromoanisole y ie lded  an o i l  which by t . l . c .  
ana lys is  appeared as a m ixture o f two compounds (ne ithe r o f which 
correspond to  the s ta r t in g  ke tone). The IR spectrum o f th is  o i l  
ind ica ted disappearance o f carbonyl absorption and the appearance 
o f OH absorption (Scheme 33).










The attem pted se p a ra tio n  o f th is  iso m e ric  m ix tu re  o f  a lc o h o ls  
proved unsuccessful -  c r y s ta l l iz a t io n  o f the base or a v a r ie ty  o f 
s a lts  such as the hydrochloride, oxalate and maleate a l l  fa ile d .
Fo llow ing the fa i lu re  to e ffe c t se p a ra tion 'o f the two a lcoho ls , the 
isom e ric  m ix tu re  was converted  to  the co rrespond ing  e s te rs  (1£3; 
R=C0CH3) and (154; R=C0CH3 ). The e s te r i f ic a t io n  was ach ieved by 
treatment o f the isomeric m ixture o f a lcoho ls  w ith ace ty l c h lo rid e  
(Scheme 34). The re s u lta n t  o i l  d is p la y e d  c h a ra c te r is t ic  e s te r 
carbonyl a t 1765 cm“ l . A l l  attempts a t the separation o f these two 
isomeric esters a lso fa ile d .
o c h 3
n ^ c h 3
c h 3








As i t  proved impossible to  separate e ith e r the isomeric a lcoho ls  or 
e s te r s ,  0 -d e m e th y la t io n  o f  th e  is o m e r ic  a lc o h o ls  to  th e  
co rrespond ing  phenols was undertaken. £ -D e m e thy la tio n  o f the  
a lcoho l (149) w itn  n -p ro p a n e th io l^ ^ ’ ' ^  y ie lded  the corresponding 
p h e n o lic  a lc o h o l5 6  U 55 ; Scheme 32). The 1 3 C-n.m.r. spectrum o f 
th is  a lc o h o l showed absence o f  the 0-CH3 s ig n a l.  The use o f  the  
propaneth io la te  anion as a means o f 0 -dem ethylation arises because 
o f  th e  s u s c e p t i b i l i t y  o f  th e  p ip e r id in o l  (149) .to undergo 
dehydration under ac id ic  cond itions.
0-Demethylation o f the isomeric a lco ho ls  (151) and (1£2) y ie lded  an 
o i l  which darkened on s tan d ing  and proved in t r a c t ib le .  Th is 
attempted synthesis was there fore  abandoned.
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2 .3 .4 .2  Successful synthesis
In  view  o f the d i f f i c u l t i e s  experienced in  sep a ra ting  the two 
isomers (1£3; R=H or C0CH3) and (1£4; r=h or C0CH3), a p p lic a t io n  
o f the syn the tic  procedure described by Casy and Ogungbamila5 7  fo r 
the synthesis o f the phenolic esters (2 £) and (156) was undertaken. 
Th is procedure u t i l i z e d  the G rignard reagent d e riv e d  from 3 -(2 ,« 
tetrahydropyranyloxy)bromobenzene (157; Scheme 3 5 ) ^ .
CH CH
CH3 c h 3
(15?) (154)






as c-3-CH3, r-4-0C0Et 






3-(2,-Tetrahydropyranyloxy)bromobenzene (THP) was syn thes ised  by 
re a c tio n  o f 3-bromophenol and d ihyd ropyran  in  the presence o f  a 
c a ta ly t ic  quan tity  o f concentrated hyd roch lo ric  acid (Scheme 35).
I n i t i a l  in v e s t ig a to ry  experim ents o f  the  s u i t a b i l i t y  o f th is  











The p re p a ra tio n  o f  the  G rignard  reagent d e rive d  from THP and 
magnesium was unsuccessful. A v a r ie ty  o f techniques were employed
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to  promote Grignard formation, a l l  o f which fa ile d .  These included 
the use o f i n i t i a t o r s  such as io d in e  and 1 , 2 -d ib rom oethane, and 
washing the magnesium w ith concentrated hyd roch lo ric  acid to  remove 
su rface  ox ides . However, re a c tio n  o f  THP w ith  n_-butyl l i th iu m  
success fu lly  generated the corresponding o rg a n o m e ta llic  reagen t.
Reaction o f th is  organom etallic  reagent w ith  l-m e thy l-4 -p ipe ridone , 
fo llo w e d  by decom position o f the r e s u lta n t  complex w ith  a c e tic  
anhydride , fu rn ish e d  the p ro te c te d  e s te r  (158*, R=COOV, Scheme 
36), which on treatment w ith, e thano lic  hydrogen c h lo rid e  gave the 
f r e e  p h e no l (1 5 9 ; R=C0CH3 ; Scheme 36) d i r e c t l y  as the
Scheme 37
- 155 -
h y d ro c h lo r id e  s a l t .  Th is trea tm en t o f  the p ro te c te d  e s te r by 
hydrogen ch lo rid e  y ie ld s  the phenolic ester by v ir tu e  o f the acid 
s u s c e p t ib i l i t y  o f the a c e ta l p o r t io n  o f the  THP e th e r to  undergo 
hydro lys is  (Scheme 37).
The synthesis o f the free phenol^ ^ 7  (159; R=C0C2 H5) was achieved 
by a s im i la r  p ro ce d u re  u s in g  p r o p io n ic  a n h y d r id e  fo r  th e  
decomposition o f the complex derived from the reaction o f 1 -m ethy l- 
4-piperidone and the organom etallic  reagent derived from THP and n- 
b u ty l lith iu m .
Characterisation o f these two phenolic esters was achieved by *H- 
and l 3 C -n .m .r. s p e c tro s c o p y . Each spe c trum  d is p la y e d  th e  
appropriate aromatic and ester s igna ls  in  accord w ith the assigned 
s tru c tu re s .
Having secured a syn the tic  procedure fo r  the synthesis o f the free 
phenols (1^9; R=C0CH3 or C0C2Hs ), the syn th e s is  o f the  p h e n o lic  
d e r iv a t iv e s  (1 3 6 ) and (1 £ 7 ) was u n d e rta k e n . Treatm ent o f 
l,2 -d im e th y l-4 -p ip e rid o n e  (1£8) w ith  the o rg a n o m e ta llic  reagent 
derived from THP and n -b u ty l l ith iu m  y ie lded  an isomeric m ixture o f 
(1&0) and ( l & l )  as jud g ed  by t . l . c .  a n a ly s is  (Scheme 3 8 ). 
Separation o f the two protected esters was achieved by u t i l iz in g  
the d i f f e r e n t ia l  s o lu b i l i t y  o f t h e i r  p rop io na te  s a l t s .  The 
$-isom er was ob ta ined as the  p ro p io n a te  s a l t  from the re a c tio n  
medium by the add ition  o f e ther. The a-isomer was not deposited by 
the add ition  o f ether, and was obtained as the base from the mother 
liq u o rs .
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Treatm ent o f each p ro te c te d  e s te r w ith  HCI then y ie ld e d  the 
corresponding phenolic esters (126) and (1J7).
Evidence o f the  s te re o ch e m is try  o f the two e s te rs  (126) and (127 ) 
was sou gh t from  n .m .r . d a ta . The 1 3 C -n.m .r. sp e c tra  o f  the 
isom e ric  e s te rs  were too s im i la r  fo r  any d ir e c t  s te reochem ica l 
deductions to  be made from the chem ica l s h i f t s .  The b u lk  o f  the 
s te reochem ica l in fo rm a tio n  was th e re fo re  d e rive d  from ^ - n .m . r .  
(see Table 26) and supported w ith  1 3 C -n.m .r. s tu d ie s  (see F igu re  
11). The re la t iv e  con figu ra tion  o f the two isomeric 1 ,2 -d im ethy l-
4 -ph e ny lp ip e rid in -4 -o ls  and re la te d  compounds has been established 
as £-2-M e, r-4 -0R  and t-2 -M e , r-4 -0R  fo r  the a-and 8 - isom ers 
re s p e c t iv e ly  (see s e c tio n  1 .4 .2 .4 .B )75. Th ere fo re , the proposed 
con fo rm ation  o f the two p h e n o lic  e s te rs  (136) and (127) is  ( l£ 2 a ) 
fo r the 8 -isomer and e ith e r (163a) or (l£3b) fo r  the a-isomer. The 
p o s s ib i l i ty  o f the conformer (162b) fo r the fr-isomer is  discounted 
on th e  b a s is  th a t  b o th  th e  2 -m e th y l and 4 -p h e n y l a re  in  
unfavourable o rie n ta tions .
OCOEt
EtOCC





N -C H 3
^ c h 3
OCOEt CH3
(163a) HO
Presented below is  evidence in  support o f the conformations (163b) 
and ( l£ 2 a) fo r the a- and 8 .-isomers respec tive ly .
The a-isomer was d istingu ished from the fr-isomer by the presence o f
e p im e r ic  c o n ju g a te  a c id s  in  th e  l H -n .m .r. spectrum  o f  th e  
hydrochloride s a l t 8 2 ’ 1 5 2  (see page 159).
Exam ination o f  the  ^ -n .m . r .  spectrum fo r  the a-isomer (1 base 
in  CDC13) provides conclusive  evidence supporting the conformation 
(l£ 3 b ). Most o f the p ipe rid in e  r in g  s ign a ls  in  th is  spectrum were 
poorly  reso lved . However, the resonance at 62.03 (assigned as the 
a x ia l C-3-H) displayed two la rg e  c o u p lin g s . The na tu re  o f these 
two la rg e  c o u p lin g s  a r is e  from (a) a gem inal c o u p lin g  w ith  the  
equa to ria l C-3-H ( 2J=14.3Hz) and (b) a v ic in a l coupling w ith  the C-
2-H ( 3 J=11.4Hz). The la rg e  3J is  in d ic a t iv e  o f an a x ia l - a x ia l
c o u p lin g , evidence suggesting  th a t the C-2-H has an a x ia l  
o r ie n t a t io n  and th e r e fo r e  th e  C -2 -m e th y l is  e q u a t o r ia l l y  
orien ta ted . Hence w ith a £-2-Me, r-4-0C0Et re la t iv e  con figu ra tion , 
the 4 -a ry l group must be a x ia l.
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The ^ - n .m . r .  spectrum  o f the ^ -iso m e r ( 1 3 ,7 ; base in  CDC13) 
supports an e q ua to ria l ly  orien ta ted C-2-methyl, and hence the 4- 
a ry l group must be e q u a to ria l, as the r e la t iv e  con figu ra tion  is  _t-
2-Me, r-4-OCOEt (as in  162a). The re s o lu tio n  o f the s igna ls  o f the 
p ip e rid in e  rin g  carbons was improved compared w ith  the a-isomer and 
the  assignment o f the  a x ia l C-3-H (61.73; 2J=14.3Hz, 3 J=11.4Hz), 
a x ia l  C-5-H (62.01; 2J=15.7Hz, 3J=15.7Hz, 4.3Hz), and e q u a to r ia l 
C-6 -H (62.78; 2 J=11.4Hz, 3 J=2.0Hz) was p o s s ib le . The resonance 
th a t provides c le a r stereochemical in fo rm ation , namely the a x ia l C-
3-H, displayed two la rge  couplings, the la rge  3J being in d ic a tiv e  
o f a x ia l-a x ia l v ic in a l coupling, supporting an a x ia l ly  o rien ta ted 
C-2-H.
Further evidence o f an a x ia l ly  o rien ta ted  aromatic system in  the a- 
isomer was provided by the chemical s h if ts  o f the este r resonances.
9
The 02 C-CH2CH3 resonances o f the a -e s te r  (136) were observed a t 
higher f ie ld  than those o f the 8 ,-ester (137). This ind ica tes tha t 
the  a -e s te r  s u b s t itu e n t is  s h ie ld e d  by the  arom atic  group7^. In 
the conformation (l£3b) the preferred plane o f the aromatic r in g  is  
approximately at r ig h t  angles to  the v e r t ic a l plane drawn through 
N - l and C-4, and in  th is  o r ie n ta t io n  the 0 2C-CH2 CH3 w i l l  be 
shie lded as they pass above the plane o f the aromatic r in g  during 
ro ta tio n  about the C(4)-0 bond1-5*5.
F u rth e r evidence fo r  the assigned con fo rm a tions  comes from the 
l H-n.m.r. spe c tra  o f the h y d ro c h lo r id e  s a l t s .  The ^ - n .m . r .  
spectrum o f the a-(136) hydroch loride in  D20, u n lik e  th a t o f the £ - 
s a l t ,  gave evidence o f  the presence o f e p im eric  con juga te  ac ids
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which a rise  as a re s u lt  o f two modes o f proton uptake at the basic 





(a) a x ia l protonation (b) equa to ria l protonation
(1£4)
Evidence fo r the presence o f epimeric conjugate acids was ind icated 
by d u p lica tio n  o f proton resonances, no ticeab ly  the N7 CH3 , 0C0CH2-> 
C-2-CH3 and 0C0-CH2 CH3. E p im e r ic  co n ju ga te  ac ids  are not 
an tic ipa ted  fo r the 3 -isomer because e q ua to ria l protonation causes 
a d d itio n a l non-bonded in te ra c tio n s  which may not be re lie v e d  by a 
conform ational change, as any departure from (162a) places the C-2- 
m ethyl and 4 - a r y l  in  u n fa v o u ra b le  o r ie n ta t io n s  (see 1& 5). 
Equatoria l protonation o f the a-isomer (1^6) can be re lie v e d  by a 
conform ational change (see Scheme 39) to  an inve rted  cha ir (166a) 



























The conformation o f the two epimeric conjugate acids was judged on 
the basis o f the m u lt ip l ic i t y  o f the C-2-H resonance. Ir ra d ia t io n  
o f  the C -2-m ethyl d o u b le t a t 61.37 (m ajor epimer as judged by 
s igna l in te n s ity )  re su lted  in  the m u lt ip le t  at 53.25 reducing to  a 
d o u b le t o f d o u b le ts  ( 3 J=11.0Hz, 2.8Hz). The la rg e  c o u p lin g  was 
due to  a x ia l - a x ia l  in te ra c t io n  w ith  the  a x ia l  C-3-H, w h ile  the  
s m a ll 3J was in d ic a t iv e  o f a x ia l- e q u a to r ia l  c o u p lin g  w ith  the  
equa to ria l C-3-H. This supports an a x ia l C-2-H as in  the conformer 
(164a). A s im i la r  procedure repeated on the C -2-m ethyl o f the  
minor epimer revealed the C-2-H as e q u a to r ia lly  orien ta ted (3J=4Hz)
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and hence supported the con fo rm ation  ( l£ 6 a or l£ 6 b). The C-2-H 
resonance o f the  JS-isomer co u ld  not be assigned due to  s ig n a l 
o v e r la p . However, exam ination o f the resonance s ig n a ls  o f the 
a x ia l and eq ua to ria l C-3-H supported an a x ia l C-2-H and hence the 
conformer (165a).
Exam ination o f  the  l 3C -n.m .r. sp e c tra  o f  the two isom e ric  e s te rs  
re v e a le d  ve ry  s m a ll chem ica l s h i f t  d if fe re n c e s . Evidence in  
support o f e q u a to r ia l ly  o r ie n ta te d  C -2-m ethy l in  both isomers 
a r is e s  from the s im i la r i t y  o f  th e i r  chem ica l s h i f t  (18.9 ppm fo r  
a -, 18.8 ppm fo r £ -) . Furthermore, the chemical s h if ts  o f the C-4 
and C- 6  are almost id e n t ic a l,  in d ica tin g  a s im ila r  ^ -e f fe c t  by the 
C-2 -m e th y l1® ^ Th is seems to  suggest th a t the d if fe re n c e  in  
con figu ra tion  o f these two isomers must occur at C-4. The assigned 
o r ie n ta t io n  o f  the  arom atic  r in g  in  both isomers (a x ia l in  a - ,  
eq ua to ria l in  0 - )  was supported by the chemical s h i f t  d iffe rence  o f 
the  a rom atic  qua te rna ry  carbon (C-P)« In  the a -iso m e r, the  C -l*  
was u p f ie ld  by 2.3 ppm compared to  the chem ica l s h i f t  o f C-1* in  
the  B.-isomer. Th is u p f ie ld  s h i f t  is  p rob a b ly  due to  s te r ic  
p o la r iz a tio n  o f the a x ia l C - l’66.
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2.4 Pharmacological Evaluation and Concluding Remarks
The 3 a -p h e n o l ic  tro p a n e  ana logue  o f p e th id in e  and re la te d  
s tru c tu re s , and the p h e n o lic  a - and ^ - 2 -m e th y l analogues o f the 
reversed ester o f pe th id ine have been synthesised. The compounds 
105, 70, 11,4, 1^5, 1^.6, 1 £ 6  and 1£7 have a l l  been subm itted  fo r  
p h a rm a c o lo g ic a l e v a lu a t io n  as e ith e r  n a rc o tic  ag o n is ts  or 
antagonists and re s u lts  received to  date are presented in  Table 9.
The an im al te s t  procedures depend on assessment o f the a n im a l’ s 
response to  a noxious stim ulus before and a fte r  adm in is tra tion  o f 
the  te s t  compound. These te s ts  u s u a lly  g iv e  a f a i r  guide to  the 
p o te n cy  o f  th e  d rug  in  man. The in t e r p r e t a t io n  o f  th e  
pharmacological re s u lts  presented below is  based on the m olecular 
fe a tu re s  o f the te s t  compounds a t the  re c e p to r, ra th e r  than 
pharm acokine tic  fa c to rs  such as absorp tion  and transpo rta tion  o f 
drug molecules.
The p h e n o lic  tropane analogue (70) o f pe th id ine displayed feeble  
agonist a c t iv i t y ,  a feature tha t does not support the proposals on 
lig a n d -re c e p to r  in te ra c t io n  o f the 4 -phenylp iperid ine analgesics 
(as discussed in  Section 2.1, page 56). I t  is  possib le to ju s t i f y  
th is  in a c t iv it y  by consideration o f the alignment o f the phenolic -  
OH w ith the receptor. In morphine the o r ie n ta tio n  o f the phenolic 
-OH is  important fo r receptor in te ra c tio n , and is  d ic ta ted  by the 
r ig id i t y  o f the molecule. However, in  the tropane analogue (70) i t  
is  fe a s ib le  tha t the bimethylene bridge prevents accurate alignment 
o f  th is  p h e n o lic  -OH w ith  the re ce p to r as is  p o s s ib le  in  the case 
o f morphine (see 1£7)> and hence is  re s p o n s ib le  fo r  the low
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T a tis  9 ANALGESIC ACTIVITY {EDsc mq/Kg SC IN MICE (95% CONFIDENCE '_ I* IT ) j 
C17 SOME TROPANE ANALOGUES OF PETHIDINE
Compound
pharmacological test
t a il - f l ic k  test a t a il - f l ic k  antagonist test d
1
PHENYLQUINONE TEST C j
Morphine Sulpnate 5.8 (5 .7 -5 .9 ) 0.23 (C .20 -0 .2 5 )
P e th id in e  H yd rocn lo rioe 7.8  (3 .0 -2 0 .6 ) i 0 .8  (0 .3 -2 .2 )
N a lo rph ine  H yd roch lo ride None a t 10 2 .6  (0 .6 9 -9 .7 5 ) 0 .6  (0 .0 2 5 -1 .4 4 )
Me
K y c o 2Et
f  u6 ? HCI
4 .0  (3 .6 -4 .3 ) 0 .5  (0 .2 -1 .7 )
c h 3
105 * 1  ^ X o C H ; j




c o 2e i
* * 1  C i o n
11* a t 30 4 .5  (1 .0 -1 9 .3 )
1
C H ,C H .P h
1 ‘
N v
2 .5  (1 .2 -5 .2 )
i
1 . 0  ( 0 .5 -2 .0 )
1
C H .—C H = C H ,
y  i
V C 0 2Et | 
* 1  0 - O H
7.7 (2 .3 -2 6 .2 )
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Notes fo r  Table 9
a. TAIL-FLICK TEST1 8 3
The procedure in v o lv e s  the a p p lic a t io n  o f a the rm a l s t im u l i  
(focused l i g h t )  to  the  t a i l  o f a mouse fo r  a f ix e d  pe rio d  o f tim e 
known to  induce a f l i c k  o f the t a i l .  Fo llow ing the subcutaneous 
adm in is tra tion  o f the p o te n tia l analgesic agent, the EDso (mgAg) 
can be determined as th a t dose which in h ib its  the t a i l  f l i c k  in  50% 
o f mice under te s t .
The t a i l - f l i c k  is  one o f the most w ide ly used screening tes ts  fo r 
potent analgesics. Almost a l l  compounds which are a c tive  in  the 
t a i l - f l i c k  te s t have, when tested, proven to  be analgesics in  man.
b. TAIL-FLICK ANTAGONISM TEST1 8 4
The a n ta g o n is t potency o f the compounds prepared was assessed by 
t h e i r  a b i l i t y  to  b lo c k  the t y p ic a l  de layed response-tim e to  a 
thermal stim ulus shown by mice medicated w ith a strong analgesic 
(m orphine). The mice were dosed w ith  the  p o te n t ia l  a n ta g o n is t 
(subcu taneous ly , mg/Kg) 10 m inutes p r io r  to  a d m in is tra t io n  o f 
morphine sulphate. The procedure described in  the t a i l - f l i c k  te s t 
was then undertaken.
C. PHENYLQUINQNE TEST1 8 3
The in tra p e rito n e a l in je c t io n  o f mice w ith  an aqueous so lu tio n  o f 
phenylquinone e l i c i t s  a w rith ing  response which is  antagonised by 
a n a lg e s ic  agents (w r ith in g  response is  characterised by repeated 
con traction  o f the abdominal musculature accompanied by extension 
o f the hind lim bs).
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Mice are in jec ted  subcutaneously w ith the compound under te s t, and 
then phenylquinone is  in jec ted  in tra p e r ito n e a lly  2 0  minutes la te r .  
The e f fe c t iv e  dose (mg/Kg) to  in h ib i t  w r ith in g  in  50% o f the te s t  
sample can hence be determined.
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a c t iv i ty .
Morphine Tropane (7 6)
OH
(p a r t ia l  f o r m u l a e )
Cljg75
The a c t i v i t y  d is p la y e d  by the tropane (£7), a n o n -p h e n o lic  
d e r iv a tiv e , can be explained by the p o s s ib i l i ty  th a t a s ig n if ic a n t 
in te ra c tio n  o f the a-phenyl substituen t w ith  the aromatic s ite  o f 
the op io id  receptor is  perm itted. Thi§ cou ld occur even though the 
con fo rm a tion  is  not a p p ro p ria te  fo r  a lig n m e n t o f  a p h e n o lic  
sub s titue n t.
The N-phenethyl tropane analogue (114) d isp layed approximately 2.5 
tim es the  potency o f morphine. Th is potency le v e l  may be due to  
the binding co n trib u tio n  o f the N-phenethyl moiety, as i t  is  w e ll 
known th a t many, i f  not a l l ,  N -phenethy l analogues o f N -m ethyl 
lig a n d s  have m arkedly h ig h e r po tenc ies  than th e i r  co rrespond ing  
parent compounds. Therefore, although the phenolic group w i l l  not 
be id e a l fo r  a s s o c ia tio n  w ith  the re c e p to r , the  presence o f  an N- 
phenethyl group may be responsible fo r the potency le v e l shown.
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I t  is  possib le tha t pharmacokinetic fac to rs  are responsib le fo r the 
marked d iffe rence  in  a c t iv i t y  between the tropane analogue (70) and 
i t s  N-phenethyl congerer (114). The l ip o p h i l ic i t y  associated w ith 
the ^-phenethyl is  much higher than tha t o f an N-methyl group and 
the re fo re  the d iffe rence  in  a c t iv i t y  between the two compounds may 
be due to  greater drug penetration across the b lood-bra in  b a rr ie r 
o f (114).
F in a l ly ,  the N - a l ly l  analogue (116) d isplayed ne ithe r agonist nor 
antagonist a c t iv i t y  (the presence o f an N - a l ly l  group in  the r ig id  
a n a lg e s ics  con fe rs  a n ta g o n is t p ro p e r t ie s ) .  I t  is  g e n e ra lly  
a cce p te d  th a t  a l l  p o te n t o p io id  a n ta g o n is ts  a re  p h e n o lic  
d e r iv a t iv e s .  T he re fo re , to  be an a n ta g o n is t the  lig a n d  must 
in te ra c t  w ith  the  p h e n o lic  s i te  o f the re c e p to r. From the 
in te rp re ta tio n  o f the in a c t iv it y  o f the phenolic analogue (70), i t  
is  suggested th a t in  the phenolic tropanes the association w ith the 
re c e p to r o f the -OH is  poor. Hence, the  absence o f  a n ta g o n is t 
p roperties in  the N - a l ly l  analogue may be understood.
A na lges ic  potency r e s u lts  on a -  and £ -2 -m e th y l analogues o f the  
reversed ester o f peth id ine were not yet a v a ila b le  a t the time o f 
w r it in g  th is  thes is . In the a -2 -methyl analogue (1^ 6 ) sYn d ia x ia l 
non-bonded in te ra c tio n s  which act against optimum a ry l conformation 
in  regard to  phenolic association w ith the receptor should be much 
le s s  than those ob ta ined  in  the tropane analogue. Hence, these 
re s u lts  are required before conclusive deductions can be drawn on 




l H -n.m .r. sp e c tra  were recorded on a JEOL GX270 MHz F o u rie r 
Transform  (FT] NMR Spectrom eter un less  o th e rw ise  s ta te d . The 
fo llo w in g  abbrevia tions are used to  describe resonance appearance 
in  the  ^ - n .m . r .  sp e c tra : s in g le t ,  s; d o u b le t, d; t r i p l e t ,  t ;
qu a rte t, q; m u lt ip le t,  m.
l 3C-n.m .r. s p e c tra  were re c o rd e d  on a JEOL GX270 FT NMR 
Spectrometer operating at 67.8 MHz un less  o th e rw ise  s ta te d . The 
m u l t i p l i c i t y  o f  th e  resonances was o b ta in e d  from  DEPT 
(D is to r t io n le s s  Enhancement by P o la r is a t io n  T ra n s fe r) and INEPT 
(In s e n s itiv e  Nucle i Enhanced by P o la r isa tio n  Transfer) spectra in  
which the phase o f the  s ig n a l in d ic a te d  the  number o f  p ro tons 
attached to  the carbon atom g iv in g  r is e  to  th a t s ig n a l.
The In f ra - re d  spec tra  ( l iq u id s  as f i lm s ,  s o l id s  as KBr d iscs  o r 
Nujol m ulls) were recorded on a Unicam SP1025 Spectrometer.
Mass s p e c tra  were measured on a VG M icrom ass 7070E Mass 
Spectrometer operating a t 70 EV E l.
E lem enta l analyses were c a r r ie d  out by B u tte rw o rth  L a b o ra to r ie s  
L td ., Middlesex.
M e lt in g  p o in ts  were recorded on a Gallenkamp appara tus, and are 
uncorrected.
O p tic a l r o ta t io n  read ings were recorded on an O p t ic a l A c t iv i t y  
L td ., AA-10 Polarim eter.
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3.2 Ancillary Chemicals
3.2.1 Phenyl vinyl ketone (118)
D im ethylam ine h y d ro c h lo r id e  (30g), paraform aldehyde (14g) and
ace tophenone (44g) were d is s o lv e d  in  e th a n o l (160m l), and
concen tra ted  h y d ro c h lo r ic  a c id  (0 .8m l) added. The r e s u lt in g
s o lu t io n  was re f lu x e d  fo r  3 hours and a llo w e d  to  co o l to  room
temperature to  g ive  N,N-dimethyl-2-benzoylethylam ine hydrochloride
as a w h ite  c r y s t a l l in e  p r e c ip ita te  (40g; 51%), m.p. 152°C
186( L i t . ,  m.p. 156°C). The p r e c ip i ta te  was d is s o lv e d  in  K2 C03 
s o lu t io n  (40%’, 200m l), e x tra c te d  w ith  e th e r (3 x 100ml), d r ie d
(MgSOj and evaporated to  g ive j^,N-dim ethyl-2-benzoylethylam ine as 
a c le a r o i l .
v max : 1700cm” 1 (C=0str)
<5,_| (CDC13; free  base):
1.80 ( 6 H; s; 2xN-CH3), 2.31 (2H; t ,  3J 6.5Hz; CH2 -N),_ 2.69 
(2H; t ,  3J 6.5Hz; CH2 -C0Ph), 6 .94-7 .07 (3H; m; A r-H ), 7 .30-7.53 
(2H; m; A r-H ).
5C (C0C13; free  base):
35 .6 8  (CH2 -C 0Ph), 44 .36  (2 x N-CH3), 53 .29  (CH2 -NMe2),
126.89 (Ar-3»; Ar-5»), 127.43 (A r- 2 ,#, A r - 6 »), 131.78 (Ar-4»),
135.88 (Ar-1>), 197.37 (C=0 ).
m/z  (Low EV.EI):
M+ 177 (7%), 58 (100%)
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N,N-Dimethyl-2-benzoyl e th y l amine (25g) was d is s o lv e d  in  acetone 
(250m l), and m ethyl io d id e  (25m l) added. The w h ite  p re c ip ita te  
produced was l e f t  s tand ing  a t room tem perature fo r  3 hours. The 
p re c ip ita te  was f i l te r e d  o f f  and washed w ith  acetone (2 x 50ml) to  
g iv e  N ,N -d im e th y l-2 -b e n zo y le th y la m in e  m ethiod ide (28g; 62%),
m.p. 200°C ( L i t . , 1 8 7  m.p. 212°C, from w ater).
The methiodide (4.0g) was suspended in  K2 C03 so lu tio n  ( 1 0 %; 50ml) 
and extracted w ith ether (4 x 100ml). The ether ex trac t was washed 
w ith  water (2 x 50m l), d r ie d  (MgSOj and evaporated i_n vacuo to  
g iv e  phenyl v in y l  ketone (1.6g; 96%) as a c le a r  o i l  w ith  a
c h a ra c te r is tic  sweet odour, s u f f ic ie n t ly  pure fo r subsequent use.
6 C (CDC1S):
128.27 (A r-3 ’ ; Ar-5»; CH2 =CH-), 129.68 (-CH=CH2), 131.94 (A r-4 ’ ), 
132.63 (A r-2 ’ ; A r - 6 ’ ), 136.87 (A r-1»), 190.38 (C=0)
3 .2 .2  3-(2-Tetrahydropyranyloxy)bromobenzene (157)
3-Bromophenol (25g) was added dropwise to  s t i r r e d ,  ic e -c o o le d  
d ihydropyran  (50g) c o n ta in in g  a few drops o f h y d ro c h lo r ic  a c id . 
The m ix tu re  was s t i r r e d  fo r  an a d d it io n a l 1.5 hours a t room 
tem pera tu re , a f te r  which i t  was d i lu te d  w ith  e th e r (75m l). The 
e th e re a l m ix tu re  was washed w ith  NaOH (10%; 2 x 25m l), water (2 x 
25ml) and then d r ie d  (MgSO^). E va po ra tio n  o f the s o lv e n t l e f t  a 
residue which s o l id i f ie d  on re fr ig e ra tio n . R e c ry s ta llis a tio n  from 
r^-hexane a f fo rd e d  th e  p u re , c o lo u r le s s  c r y s t a ls  o f  3 - (2 -  
tetrahydropyranyloxy)bromobenzene (14.3g; 38%), m.p. 37°C ( L i t . , 5 7
m.p. 39-40°C; L i t . , 1 8 1  reported an o i l ) .
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v max : no c h a ra c te r is tic  s ig n a l.
5h (CDC1s):
1 .49-1 .97 (6 H; m; 0-CH2 -CH2 -CH2 -CH2 -CH), 3 .52-3 .38 (1H-, m* 0- 
CH-CH 2), 3 .75-3 .84 (1H; m; 0-CH-CH2), 5.33 (1H; t ,  3J 2Hz; 
O-CH-O), 6.91-7.22 (4H; m; A r-H ).
6 C (CDCI3 ):
18 .52  (CH2CH2CH2CH), 25 .15  (0 -C H 2CH2 ), 30 .1 9  (0 -CH-CH2),
61.69 (0-CH2) ,  96 .23  (O-CH), 115.2  ( A r - 4 ’ ) ,  119.8  (A r-2 » ),
122.6 (A r -1 ’ ) ,  124.5 (Ar-6»),  130.4 (A r-5»), 157.9 (Ar-3»).
m/z  ;
M+ 256: 258 ( 6  : 6.2%), 85 (100%).
3.2.3 (+)-3,-Nitrotartranilic acid (145)
A s o lu tio n  o f 3 -n itro a n ilin e  (8.0g) and (+ ) - ta r ta r ic  acid (8 . 6 g) in  
dry te tra h y d ro fu ra n  (200ml) was a llo w e d  to  stand under N2 fo r  18 
hours a t 25°C in  the  presence o f d ic y c lo h e x y lc a rb o d iim id e  (13g). 
The d icyclohexylurea which formed was removed by f i l t r a t io n ,  and 
the f i l t r a t e  made basic w ith NaOH (10%) and extracted w ith benzene 
(3 x 25ml). The basic so lu tio n  was a c id if ie d  w ith  HCI (5%) and on 
coo ling  gave the ta r t ra n ila te .  R e c ry s ta llis a tio n  from water and 
d ry in g  gave pure (+ )-3 ,- n i t r o t a r t r a n i l i c  ac id  (5 .4g; 35%) m.p.
209°C ( L i t . , 92 207-208°C); [ a ] 2^  = +92.0° (c 0.5, MeOH)
v max : 3300-3450 cm- 1  (OH s t r ) ,  1730 cm- 1  (C=0 s t r  o f -C00H), 
1680 cm- 1  (C=0 s t r  o f -CONHj.
«H (DMS0-d6] :
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4.47 (1H; d, 3J 3Hz; CH-COOH), 4.48 (1H; d, 3J 3Hz CHCONH), 
7.62 (1H; m; 7.92 (1H; m; A r-6 ’H), 8.10 (1H; m; A r-
4’H), 8.83 (1H; m; A r-2 ’H), 10.24 (1H; s; COOH).
6C (DMS0-d6)
72.39 (CH-COOH), 73.83 (CH-CONH), 114.0 (A r -2 ’ ) ,  118.31 (A r -4 ') ,
126.03 (A r-6 ’ ), 130.25 (Ar-5»), 139.88 (Ar-1»), 148.12 (A r-3 ’ ), 
171.81 (CONH), 174.00 (COOH).
m/z  (Low EV.EI) :
M+ 270 (25%), 252 (18%), 138 (100%), 92 (30%).
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3,3 The Tropanes
3.3 .1  Methyl meso-aa*-dibromoadipate (73)
A m ix tu re  o f a d ip ic  ac id  (lOOg) and th io n y l  c h lo r id e  (200g) was
heated and s t i r r e d  u n t i l  com plete s o lu t io n  occurred and the 
e vo lu tio n  o f hydrogen ch lo rid e  ceased. -The excess th io n y l ch lo rid e  
was removed in  vacuo. A p o r t io n  o f the  r e s u lt in g  ac id  c h lo r id e  
(lOg) was treated w ith dry bromine (20g). The r e s u lt in g  s o lu t io n  
was heated and s t i r r e d  an a d d it io n a l 2 hours, and then added 
cau tious ly  to  methanol (50ml), w h ile  the temperature was maintained 
below 10°C. I t  was then s t i r r e d  a t room tem perature o v e rn ig h t. 
The excess methanol was removed by e va p o ra tio n  in  vacuo and the 
o i ly  residue d isso lved in  ether (50ml). The ether laye r was washed 
w ith  sodium b is u lp h ite  (2%; 2 x 50m l), sodium carbonate (3%;
2 x 100ml) and then water (3 x 100ml), d ried (MgSOj and evaporated 
in  vacuo to  g iv e  m ethyl meso-aa’ -dibromoadipate as a white semi­
s o lid  (6.0g*, 33%). This sem i-so lid  was induced to  s o l id i f y  by the 
a d d it io n  o f pe tro leum  s p i r i t  (b .p . 60-80°C) and had m.p. 73°C 
( L i t . , 100 m.p. 74-76°C).
v max : 1745 cm"1 (C=0 s t r )
<5 (C0C13; recorded on a JEOL J.N.M.-PMX 60 NMR Spectrom eterH
operating at 60 MHz):
2.10-2 .46 (4H; m; CH2-CH2), 3.81 (6H; s, 2 x 0CH3), 4 .16-4 .36 
(2H; m; 2 x CHBr).
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5 (CDC13; recorded on a JEOL FX90X F.T. NMR Spectrom eter
v
operating at 22.5 MHz):
32.45 (CH2-CH2), 44.26 (2 x CH-Br), 53.15 (2 x 0CH3), 169.6
C2 x C=0).
m/z  : M+ 330 (1.6%) : 332 (3.0%) : 334 (1.4%).
3.3.2 cis - 2,5-Dicarbomethoxy-Ti-benzylpyrrolidine (76) and
trans-2,5-Dicarbomethoxy-N-benzylpyrrolidine (77)
A s o lu tio n  o f methyl meso-aa’-dibromoadipate (£3> lOOg) in  to luene 
(300m l) was heated to  r e f lu x ,  hea ting  was then d is c o n tin u e d , and 
benzylam ine (lOOg) added a t a ra te  s u f f ic ie n t  to  m a in ta in  modest 
r e f lu x  (a p p ro x im a te ly  1 hour). At the  end o f the a d d it io n  the 
re a c tio n  m ix tu re  was re f lu x e d  fo r  24 hours. The s o lu t io n  was 
cooled and the s o lid  benzylamine hydrobromide f i l te r e d  o f f .  The 
f i l t r a t e  was washed w ith  water (2 x 50m l), d r ie d  (MgSO,,) and 
evaporated in  vacuo. The re s u lta n t o i l  was d isso lved in  dry ether 
(200ml) and tre a te d  w ith  e th e re a l-H C l. The s o l id  produced was 
f i l te r e d ,  dried and re c ry s ta llis e d  from acetone to g ive  c is -2 ,5 - 
dicarbom ethoxy-N-benzylpyrro lid ine hydroch loride (49g; 52%), m.p.
122°C. The mother l iq u o rs  were reduced in  volume under reduced 
pressure and allowed to  coo l, y ie ld in g  a m ixture o f c is  and tra n s - 
2 ,5 -d ic a rb o m e th o x y -N -b e n z y lp y rro lid in e  h y d ro c h lo r id e . Th is 
mixture was removed by f i l t r a t io n ,  the f i l t r a t e  was evaporated in  
vacuo to  dryness and the re s id ue  was r e c r y s ta l l is e d  from e th y l 
acetate to g ive pure tra ns -2 ,5 -d ica rb om e thoxy-N -be nzy lpy rro lid ine  
hydrochloride (1.4g*, 1.5%), m.p. 113°C.
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c is -2 ,5-dicarbom ethoxy-N-benzylpyrrolidine (76)
v max : 1750 cm’ 1 (C=0 s tr ) ,  760, 710 cm’ 1 (monosub, benzene).
: see tab le  10, No.l
6q : see tab le  11, No.l
Found s C, 57.20; H, 6.53;
C15H2qN0«,C1 requ ires: C, 57.41;
m/z  : see tab le  12
tra n s -2,5-dicarbom ethoxy-N-benzylpyrro lid ine (77) 
v max : 1750 cm-1 (0=0 s tr ) ,  770, 710 cm” 1 (monosub, benzene).
6|_| : see tab le  10, No.2
<5q : see tab le  11, No.2
Found : C, 57.13; H, 6.59; N, 4.43%
C15H20NO„Cl requ ires : C, 57.41; H, 6.38; N, 4.46%
m/z  : see tab le  12
3.3.3 cis-N-Benzyl-2,5-bis(hydroxymethyl)pyrrolidine (78)
A s o lu tio n  o f cis-2,5-dicarbomethoxy-N-benzy lp y r ro l id in e  (76*, 62g) 
in  dry tetrahydro furan (300ml) was added s lo w ly , w ith  s t i r r in g ,  to  
a suspension o f L iA lH ^ (18 .6g) in  dry te tra h y d ro fu ra n  (250m l) a t 
0°C. The m ix tu re  was s t i r r e d  and re f lu x e d  fo r  1 hour, coo led  to  
0-5°C and then c a u t io u s ly  tre a te d  w ith  water (300m l). A fte r  
s tand ing  fo r  1 hour a t room tem perature the s o l id  m a te r ia l was 
f i l t e r e d  o f f .  The f i l t r a t e  was washed w ith  water (2 x 50ml), dried 
(MgS0,J and evaporated _in vacuo to  y ie ld  c i s - N-benzy 1 -2 ,5 -b is -
N, 4.49%
H, 6.38; N, 4.46%
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(h y d ro x y m e th y l)p y rro lid in e  as a l i g h t  y e llo w  o i l .  Treatm ent o f 
th is  o i l  w ith  ethereal-HC l gave the hydrochloride (44g; 76%) m.p. 
121 °C ( L it . ,  109 m.p. 118-120°C).
v max : 3500-2300 cm-1 (OH s t r ,  NH s t r ) ;  780, 720 cm-1
(monosub, benzene).
5h : see tab le  10, No.3
Sc : see tab le  11, No.3
m/z  : see tab le  12
3.3.4 cis-N-Benzyl-2,5-bis(chloromethyl)pyrrolidine (72)
Thionyl ch lo rid e  (76g) was added, w ith s t i r r in g ,  to  a suspension o f 
c is -N-benzy 1 -2 ,5 -b is  (hydroxyme thy  l)p y r ro lid in e  (78*, 47g) in  dry
to lu e n e  (300m l). The m ix tu re  was s t i r r e d  fo r  2 hours a t room 
tem pera tu re , and fo r  an a d d it io n a l hour a t 30°C, u n t i l  com plete 
s o lu tio n  occurred and the e vo lu tio n  o f hydrogen ch lo rid e  ceased. 
Dry ether (300ml) was added and a s o lid  p re c ip ita te d . This s o lid  
was c o l le c te d  by f i l t r a t i o n ,  washed w ith  dry e th e r (2 x 50m l), 
d r ie d  and then r e c r y s ta l l is e d  from iso p ro p a n o l to  g iv e  c is -N - 
benzy 1-2, 5-b is (ch lo rom e th y l)p y rro lid ine  h y d ro c h lo r id e  (33g; 53%)
m.p. 164°C ( L i t . , 108 m.p. 163-164°C).
v max : 1600 cm"1 (C . . . C s t r ) ;  760, 710 cm"1 (monosub.
benzene)
<5|_| : see tab le  10, No.4
<Sq : see tab le  11, No.4
m/z  : see tab le  12
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3.3.5 cis-N-Benzyl-2,5-bis(iodomethyl)pyrrolidine ( §2)
A mixture o f anhydrous sodium iodide (1.7g) and dry acetone (1 0 0 m l)  
was heated on a steam bath fo r  1 hour. c i s - N -B e n z y l-2 ,5 -b is  
(c h lo ro m e th y l)p y r ro lid in e  (72; 2g) was then added and hea ting
m a in ta in e d  f o r  24 h o u rs . The m ix tu re  was c o o le d  to  room 
tem pera tu re , and the s o l id  f i l t e r e d  o f f .  The f i l t r a t e  was 
concen tra ted  _in vacuo and ch lo ro fo rm  (50m l) was added. The 
c h lo ro fo rm  was washed w ith  sodium b is u lp h i te  (10%; 2 x 100ml),
sodium hydrogen carbonate (5%; 50ml) and then water (2 x 50m l),
d ried (MgSOj and evaporated under reduced pressure to  y ie ld  c is -N- 
benzy 1-2 ,5-b is  (iodomethyl )p y rro lid in e  as a ye llow  o i l  (1.6g; 48%).
v max : 760, 710 cm"1 (monosub, benzene)
6h j see tab le  10, No.5
6C : see tab le  11, No.5





R n- ch2- H2H5 H3H„ Other Protons
1 b
76




trans co2ch3 e 63.83,m 61.91,m 
62.30,m
0CH3 63.63, s 
A ryl-H  67.20-7.31,m
3 c
78












c is ch2i 63.70,S 62.93,s 62.60-
2.80,m









S p e c t r a  r e c o r d e d  in  CDC13 w i t h  i n t e r n a l  
te tra m e th y ls ila n e , 6 values ( in  ppm) re fe r  to  centres o f 
resonance s igna ls  and hence re p re sen t o n ly  approxim ate 
chemical s h if ts  in  most cases.
S p e c tra  were re c o rd e d  on a B ru c k e r WH-400 NMR 
Spectrometer operating at 400 MHz.
S p e c tra  were re c o rd e d  on a JEOL J.N .M .-PM X60 NMR 
Spectrometer operating at 60 MHz.
As hydrochloride s a lt .
S ig n a l appears as an AB q u a r te t;  63.95 fo r  one p ro ton  
and 63.78 fo r the other; 2J = 13Hz.
Table 11 19C-N.M.R. CHARACTERISTICS OF SOME N-BENZYLPYRROLIDINES a
R
No. Compound Isomer
R 19C Chemical S h ifts  (ppm; TMS in te rn a l standard)
Designation
n- ch2 C -  2 C -  3
Aromatic C
-  5 -  4 Cq Co Cm Cp Other carbons
1 76 c is C02CH3 59.92 67.61 30.82 139.6 131.8 130.2 129.4 02-CH3: 
C = 0  :
53.80
175.9
2 77 trans co2ch3 54.07 63.38 28.39 138.6 129.0 128.2 127.1 02-CH3: 
C = 0 :
51.36
174.4
3 78 c is ch2oh 58.29 65.88 27.19 139.4 129.1 128.4 127.3 CH20H : 63.54
4 72 c is ch2c i 58.02 65.93 27.25 138.6 127.6 127.4 126.3 CH2C1 : 46.59
5 82 c is ch2i 57.91 66.79 26.71 139.2 128.7 128.3 127.3 CH2I  s 30.28
a. Spectra were recorded on a J.E.O.L. FX90X Fourier Transform N.M.R. Spectrometer operating a t 22.5 MHz; 
bases in  COCl3
Table 12 PERCENT ABUNDANCE OF DIAGNOSTIC FRAGMENT IONS OF SOME N-BENZYLPYRROLIDINES a
Compound Isomer R M + l
Ion Types ^
Designation
A B C D E F
76 c is CO2CH3 100 58 17 27 37 8 -
77 trans CO2CH3 97 55 22 100 42 17 -
78 c is CH2OH 80 38 23 100 37 13 27






28 85 13 93°
(36)
00u>
a. Spectra recorded on ISO.BUT (C l) programme.
b. Ion types are: A B
c z iR tip  o  y  chj-CiPx
1 u ^  Hx ’ 1CH2Ph H M n CHph
c. Values in  parentheses represent fragment abundance o f ion contain ing high atomic weight isotope.
d. M+l fo r 72; 258 (47%) : 260 (28%) : 262 (5%).
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3.3.6 Methyl 3j8-hydroxy-8-methyl-8-azabicyclo[3,2,1] octane-3a-
carboxylate
(a-Ecgonine methyl es te r; 90)
A saturated aqueous s o lu tio n  o f potassium cyanide (18g) was added 
to  a saturated aqueous so lu tio n  o f tropan-3-one hydrochloride (40g) 
w h ile  the temperature was maintained below 10°C. The white s lu r ry  
was s t ir re d  at room temperature fo r 30 minutes, f i l te r e d ,  and the 
r e s u l t in g  crude cyanohydrin  washed w ith  water (100m l), e th a n o l 
(75m l) and e th e r (100m l), and then d r ie d  _in vacuo. The cake was 
added portionw ise to 500ml o f concentrated hydroch lo ric  acid w ith 
s t i r r in g  w h ile  the tem perature o f the  ac id  was kept below 25°C. 
The r e s u lt in g  m ix tu re  was heated on a water bath a t 80°C fo r  48 
hours and then evaporated to  dryness under reduced pressure. The 
crude a-ecgonine hydrochloride was dried by azeotropic d is t i l la t io n  
w ith  to luene. The s o lid  was added to  750ml o f methanol saturated 
w ith dry hydrogen ch lo rid e , and re fluxed  fo r 20 hours. The so lve n t 
was evaporated in  vacuo, the residue d isso lved  in  water (150ml) and 
f i l t e r e d .  The f i l t r a t e  was made basic w ith potassium carbonate and 
extracted w ith chloroform  (4 x 200ml). The combined extracts  were 
washed w ith  water (2 x 50ml), dried (MgSOj and evaporated iin vacuo 
to  g ive  a-ecgonine methyl ester (26g*, 57%), m.p. 112-113°C (L it . ,
129 m.p. 114°C).
v max s 2500-3300 cm-1 (OH s t r ) ,  1710-1770 cm’ 1 (C=0 s t r )
<5h : see tab le  13, No.l
<Sq : see tab le  14, No.l




(3ot-B is (metamethoxyphenyl)hydroxymethyl-3B-tropanol; 96)
a-Ecgonine methyl ester (9X1', 8.0g) was heated under re f lu x  fo r  90 
m inutes w ith  the  G rignard  reagent prepared from 3-brom oan iso le  
(5 6 .8g) and magnesium (8.0g) in  dry te tra h y d ro fu ra n  (200m l). The 
s o lu t io n  was then s t i r r e d  a t room tem pera tu re  o v e rn ig h t. The 
cooled product was then poured onto ice and ace tic  acid (50ml) and 
e x tra c te d  w ith  e th e r (3 x 50m l). The aqueous la y e r  was b a s if ie d  
w ith  s tro n g  aqueous ammonia and e x tra c te d  w ith  c h lo ro fo rm  (3 x 
100ml). The combined chloroform  extracts  were washed w ith water (2 
x 50ml), dried (MgSOlf) and evaporated to  g ive  3B-hydroxy-3a- b is (3 - 
m ethoxyphenyl)hydroxym ethyl -8 -m e th y l-8 -a z a b ic y c lo [3 ,2 ,j]o c ta n e  
(13 .8g; 90%) as a l i g h t  y e llo w  o i l .  Treatm ent o f  th is  o i l  w ith
ethereal-H C l gave the hydrochloride, m.p. 239-241°C (acetone).
v max s 3150-3400cm"1 (OH s t r ) ,
: see tab le  13, No.2
6q : see tab le  13, Nos. 2 and 3
Found : C, 65.79; H, 7.39; N, 3.21%
C23H30N0ltCl requires : C, 65.79; H, 7.16; N, 3.34%
see tab le  17
-  186 -




A suspension o f the d io l  h y d ro c h lo r id e  (96-HC1; lOg) and fused 
powdered zinc ch lo rid e  (30g) in  ace tic  anhydride (30ml) was s t ir re d  
fo r  24 hours a t room tem perature (s o lu t io n  com plete w ith in  40 
m inu tes). I t  was poured in to  a s o lu t io n  o f sodium hydrox ide  in  
water (15%; 400ml) and then extracted w ith chloroform  (5 x 200ml).
The chloroform  was washed w ith water (3 x 100ml), dried (MgSOj and 
evaporated to  y ie ld  the t i t l e  compound as a dark brown o i l  (7.5g; 
86%).
v max : 1780 cm-1 (C=0 s t r )
6q : see tab le  14, No.4
m/z  : see tab le  17
3.3.9 3J3-(3-Methoxybenzoyl)-3o-(3-methoxyphenyl)-8-methyl-8- 
azabicyclo[ 3,2,1] octane oxime hydrochloride
(3a-(3-Methoxyphenyl)-38.-tropanyl(3- 
methoxyphenyl)ketoxime hydroch loride ; 101)
A mixture o f 3§-(3-methoxybenzoyl)-3a-(3-methoxyphenyl)-8-methyl-8- 
a za b icyc lo [3 ,2 ,l]o c ta n e  (99; lOg), hydroxy lam ine h y d ro c h lo r id e  
(8.0g), pyrid ine  (50ml) and p ropa n -l-o l (200ml) was re fluxed  fo r 16 
hours. On coo ling  a s o lid  was deposited which was f i l t e r e d  o f f  and 
washed w ith  w a te r . The r e s u l t in g  s o l i d  was d r ie d  and 
r e c r y s ta l l is e d  from water to  g iv e  3 j3 -(3 -m ethoxybenzoy l)-3a -(3 - 
m ethoxyphenyl)-8 -m ethyl-8-azab icyclo [3 ,2 ,l]octane oxime h y d ro -
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c h lo rid e  (4.2g; 37%), m.p. 280-282°C.
v max s 3130-3500 cm’ 1 (OHstr)
S,_| : see tab le  13, No.3
6 C ; see tab le  14, No.5
Found : C, 62.98; H, 7.22; N, 6.38%
C2 3 H2 9 N2 O3CI.H 2 O requires : C, 63.50; H, 7.13; N, 6.44% 
m/z  : see tab le  17
3.3.10 3a-(3-Methoxypheny1) - 8 -m ethy l-8 -azabicyclo [3,2,1] octane-
3^-carboxy lic  acid hydrochloride
(3 a -(3 -M e th o x y p h e n y  1 )-3B _-tropane c a r b o x y l ic  ac id  
hydrochloride*, 103)
Dry hydrogen c h lo r id e  was passed in to  a suspension o f 33.— (3— 
methoxybenzoy1)-3a-(3-m ethoxyphenyl)-8-m ethyl-8-azabicyclo[3,2 ,1 ] 
octane oxime h y d ro c h lo r id e  (101; lOg) in  g la c ia l  a c e t ic  ac id  
(100ml). A fte r a few minutes, complete so lu tio n  occurred and the 
whole was heated on a steam bath w h ile  hydrogen ch lo ride  was s lo w ly  
passed in to  the s o lu t io n .  A fte r  2 hours the s o lu t io n  was 
evaporated to  dryness under reduced p ressure . The c r y s t a l l in e  
re s id u e  was b o i le d  w ith  ace tone  to  y ie ld  th e  amino a c id  
hydrochloride (3.6g; 48%), m.p. 210°C (methanol-ether).
v max : 2500-3000 cm’ 1 (OHstr), 1730 cm’ 1 (C=0str)
: see tab le  13, No.4
<Sq : see tab le  14, No. 6
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Found : C, 61.48; H, 7.36; N, 4.18%
C i6 H2 2 N03C1 requ ires : C, 61.63; H, 7.07; N, 4.30%
m/z  : see tab le  17
3.3.11 Ethyl 3a-(3-methoxyphenyl)-8-methyl-8-azabicyclo[3,2,l]
octane-38rcarboxylate hydrochloride
( E th y l  3 a -(3 -m e th o x y p h e n y l)-3 8 r tropane c a rb o x y la te  
hydrochloride; 105)
A s o lu t io n  o f 3 a -(3 -m e th o xyp h e n y l)-8 -m e th y l-8 -a za b icyc lo [3 ,2 ,l] 
o c ta n e -3 8 .-ca rb o xy lic  ac id  h y d ro c h lo r id e  (103; lOg) in  a b s o lu te  
ethanol (2 0 0 ml) saturated w ith dry hydrogen ch lo ride  was re fluxed  
fo r  24 hours. E vapo ra tio n  to  dryness gave a c r y s t a l l in e  s o l id  
which was r e c r y s ta l l is e d  from e th a n o l-e th e r  to  g iv e  the t i t l e  
compound (6 .3g; 58%), m.p. 135°C.
v max : 1710-1750 cm” 1 (C=0str)
6 h : see tab le  13, No.5
<5C : see tab le  14, No.7
Found : C, 61.01; H, 7.96; N, 3.80%
C1 8 H2 6 N03 C1.H20 requires : C, 60.67; H, 7.56; N, 3.92%




(E thyl 3a-(3-hydroxyphenyl)-38r tropane carboxylate; 70) 
Boron tr ib ro m id e  in  d ich lo rom ethane (1.0M; 10ml) was added to  a
s o lu tio n  o f e th y l 3a-(3-m ethoxyphenyl)-8-m ethyl-8-azabicyclo 3,2,1 
octane-38^-carboxyla te  (105, as base; l.O g) in  d ry  c h lo ro fo rm  
(5m l). The m ix tu re  was s t i r r e d  a t room tem perature  fo r  2 hours, 
and then poured onto a m ix tu re  o f ic e  and ammonia. The l ib e ra te d  
fre e  base was e x tra c te d  w ith  c h lo ro fo rm  (3 x 50m l), the combined 
chloroform  extrac ts  were dried (MgS0,J and evaporated vacuo to  
y ie ld  a l ig h t  brown o i l .  Treatment o f the o i l  w ith  e therea l-H C l, 
and subsequent c r y s ta l l is a t io n  o f the re s u lt in g  s o lid  from ethanol, 
gave e th y l  3 a -(3 -h y d ro x y p h e n y 1 ) -3 8 - t ro p a n e  c a r b o x y la te  
hydroch loride (0.45g*, 41%), m.p. 208-209°C.
v max : 3200-3300 cm"1 (OHstr), 1740 cm"1 (C=0str)
<SH : see tab le  13, Nos. 6 and 7
: see tab le  14, No.8
Found : C, 62.92; H, 7.62; N, 4.15%
c i7 H2*»N03Cl requires : C, 62.67; H, 7.37; N, 4.30% 
m/z  s see tab le  17
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Table 13 XH-N.M.R. CHARACTERISTICS OF SOME 3,3-OISUBSTITUTEP TRQPANESa
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Aryl-H  66.85,7.20 
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Notes to Table 13
a. 5 values re fe r to  centres o f resonance s ign a ls  and hence 
represent on ly approximate chemical s h if ts  in  most cases. 
J (approx) and values are given in  Hz.
b. Unresolved, near-symmetrical m u lt ip le t.
c. Narrow m u lt ip le t.
d. 2-Proton m u lt ip le t w ith two prominent lin e s .
e. 2-Proton s igna l o f two broad lin e s .
f .  4-Proton m u lt ip le t (poorly reso lved).
g. M u lt ip le ts , higher 1 and lower f ie ld  3 proton in te n s ity .
h. 2-Proton s igna l w ith two prominent lin e s .
i .  2-Proton m u lt ip le t.
j .  M u lt ip le ts ,  higher 1, middle 1 and lower f ie ld  2 proton
in te n s ity .
k. M u lt ip le ts ,  higher 1, middle 2 and lower f ie ld  1 proton
in te n s ity .
1. Spectrum  re c o rd e d  on a JEOL GX 400 MHz FT NMR
Spectrometer.
m. Spectrum  re c o rd e d  on a B ru c k e r WH-400 MHz NMR
Spectrometer.
Table 14 1 *C -N .M ,R . CHARflCTF.RISl ICS OF SOME 3.3-UISUBSTITUTEO TROPANES3
C Chemica] S h if ts  (ppm; TMS I n t .  S tandard)
E s te r
CH2/
CHj
A rom atic CCompound O-CHaS o lven t C-3 C=0 or 
C=N or
N-CH, C - l C-6C-2No
-7
C-6C -3 ’C - l ’ C -2 ’-C-OH
52.3571.55CDC1 39.30 58.42 27.27
(7 5 .0 ) (7 5 .8 ) 120.7114.6 128.1111.5 158.7CDC1 39.98 58.78 41.82 28.88
(80 .5 0 )(77 .3 6 ) 122.1160.0 J 15.8 128.7148.2 112.555.5340.36 60.19 29.53MeOH
119.3
(1 1 9 .3 )
129.1
(1 2 8 .3 )
159.5
(15 8 .7 )
115.1
(1 1 3 .2 )






(1 2 8 .0 )
101 158.9
(15 8 .4 )
39.49 60.89 162.7 113.4
( 111.0 )
37.59
117.4127.5139.3 110.2 157.6 121.1103 60.00 21.06 173.4 53.50DMSO 32.50
119.1 60.35
14.14
CDC1 128.945.83 143.8 111.5 113.339.33 59.10 40.52 27.63
118.0 60.78
13.99
129.0CDC1 175.8 156.8 114.5114.238.97 59.18 26.74
a . Values in  parentheses may be in te rch a n g e d .
b . Spectra were recorded on a J .E .O .L . FX 90X F o u r ie r  Transform  N.M .II. Spectrom eter o p e ra tin g  a t 22 .5  M lz.
c . As base.
d . H igh f i e ld  resonance (CHa). Low f i e ld  resonance (CH2).
e. S ig n a l no t seen due to  low c o n c e n tra t io n .
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3.3.13 Ethyl 3a-(3-methoxyphenyl )-8-azabicyclo [3,2,1] octane-3fr-
carboxylate
(E th y l 3a -(3 -m ethoxyphenyl)-3 j3 -nortropane carboxylate*,
1Q8)
E th y l 3a -(3 -m ethoxypheny l)-8 -m ethy l-8 -azab icyc lo [3 ,2,1] octane-3g- 
carboxyla te (105, as base; 5.0g) and t r ic h lo ro e th y lc h lo ro fo rm a te  
(6 . 0 g) were d is s o lv e d  in  dry to lu e n e  ( 1 0 0 m l), and anhydrous
potassium carbonate (2.0g) was added. The m ixture was re fluxed  fo r 
2 days, cooled and ether added (200ml). The re s u lt in g  s o lu tio n  was 
washed w ith  NaOH (5N, 2 x 80ml) and then w ith  water (3 x 50m l). 
The organic laye r was separated, dried (MgSOj and evaporated under 
r e d u c e d  p r e s s u r e  t o  g i v e  a gum . The e x c e s s
tr ic h lo ro e th y lc h lo ro fo rm a te  was removed vacuo to  g ive  a white 
s o lid .  This white s o lid ,  in  ace tic  acid (90%; 150ml), was treated
w ith  powdered z in c  (1 .5 g ) and th e  m ix tu re  s t i r r e d  a t room 
tem perature fo r  16 hours. The m ix tu re  was b a s if ie d  w ith  ammonia 
and extracted w ith chloroform  (4 x 250ml). The combined chloroform  
e x tra c ts  were washed w ith  water (2 x 50m l), d r ie d  (MgS0,J and 
evaporated _in vacuo to  y ie ld  e th y l 3 a -(3 -m e tho xyp he n y l)-8 - 
a z a b ic y c lo [3 ,2 , l]o c ta n e -3 £ -c a rb o x y la te  as a l i g h t  brown gum. 
Treatment o f  th is  gum w ith  e th e re a l-H C l gave the h y d ro c h lo r id e
(3 .2g; 60%), m.p. 201-204°C (e thanol).
v max : 3340 cm" 1 (N-H s t r ) ,  1730 cm" 1 (C=0str)
5h : see tab le  15, No.l
s see tab le  16, No.l
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Found : C, 62.83; H, 7.59; N, 4.11%
c i 7 H2 «fN0 3Cl requires : C, 62.67; H, 7.37; N, 4.30% 
m/z  : see tab le  17
3.3.14 Ethyl 8-(cyclopropylmethyl)-3a-(3-methoxyphenyl)-8- 
azabicyclo [3,2,1 ]octane-3jJ-carboxy late
(E th y l ^ -(cyc lo p ro p y lm e th y l)-3 a -(3 -m e th o x y p h e n y l)-3 8 - 
nortropane carboxylate; 1 1 0 )
Cyclopropylm ethyl bromide (1.8g) was added dropwise to  a m ixture o f 
e th y l 3a-(3-m ethoxyphenyl)-8-azabicyclo[3,2,l] octane-38-carboxylate 
(108; 1.5g) and potassium  carbonate (2 .9g) in  a b so lu te  e th an o l
(90ml). The re s u lt in g  m ixture was re fluxed  fo r 2 days, cooled and 
e th e r added (200m l). S o lid  m a te r ia l was f i l t e r e d  o f f  and the 
f i l t r a t e  washed w ith water (2 x 20ml), dried (MgSOJ and evaporated 
in  vacuo to  g ive  e th y l 8-(cyclopropylm ethyl)-3a-(3-m ethoxyphenyl)- 
8 -a z a b ic y c lo [3 ,2 ,l]o c ta n e -3 g >- c a r b o x y la te  as a w h ite  s o l i d .  
Treatment o f an e thano lic  s o lu tio n  o f th is  s o lid  w ith  ethanolic-H C l 
gave the hydrochloride ( l . lg ;  56%), m.p. 184-185°C (acetone).
v max s 1730cm"1 (C=0str)
6 h : see tab le  15, No.2
5q : see tab le  16, No.2
Found : C, 66.73; H, 7.79; N, 3.73%
C2 iH 3 0 N03C1 requires : C, 66.40; H, 7.91; N, 3.69%
see tab le  17
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3.3.15 E th y l  8 - (c y c lo p ro p y lm e th y l) -3 a -(3 -h y d ro x y p h e n y l) -8 -  
azabicyclo [3 ,2 ,1 ] octane-3&-carboxylate (115)
E th y l 8 -(c y c lo p ro p y lm e th y l)-3 a -(3 -m e th o x y p h e n y l)-8 -a z a b ic y c lo -
[3 ,2 ,l]o c ta n e -3 £ -c a rb o x y la te  (110; 0.8g) in  dry chloroform  (5ml)
was trea ted w ith boron trib rom ide in  dichloromethane (1.0M; 10ml)
by the same procedure described in  section 3.3.12, to  g ive  e th y l 8 -  
(cyclopropylm ethyl)-3a-(3-hydroxyphenyl)-8 -azab icyc lo [3 ,2 ,1 ]-  
octane-38-carboxylate as an o i l .  Treatment o f th is  o i l  w ith 
e th e re a l-H C l gave the h y d ro c h lo r id e  ( 6 6 mg; 7.7%), m.p. 238°C
(e thano l).
v max : 3150-3250 cm- 1  (0-H s t r ) ,  1740 cm’ 1 (C=0str)
6 ,_| : see tab le  15, No.3
<5C : see tab le  16, No.3
Found : C, 66.10; H, 7.33; N, 3.79%
C2 0 H2 8 N03C1 requires : C, 65.66; H, 7.66; N, 3.83%
m/z  : see tab le  17
3.3.16 E th y l 8 - a l l  y l-3a -(3 -m e tho xyp he n y l)-8 -aza b icyc lo [3,2,1] 
octane-3£-carboxylate
(E th y l  hJ—a 1 l y  1 -3 a -(3 -m e th o x y p h e n y l)-3 8 -n o rtro p a n e  
carboxylate; 113)
E thy l 3a-(3-m ethoxyphenyl)-8-azabicyclo[3 ,2 ,l]octane-38-carboxyla te  
(1Q8> 1.5g) and potassium  carbonate (2 .9g) in  a b s o lu te  e th a n o l
(90ml) were treated w ith a l l y l  bromide (1.3g) by the same procedure 
described in  section 3.3.14. E thy l 8 -a lly l-3a -(3 -m e thoxyp hen y l)-8 -
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azab icyc lo [3 ,2 ,l]octane-38-carboxyla te  was obtained as a c le a r o i l .  
Treatment o f the o i l  w ith  e th e re a l-H C l gave the h y d ro c h lo r id e  
(0 .7g; 37%), m.p. 175°C (acetone).
v max : 1740 cm” 1 (C=0str)
5h : see tab le  15, No.4
6 q : see tab le  16, No.4
Found : C, 65.46; H, 7.52; N, 3.81%
C2 0 H2 8 N03C1 requires : C, 65.66; H, 7.66; N, 3.83%
m/z  : see tab le  17
3.3.17 Ethyl 8-allyl-3a-(3-hydroxyphenyl)-8-azabicyclo[3,2>l]
octane-38-carboxylate (116)
E th y l 8 - a l  ly l-3 a -(3 -m e th o x y p h e n y l ) - 8 -azab icyc lo [ 3,2,1 ]octane-38- 
carboxylate (113*, 0.6g) in  dry c h lo ro fo rm  (5m l) was tre a te d  w ith  
boron tr ib ro m id e  in  d ich lo rom ethane (1.0M; 10ml) by the  same
procedure described in  section 3.3.12, to  g ive  e th y l 8 -a l ly l-3 a - (3 -  
hyd roxyphenyl)-8 -azab icyc lo [3 ,2 ,l]octane-38 .-carboxyla te  as an o i l .  
Treatm ent o f th is  o i l  w ith  e th e re a l-H C l gave the h y d ro c h lo r id e  
(52mg; 8 %), m.p. 199-20l°C (e thanol).
v max s 3200-3100 cm- 1  (OHstr), 1740 cm" 1 (C=0str)
<SH : see tab le  15, No.5.
: see tab le  16, No.5
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Found : C, 64.59; H, 7.21; N, 3.79%
C1 9 H2 6 N03C1 requires : C, 64.86; H, 7.39; N, 3.98%
m/z  : see tab le  17
3.3.18 Ethyl 3a-(3-methoxyphenyl)-8-phenethyl-8-azabicyclo-
[3,2,1]octane-3£-carboxylate
(E th y l 3a -(3 -m ethoxypheny l)-N -phenethy l-38-nortropane 
carboxylate; 109)
E thy l 3a-(3-methoxyphenyl)-8-azabicyclo [3,2,1] octane-38-carboxylate 
(108; 1.5g) and potassium  carbonate (2 .9g) in  a b s o lu te  e th an o l
(90m l) were tre a te d  w ith  phene thy l bromide (1 .4g) by the  same 
procedure described in  section 3.3.14. E thy l 3a-(3-methoxyphenyl)- 
8 -phene thy l-8 -azab icyc lo [3 ,2 ,l]oc tane -38^-ca rboxy la te  was obtained 
as an o i l .  Treatment o f  th is  o i l  w ith  e th e re a l-H C l gave the
9
hydroch loride (1.2g; 54%), m.p. 194°C (acetone).
v max : 1730 cm" 1 (C=0str)
<SH : see tab le  15, No. 6
: see tab le  16, No. 6
Found • C, 70.00; H, 7.33; N, 3.03%
C2 5 H3 2 NO3 CI requires : C, 69.84; H, 7.45; N, 3.26%




E th y l 3a -(3 -m ethoxypheny l)-8 -phenethy l-8 -azab icyc lo [3 ,2 ,l] octane- 
3 £ -ca rb o xy la te  (109; 0.6g) in  dry c h lo ro fo rm  (10m l) was tre a te d
w ith boron trib rom ide (1.0M*, 10ml) by the same procedure described
in  section 3.3.12, to  g ive  e th y l 3a-(3-hydroxyphenyl)-8-phenethyl- 
8 -a za b icyc lo [3 ,2 ,l]o c ta n e -3 6 .-ca rb o xy la te  as a l i g h t  brown semi­
s o l id .  Treatm ent o f th is  s e m i-s o lid  w ith  e th e re a l-H C l gave the 
hydrochloride (113mg*, 17%), m.p. 214-215°C (e thanol).
v max : 3200-3450 cm” 1 (OHstr), 1740 cm” 1 (C=0str)
6|_j : see tab le  15, No.7
6C : see tab le  16, No.7
Found : C, 69.02; H, 6.99; N, 3.48%
C2lfH30N03Cl requires : C, 69.31; H, 7.22; N, 3.37%
m/z  : see tab le  17
3.3.20 Ethyl 8-(2-benzoylethyl)-3a-(3-methoxyphenyl)-8- 
azabicyclo[ 3,2,1] octane-30-carboxylate
( E th y l  N -(2 -be nzoy  1 e th y l)-3 a -(3 -m e th o x y p h e n y l) -3 £ - 
nortropane carboxylate; 117)
E thy l 3a-(3-m ethoxyphenyl)-8-azabicyclo[3,2,1] octane-38-carboxylate 
(1Q8; 0.8g) was d is s o lv e d  in  dry to lu e n e  (6m l) and phenyl v in y l  
ketone (1.5g) added. The s o lu tio n  was re fluxed  overn ight and then 
evaporated in  vacuo. The o i l y  res idue  was d is s o lv e d  in  e th e r 
(100ml) and e x tra c te d  w ith  HC1 (0.2M; 2 x 50m l). The aqueous
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la y e r  was washed w ith  e th e r (3 x 60m l), b a s if ie d  w ith  K2C03 (30%; 
60m l), and e x tra c te d  w ith  c h lo ro fo rm  (3 x 100m l). The combined 
c h lo ro fo rm  la y e r  was washed w ith  water (2 x 50m l), d r ie d  (MgSOJ 
and evaporated jLn vacuo to  g iv e  e th y l 8 -(2 -b enzoy le th y l)-3a -(3 - 
m e thoxyphenyl)-8 -azab icyc lo [3 ,2 ,l]octane-3£-carboxyla te  as an o i l .  
Th is o i l  was d is s o lv e d  in  acetone and tre a te d  w ith  a s o lu t io n  o f 
maleic acid in  acetone to  y ie ld  the maleate s a l t  (1.3g*, 87%), m.p. 
145°C (acetone).
v max : 1700, 1730 cm"1 (2 x C=0str)
6h : see tab le  15, No.8
<5C s see tab le  16, No.8
Found : C, 67.20; H, 6.53; N, 2.46%
C3 oh 3 sn 0 8 requires : C, 67.04; H, 6.52; N, 2.60%
see tab le  17
-  2 0 0  -
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Notes to Table 15
a. 6 values re fe r to  centres o f resonance s igna ls  and hence 
represent on ly approximate chemical s h if ts  in  most cases. 
J (approx) and values are given in  Hz.
b. Unresolved near-symmetrical m u lt ip le t.
c. 2-Proton s igna l w ith two prominent lin e s .
d. 2-Proton m u lt ip le t w ith two prominent lin e s .
e. 2-Proton m u lt ip le t.
f .  M u lt ip le ts , higher 1 and lower f ie ld  2 proton in te n s ity .
g. Signal overlaps CH2-Ch[3 resonance.
h. Spectrum  rec o rd ed  on a JEOL GX 400 MHz FT NMR
Spectrometer.
i .  4-Proton m u lt ip le t poorly resolved,
j .  1-Proton m u lt ip le t.
k. 2-Proton m u lt ip le t.
1. M u lt ip le ts ,  higher 1, middle 2 and lower f ie ld  1 proton
in te n s ity .
m. M u lt ip le ts ,  higher 1, middle 1 and lower f ie ld  2 proton
in te n s ity .
n. Signals overlap.
o. M u lt ip le ts , higher 1 and lower f ie ld  8 proton in te n s ity ,
p. Broad m u lt ip le t.
q. Narrow m u lt ip le t.
r .  Complex m u lt ip le t o f 9 proton in te n s ity .
13C Chemical  S h i f t s  ( p . p . m . ; IMS I n t e r n a l  S t and a r d)
N itrogen  S ubs tituen t
<t =  o  o  o  o  o  |z  o  |oI X3 a o  xj l  i  ~n  / \  ix \  gn  .n ii | o — |o  / i v
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'a o ls  17 PERCENT ABUNDANCE OF DIAGNOSTIC FRAGMENT IQN'S OF SQN£ 3 .3-DI5USSTITUTED TRQRANES AND RELATED COMPOUNDS
R3
ION TYPES 3
Compound R1 R2* RJ
♦
M A B C 0 E Other







42 36 30 8 18 M+-R2 (10 0 ); R2+ (50)
99 Me Ar
II






Ar-C - 11 100 45 _ 11 13
| 103 Me Ar COOH 40 100
i
92 47 50 53
| 105
|
Me Ar C02£ t 45 100 92 47 42 28
1
70 Me Ar* C02£ t 42 92 100 45 52
1
33
10S H Ar C02£ t 19 100 30 21 12 -
110 ch2- < ] Ar C02£ t 19 35 100 25 24 ~ 1 R‘ *  (51)
115 ch2- 0 A r ’ C02£ t 15 39 100 20 23 -
+
R1 (44)
113 ch2- ch=ch2 Ar C02£ t 50 49 100 47 35 - R1+ (35)
116 ch2- ch=ch2 A r ’ C02£ t 45 53 100 45 45 27 Rl+  (36)




A r ' C02E t c 13 7 5 - - M*-91 (93)
+ +
117 PhCCH2CH2 Ar C02Et 25 20 23 D 22 - PhC0CH=CH2 (2 7 ) ; PhCO (68)
a. Ion types a re : 
A
n^ r'
b . Ar = C3
n- r'
O C H ,




h c = n - R ’
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3.3.21 3a-Hydroxy-8-methyl-3§-phenyl-8-azabicyclo[3,2,l] octane
(38r Phenyl-3a-tropanol; 129; R=H)
Tropan-3-one (lOg) in  dry e th e r (50m l) was added to  a s t i r r e d  
s o lu t io n  o f p h e n y l- l i th iu m  {prepared from bromobenzene (46g) and 
l i th iu m  ( 2 . 2 g )} in  dry e th e r ( 1 0 0 m l) over a p e rio d  o f 2 0  m inutes. 
The mixture was s t ir re d  fo r 30 minutes a t room temperature and then 
re fluxed  fo r 90 minutes. The re s u lt in g  so lu tio n  was cooled, poured 
onto ice and HC1 (2M*, 50ml) and a s o lid  separated. This s o lid  was 
washed w ith  e th e r (2 x 50m l), b a s if ie d  w ith  NaOH (20%) and the 
l ib e ra te d  fre e  base e x tra c te d  w ith  c h lo ro fo rm  (3 x 100ml). The 
combined c h lo ro fo rm  e x tra c ts  were washed w ith  water (2 x 50m l), 
d r ie d  (MgSOJ and evaporated to  y ie ld  3a -hyd roxy-8 -m e thy l-3 B r  
pheny l-8 -azab icyc lo [3 ,2 ,l]o c tan e  as a w h ite  s o l id  (7.9g; 51%),
m.p. 159-160°C ( L i t . , 1 2 1  161-162.5°C).
v max : 3200-3400 cm” 1 (OH s t r )
<SH i see tab le  18, No.l
6 q : see tab le  19, No.l
m/z  : see tab le  2 0
3.3.22 3a-Acetyloxy-8-methyl-30-phenyl-8-azabicyclo[3,2,1] octane
(59)
Tropan-3-one (lOg) in  dry e th e r (50m l) was added to  a s t i r r e d  
s o lu tio n  o f p h e n y l- lith iu m  {prepared from bromobenzene (46g) and 
l i th iu m  (2 .2g )} in  dry e th e r (100m l). The m ix tu re  was s t i r r e d  
overn ight and then re fluxed  fo r 1 hour. The re s u lt in g  s o lu tio n  was 
cooled and ace tic  anhydride added (50ml). The m ixture was s t ir re d  
fo r  5 hours and then poured onto ice  and a c e tic  ac id  (50m l). The
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aqueous la y e r  was separa ted , washed w ith  e th e r ( 2  x 1 0 0 m l), 
ba s ifie d  w ith K2 C03 and extracted w ith chloroform  (3 x 100ml). The 
combined ch lo ro fo rm  e x tra c ts  were washed w ith  water (2 x 50m l), 
d r ie d  (MgS0,J and evaporated in^ vacuo to  y ie ld  a dark brown o i l .  
The o i l  was t r itu ra te d  w ith petroleum s p i r i t  (b.p. 60-80°C) and the 
petroleum s p i r i t  was separated and evaporated in  vacuo to  y ie ld  a 
ye llow  o i l .  Treatment o f th is  o i l  w ith  ethereal-HC l and subsequent 
r e c r y s t a l l i s a t io n  from e th a n o l gave 3 a -a c e ty lo x y -8 -m e th y l-3 £ - 
ph e ny l-8 -a za b icyc lo [3 ,2 ,l]o c ta n e  h y d ro c h lo r id e  (9 .3 g ;  44%)
m.p. 198°C.
v max : 1750 cm“ l (C=0str)
6 |_| : see tab le  18, No.2
6 q : see tab le  19, No.2
m/z  s see tab le  2 0
3.3.23 8-Methyl-3-phenyl-8-azabicyclo[3,2,1] oct-2-ene
(3-Phenyltrop-2-ene; 1^0; R=H)
A m ix tu re  o f 3 a -h y d ro x y -8 -m e th y l-3 j3 -p h e n y l-8 -a z a b ic y c lo [3 ,2 ,l]  
octane (129*, R=H*, 6 g), concentrated HC1 (46ml) and g la c ia l ace tic  
ac id  (96m l) was heated under r e f lu x  fo r  12 hours. Most o f the 
so lve n t was removed i.n vacuo, the residue d isso lved in  water and 
the s o lu t io n  made a lk a l in e  w ith  NH^OH. This was e x tra c te d  w ith  
chloroform  (3 x 75ml). The combined chloroform  ex tra c t was dried 
(MgSO,,) and e v a p o ra te d  to  g iv e  8 -m e th y  1 -3 -p h e n y  1  - 8 -  
a z a b ic y c lo [3 ,2 ,l]o c t-2 -e n e  as an o i l  which was d i s t i l l e d ,  and the 
fra c tio n  having b.p. 126°C/l.5mm Hg c o lle c te d  (5.2g#, 95%)
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( L i t . , 1 2 1  b .p . fo r 120; R=H, 113-115°C/0.45 mm Hg).
v max : 1600, 1500cm” 1 (C=Cstr)
5h : see tab le  18, No.3
6 C : see tab le  19, No. 3
m/z  : see tab le  2 0
3.3.24 8-Methyl-3a-phenyl-8-azabicyclo[3,2,1]octane
(3a-Phenyltropane; 1^1\ R=H) 
8-M ethy l-3 -pheny l-8 -azab icyc lo [3 ,2 ,l] oc t-2 -e n e  (13,0; R=H> 3g) in  
methanol (100ml) was hydrogenated over pa llad ium  charcoal (0.5g) a t 
60 p .s . i .  in  a ro ck in g  Parr apparatus a t room tem perature fo r  16 
hours. The c a ta ly s t was f i l te r e d  o f f  and the f i l t r a t e  evaporated 
to  g iv e  8 -m e th y l-3 a -p h e n y l-8 -a z a b ic y c lo  [3,2,1] octane as an o i l .  
Treatm ent o f th is  o i l  w ith  e th e re a l-H C l gave the h y d ro c h lo r id e  
(2 .1g; 5Q%), m.p. 218-219°C ( L i t . , 1 6 3  m.p. 217.4-218.8°C).
v max j 770, 720 cm” 1 (monosub, benzene)
5|_l : see tab le  18, No.4
<5C : see tab le  19, No.4
m/z  : see tab le  2 0
3.3.25 8-Methyl-38-phenyl-8-azabicyclo[3,2,1] octane
(38r Phenyltropane; 132) 
3a-Hydroxy-8-m ethyl-38-phenyl-8-azabicyclo[3,2,l] octane (129*, R=H; 
3g) was added ra p id ly  to  a s t ir re d  suspension o f Raney Ni (30g) in  
absolute ethanol (300ml), and re fluxed  fo r 48 hours. The c a ta ly s t 
was f i l t e r e d  o f f  and the ethanol removed in  vacuo to  y ie ld  a white
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sem i-so lid . Ether (100ml) was added to th is  sem i-so lid , the s o lid  
m a te r ia l which formed was f i l t e r e d  o f f  (shown to  be 1£9; R=H).
The f i l t r a t e  was dried (MgSOJ and evaporated in  vacuo to  y ie ld  an 
o i l  which was d is t i l le d .  The fra c tio n  having b.p. 110°C/4mm Hg was 
c o l le c te d  (0 .2g; 7%) ( L i t . , 1 6 3  b .p . fo r  132, 92-94°C/0.2mm Hg).
Treatment o f the o i l  w ith  ethereal-HC l gave 8-m ethyl-38-phenyl-8 - 
a za b icyc lo [3 ,2 ,l]o c ta n e  h y d ro c h lo r id e , m.p. 203°C ( L i t . , * 6 5  m.p. 
203.2 -  205.2°C).
v max : 760, 710 cm" 1 (monosub, benzene)
6 h : see tab le  18, No.5
<SC : see tab le  19, No.5
m/z  : see tab le  2 0
3.3.26 3a-Hydroxy-38-(3-methoxyphenyl)-8-methyl-8-azabicyclo-
[3 ,2 ,l]o c ta n e  (1£5) 
n -B u ty l l i th iu m  (7.7g) in  hexane was added to  3 -brom oan iso le  
(22.4g) in  anhydrous te tra h y d ro fu ra n  (100m l) under N2 a t -55°C . 
The mixture was s t ir re d  at -50°C fo r 2 hours and then tropan-3-one 
(lOg) was added, w ith  s t i r r in g  a t -45°C, ove r 30 m inu tes. The 
m ix tu re  was s t i r r e d  a t 25°C fo r  1 hour, coo led  to  -10°C and then 
quenched w ith iced-water. F o llo w in g  a c id i f ic a t io n  w ith  HC1 ( 6 M) 
the m ix tu re  was e x tra c te d  w ith  e th e r (3 x 100m l). The aqueous 
laye r was b a s ifie d  w ith aqueous NaOH (5M) and the product extracted 
w ith ether (3 x 100ml). The ether ex tra c t was washed w ith  water (2 
x 25m l), d r ie d  (MgS0,J and evaporated under reduced pressure to  
y ie ld  a ye llow  o i l .  Anhydrous ether (50ml) was added to th is  o i l  
and 3a-hydroxy-30r (3 -m e tho xyp h e n y l)-8 -m e th y l-8 -a za b icyc lo [3,2,1]
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octane separated as a w h ite  s o l id  (5.4g; 30%), m.p. 125-126°C
(e thy lace ta te ).
v max : 3100-3300 cm” 1 (OHstr)
6 h : see tab le  18, No. 6
<5C : see tab le  19, No. 6
Found: C, 72.77; H, 8.74; N, 5.49%
C1 5 H2 iN02 requires : C, 72.87; H, 8.50; N, 5.66%
m/z  : see tab le  2 0
3.3.27 3-(3-M ethoxyphenyl)-8-m ethyl-8-azabicyclo [3 ,2 ,l]oct-2-ene 
(l^O-, R=0Me)
3a-Hydroxy-30- (3-methoxyphenyl ) - 8 -m ethyl-8 -azabicyclo[ 3 ,2 ,1 ] -octane 
(125; 2g) was tre a te d  w ith  concen tra ted  HC1 (40m l) and g la c ia l
a c e tic  ac id  (80m l) by the same procedure as described  in  s e c tio n
3.3.23 to  g ive 3-(3-m ethoxyphenyl)-8 -m e th y l- 8 - a z a b ic y c lo - [3 ,2 ,1 ] 
oct-2-ene as a c le a r o i l  (1.4g*, 76%). Treatment o f th is  o i l  w ith
ethereal-HC l gave the hydroch lo ride« m.p. 220°C (acetone).
v max : 770, 720 cm" 1 (monosub, benzene)
5h : see tab le  18, No.7
Sc : see tab le  19, No.7
Found: C, 67.87; H, 7.84; N, 5.04%
c i 5 H20NOCl requires : C, 67.79; H, 7.53; N, 5.27%
: see tab le  2 0
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3.3.28 3a-Hydroxy-3j5-(3-hydroxyphenyl)-8 -m ethy l-8 -azab icyc lo -
[3 ,2 ,l]o c ta n e  (1£9; R=0H)
r i - B u t y l  l i t h i u m  (1 .3 g )  in  hexane  was added to  3 - ( 2 -  
te t ra h y d ro p y ra n y lo x y )b ro m o b e n  zene (4 .5 g )  in  a n h y d ro u s  
te tra h y d ro fu ra n  (50m l) under N2 a t -55°C over a p e rio d  o f 20 
m inu tes. The m ix tu re  was s t i r r e d  a t -50°C fo r  2 hours and then 
tropan -3 -one  (2g) in  te tra h y d ro fu ra n  (30m l) was added, w ith  
s t i r r in g  a t -45°C, over 30 m inutes. The m ix tu re  was then poured 
onto ic e  and ammonium c h lo r id e  and e x tra c te d  w ith  e th e r (3 x 
100m l). The combined e th e r e x tra c ts  were washed w ith  water (2 x 
25ml), dried (MgSOj and then evaporated in  vacuo to  y ie ld  a l ig h t  
ye llow  o i l .  Treatment o f th is  o i l  w ith  ethereal-HC l y ie lded  3a- 
hydroxy-38.-(3-hydroxyphenyl)-8 -m ethy l-8 -azab icyc lo [3 ,2 ,1 ] octane 
h y d ro c h lo r id e  as a white s o lid  (2.3g*, 59%), m.p. 254°C (e thanol).
v max : 3200-3400 cm” 1 (OHstr)
S|_j : see tab le  18, No. 8
; see tab le  19, No. 8
Found: C, 62.48; H, 7.49; N, 5.12%
CllfH2 0 N02Cl requires : C, 62.33; H, 7.42; N, 5.19%
see tab le  2 0
2 1 0
T a D le  13 ‘ h -N . M. R . CHARACTERIST ICS OF SOME 3 .3 —01. SUBSTITUTED TRQPANES5
NO. Compound N-CH3 1(5 )-H 2 (4 )-H 6 (7 )-H
I
Other Protons
1 (129; FhH) 
in  C0C13 b
62.33, s 63.23 d |








OH 51.70 broad s 
A ry i-H  67.25, 7.52
2 (59)
in  CDCI3
62 .3 , s 63.25 . ! 
V^ 8  d 9
g COCH3 61.98, s 
A ry l-H  67.20, s
(130; R=H) 
j in  CDClj




CH=C 66.22, d, J6 .5  
I A ry i-H  67 .15 -7 .3 7 , m
4 | (131; R=H)
! ~ b I HC1 in  c
COCI 3
62.74, s 63.31 ,  |
wi* 1 0  0
1
f
I 63- 15e 62.56
61.84
62.00
3-H 63.44, oroad t  
3 J ~  ~
A ry l-H  67 .24 -7 .44 , m
5 ! (132) in  
j in  CDCI3
1
53.22 | 




! 3-H 62.83, sep te t




| (125; R=0Me) 
in  COCia b







OCH3 63.79, s 
j A ry i-H  66.75, 7 .08 , 7.23








i OCH3 63.84, 3 
CH=C 66.25 J6.5  
A ry l-H  67 .13 -7 .3 9 , m
•
3 1(129, R=0H) 
HC1 in  020°







A ry l-H  66.77, 6.96 7.25 1
I1
1
a. 6 v a lu e s  r e f e r  to  c e n tre s  o f  resonance  s ig n a ls  and hence re p re s e n t o n ly  a p p ro x im a te  
cnem ical s h i f t s  in  most cases.
J (approx) and W% va lues are g iven  in  Hz.
b . Spectra recorded on a JEOL GX 400mhz FT N.M.R. Spectrom eter.
c . Spectrum recorded on a JEOL JNM-Pmx 60NWz nmp. Spectrom eter.
d. Unresolved near sym m etrica l m u l t ip le t .
e. 2 -P ro ton  m u l t ip le t  w ith  two prom inent l in e s .
f .  2 -P ro ton  m u l t ip le t .
g. O verlapping unreso lved m u lt ip le ts  (6 2 .0 -6 2 .5 ) .
h. 2 -P ro ton  complex m u l t ip le t .
i .  M u lt ip le ts  (6 1 .5 1 -2 .2 2 ; 6H) and (62 .7 4 -2 .9 0 ; 2H).
j .  P art o f  two o ve rla p p in g  m u lt ip le ts  (4 -p ro to n  in te n s i t y ) ,
k . Two 2 -p ro to n  m u lt ip le ts  which o ve rla p .
Table 19 1’e-N .M .R . CHARACTERISTICS OF SOME 3.3-D1SUBSTITUTED TROPflNES RND RELATED COMPOUNDS3
1 3C C h e m ic a l S h i f t s  (ppm ; TMS I n t .  S ta n d a r d )






C -3 C - l ' C - 2 ’ C - 3 ' C -4 * C - 5 ’ C -6 * O th e r  C a rb o n s
1 1 2 9 ; R=H 4 0 .2 9 6 0 .7 9 4 5 .4 3 2 5 .5 3 7 2 .6 4 1 5 0 .3 1 2 8 .0 1 2 4 .5 1 2 6 .5 1 2 4 .5 1 2 8 .0
2 59 b 3 9 .7 6 6 0 .4 6 4 0 .4 7 2 5 .4 6 7 8 .6 6 1 4 5 .5 1 2 8 .1 1 2 4 .2 1 2 6 .8 1 2 4 .2 1 2 8 .1 1 6 9 .3  c  
2 2 .5 4
3 1,50; R=H 
b
3 4 .8 3 ( 5 7 . 7 5 )
( 5 6 . 1 2 )
1 2 5 .4
3 2 .1 3
( 3 1 . 3 7 )
( 2 8 . 3 3 )
1 3 0 .8 1 3 8 .6 1 2 6 .7 1 2 3 .1 1 2 5 .5 1 2 3 .1 1 2 6 .7
4 1 3 1 ; R=H 4 0 .6 3 5 9 .7 1 3 8 .5 5 2 7 .9 9 3 2 .3 4 1 4 6 .3 1 2 8 .1 1 2 7 .2 1 2 5 .5 1 2 7 .2 1 2 8 .1
5 l 32 4 0 .5 4 6 1 .5 9 3 9 .2 3 2 6 .2 2 3 4 .8 7 1 4 5 .9 1 2 8 .4 1 2 7 .2 1 2 6 .0 1 2 7 .2 1 2 8 .4
6 !2 5 4 0 .3 2 6 0 .7 8 4 5 .3 7 2 5 .6 2 7 2 .8 8 1 5 2 .2 1 1 0 .6 1 5 9 .5 1 1 1 .8 1 2 9 .1 1 1 7 .0 5 5 .2 7  d
7 1 3 0 ; b 
R=OMe
3 6 .2 4 ( 5 9 . 3 7 )
( 5 7 . 7 5 )
1 2 4 .2
3 3 .8 0
( 3 2 . 9 9 )
( 3 2 . 9 9 )
1 3 2 .5 1 4 1 .8 1 1 0 .9 1 5 9 .8 1 1 2 .3 1 2 7 .1 1 1 7 .3 5 4 .9 0  d
8 1 £ 9 ;R = 0 H 4 0 .0 3 6 1 .0 7 4 4 .8 3 2 5 .1 1 7 7 .3 3 1 5 1 .5 1 1 3 .7 1 5 7 .4 1 1 4 .8 1 2 9 .1 1 1 5 .5
a .  B a s e s  in  C D C 1 ,; v a l i  je s  in  p a r e n th e s e s  may be  in t e r c h a n g e d .
b .  S p e c t r a  w e re  r e c o r d e d  on JEOL FX 90X  F o u r i e r  T ra n s fo r m  NMR S p e c tr o m e te r  o p e r a t in g  a t  2 2 . 5  MHz.
c .  H ig h  F ie l d  re s o n a n c e  (C H 3 ) .  t 0 w f i e l d  re s o n a n c e  ( C = 0 ) .
d .  OMe s ig n a l  o f  a r y l  g r o u p .
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Table 20 PERCENT ABUNDANCE OF DIAGNOSTIC FRAGMENT IONS OF SOME
3,3-DISUBSTITUTED TROPANES AND RELATED COMPOUNDS
ION TYPES3
No. Compound M+ A B C D E F
1 129; R=H 23 1 0 0 75 43 13 - 42
2 59 b - - - 4 63 13
3 130; R=H 13 - - - - 1 0 0 5
4 131; R=H 38 1 0 0 1 0 0 43 - 17 47
5 132 43 1 0 0 97 43 - 32 52
6 125 30 1 0 0 72 55 1 2 - 30
7 130; R=OMe c - - - - 5 13
8 129; R=OH 33 1 0 0 75 50 1 2 - 28
a. Ion types are:
A B C
D E F
c h 3n = c h  
c h 3
b. not seen; M+l observed in  ISO-BUT Cl spectrum (260; 3%)
c. M+ not seen;
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3.4 The P iperid ines
3.4.1 D ie thy l 3,4-dimethyl-4-azaheptanedioate (141)
E thy l crotonate (120g) was added to 33% w/v methylamine in  I.M.S. 
( 1 0 0 m l); the mixture was heated under re f lu x  fo r  8  hours and then
frac tiona ted  to g ive e th y l 3-methylaminobutyrate b.p. 68°C/10mm Hg
(85g; 56%). ( L i t . , 1 8 8  b .p . 72°C/l2.5mm Hg).
v max : 1730cm"1 (C=0str)
6  (CDC13; free base):H
1.21 (3H; t ;  CH2 -CH3), 1.36 (3H; d; CH-CH3), 2.29 (2H; d; 
CH-CH2 -C0), 2.50 (3H; s; N-CH3), 2.95 (1H; m; CH-CH3), 4.16 
(2H; q; -0-CH2 CH3).
6 q (CDC13; free base):
14.35 (CH2 -CH3), 20.15 (CH-CH3), 33.75 (N-CH3), 41.50 (CH-CH2 -C0), 
'52.28 (CH-CH3), 60.03 (0-CH2 -CH3), 172.0 (C=0)
A mixture o f e th y l 3-methylaminobutyrate (80g) and e th y l a c ry la te  
(65g) was ke p t a t room te m p e ra tu re  fo r  10 days and the n  
frac tiona ted  to g ive  d ie th y l 3,4-dim ethyl-4-azaheptanedioate, b.p. 
108°C/lmm Hg (84g; 62%) ( L i t . , 1 8 9  b .p . 129°C/6mm Hg).
v max : 1730cm"1, 1750cm"1 (C =str).
5h (CDC13; free base):
1.20 (3H; d; CH-CH3 ) , 1.43 ( 6 H; t ;  2 x CH2 -CH3), 2.33 (3H; s; 
N-CH3 ), 2 .49-2 .83 ( 6 H; m; 2 x CH2 -C0, CH2 -N ), 3.33 (1H; m; 
CH-CH3), 4.20 (4H; q; 2 x O-C^-Chfe).
6 C (CDC13; free base) :
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13.81 (2 x CH2 CH3), 33.48 (CH2 CH2 CO), 33.97 (N-CH3), 38.19 
(CH-CH2 C0), 48.65 (C H ^H ^), 55.37 (CH-CH3), 59.59 (2 x 0-CH,-CH, ), 
171.62 (2 x C=0)
3 .4 .2  1 ,2-D im ethyl-4-piperidone (138)
D ie th y l 3 ,4 -d im e thy1 -4 -azahep taned ioa te  (141; 50g) was added
s lo w ly  to  a s t i r r e d  m ix tu re  o f  sodium amide ( l l g )  in  to lu e n e  
(400m l). The p roduct was heated under r e f lu x  o v e rn ig h t,  then 
cooled and a c id if ie d  cau tious ly  w ith hyd roch lo ric  acid (2M). The 
to lu e n e  la y e r was separated and e x tra c te d  w ith  d i lu t e  HC1 (5 x 
100ml), and the combined acids were then heated under re f lu x  fo r 15 
hours. The s o lu t io n  was concen tra ted  under reduced p ressu re , 
ba s ified  w ith s o lid  NaOH and extracted w ith chloroform  ( 8  x 150ml). 
The combined ch lo ro fo rm  e x tra c ts  were washed w ith  water (2 x 
100ml), d r ie d  (MgS0,J and evaporated in  vacuo. The re s id u e  was 
frac tiona ted  to  g ive l,2 -d im e thy l-4 -p ipe ridone , b.p. 36-40°C/0.2mm 
Hg (13.5g; 51%) ( L i t . , 7 3  55-57°C/7mm Hg).
v max : 1730cm-1 (C=0str)
6  (CDC13; free base):
1.20 (3H; d; CH-CHg), 2.43 (3H; s; N-CIja), 2 .20 -2 .90  ( 6 H; m; 
C3-H, C5-H, C6 -H ), 3.00-3.33 (1H; m; C2-H).
6 C (CDC13; free base):
19.61 (C2-CH3), 41.12 (C -5), 41.44 (N-CH3), 48.59 (C -3 ), 54.55 
(C-6 ), 58.51 (C -2), 207.16 (C=0)
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3.4.3 a - and 3- l,2-Dimethyl-4-phenylpiperidin-4-ol (1^9 and 
1£0)
l ,2 -D im e th y l-4 -p ip e r id o n e  (138*, 15g) was added to p h e n y l- lith iu m  
{from bromobenzene (23g) and lith iu m  (2.0g)} in  dry ether (150ml). 
The m ix tu re  was s t i r r e d  o v e rn ig h t a t room tem perature and then 
re fluxed  fo r 4 hours. The cooled product was poured onto ice and 
ace tic  acid (40ml). The aqueous phase was separated, washed w ith 
ether (2 x 40ml), and concentrated under reduced pressure. I t  was 
then made a lk a lin e  w ith strong aqueous ammonia and the lib e ra te d  
fre e  base e x tra c te d  w ith  ch lo ro fo rm  ( 6  x 100ml). The combined 
c h lo ro fo rm  e x tra c t  was d r ie d  (MgS0,J and evaporated to  y ie ld  a 
l ig h t  ye llow  o i l .  This residue was d ilu te d  w ith petroleum s p i r i t  
(b.p. 60-80°C’, 750ml) and the re s u lta n t s o lid  was re c ry s ta ll is e d
from the same so lven t to  g ive _8 -l,2 -d im e thy l-4 -p h en y lp ip e rid in -4 -o l 
(10.4g; 43%), m.p. 108-110°C. ( L i t . , 7 5  106-108°C).
v max : 3050-3300cm “ 1 (O -H s tr ) ,  760, 710cm-1 ( monosub.
benzene).
<SH s see tab le  2 1
: see tab le  22, No.2
m/z  : M* (6 6 %), 70 (100%), 71 (18%), 42 (23%)
The mother liq u o rs  were reduced in  volume under reduced pressure to  
ap p ro x im a te ly  250ml and l e f t  to  stand o v e rn ig h t. A s o l id  was 
deposited which was shown to  be a - l,2 -d im e th y l-4 -p h e n y lp ip e rid in -4 - 
o l (9.8g; 40%), m.p. 120°C. ( L i t . , 7 5  122-123°C).
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v max : 3100-3400 cm" 1 (OH s t r ) ,  770, 710cm "1 (monosub,
benzene).
: see tab le  2 1
: see tab le  22, No.l
: M;  (73%), 70 (100%), 71 (25%), 42 (27%).
3.4.4 (i)-or4-Acetyloxy-l,2-dimethyl-4-phenylpiperidine
A c e ty l c h lo r id e  (4 .0 g ) was added to  ( t ) - a - l , 2 - d im e th y l - 4 -  
pheny lp ipe rid in -4 -o  1(129', l.Og) in  toluene (130ml) and the m ixture 
was heated under re f lu x  overn igh t. The cooled product was d ilu te d  
w i th  e th e r  and th e  ( t  ) - a _ -4 -a c e t  y lo x y - l , 2 - d im e t h y 1 -4 -  
p h e n y lp ip e r id in e  h y d ro c h lo r id e  (0.61g*, 44%), m.p. 186°C, ( L i t . , 7 5  
184-185°C) c o lle c te d  by f i l t r a t io n .
v max : 1750cm"1 (C=0 s t r )
6  (CDC13; free base):
H
1.10 (3H; d, 3J 6.2 Hz; C-2-CH3), 1.69 (1H; d x d, 2J 16 Hz,
3J 11.3 Hz; ax 3-H), 2.03 (3H; s; C0CH3), 2.32 (3H; s; N-CH3), 
2 .06-2 .25 (5H; m; C-2-H, eq 3-H, eq 5-H, ax 5-H, ax 6 -H ), 2.78 
(1H; d x q, 2J 13.5 Hz, 3J 6  Hz, 2.3 Hz; eq 6 -H ), 7 .21-7 .33 (5H; 
m; A r-H ).
6 C : see tab le  22, No.3
m/z  : M4" (8 %), 187 (100%), 172 (75%).
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Table 21
1H-N. M. R. CHARACTERISTICS OF a- AND 8- 1,2-DIN£THYL-
4-PHENYLPIPERIDIN-4-OLa
No.l
a -1 ,2-Dimethy1-4- 
phenylpiperidin-4-ol
No.2
J3-1,2-Dime thy 1-4- 
phenylpiperiain-4-ol
N-CHj 52.35, s 62.22, s
C2-CH3 51.10, d 51.13, d
J 6.25 0 6.2
2-H 52.40, m b -62.10, m C
ax 3H d 51.77
*013.6, 3010.5
eq 3H d e
ax 5H 62.20,
*013.6, 3J13.6, 5.0
eq 5H d e
ax 6H 52.62
*011.8, 3011.8, 2.48 e
eq 6H 62.80 62.80






a. Spectra recorded in CDC13 with in te rn a l te tra m e th y ls ila n e . 6 values
refer to centres of resonance signals and hence represent only approx­
imate chemical shifts in most cases. J (approx) values are given in Hz.
b. Complex m ultip le t, signal reduces to doublet of doublets (3011.2, 3.1 Hz)
by irrad iation of C-2-methyl doublet.
c. Part of m u ltip le t  at 62.1; ir ra d ia t io n  at 62.1 causes the C-2-methyl 
doublet to reduce to a singlet.
d. Poorly resolved m ultiplet (61.70-1.84; proton intensity 3H).
e. Signals part of poorly resolved multiplets.
f . M ultiplets, higher 1, middle 2 and lower fie ld  2 proton intensity.
Table 22 1 aC- N.M.R. CHEMICAL SHIFTS OF 2-METHYL ANALOGUES OF REVERSED ESTERS OF PETHIDINE 3
OR
CH
13 O ie m ic a l S h i f t s  (ppm; TMS I n t .  S ta n d a rd )
No. Ccxnpound Isom er R N - q i j C -2 C -3 C -4 C -5 C -6 C -2
A ro m atic  C
D e s ig n a tio n -Me
Cq Co Cm Cp R
1 a - H 4 2 .1 3 5 6 .2 6 4 4 .1 3 7 1 .6 5 3 8 .2 6 5 3 .0 6 1 9 .6 2 1 4 5 .0 1 2 8 .3 1 2 6 .6 1 2 7 .3
2 140 3 - H 4 2 .7 3 5 4 .6 2 4 7 .2 2 7 1 .8 7 3 8 .2 7 5 2 .5 3 2 0 .3 0 1 4 8 .6 1 2 8 .2 1 2 4 .5 1 2 6 .9
3 a c e ta te  
e s te r  o f
a - coch3 4 2 .4 9 5 4 .2 6 4 4 .2 1 8 1 .0 5 3 5 .8 4 5 2 .2 6 2 0 .2 8 1 4 4 .0 1 2 8 .2 124 .1 1 2 7 .0 1 6 9 .0
2 1 .9 0
a . S p e c tra  re c o rd e d  as base in  CCC13 .
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3.4.5 Resolution of (l)-a-l,2-dimethyl-4-phenylpiperidin-4-ol
A s o lu t io n  o f  ( t ) - a - l ,2 - d im e th y l-4 -p h e n y lp ip e r id in -4 - o l ( 1 2 9 * 
1.2g) in  methanol (50m l) was added to  a suspension o f ( - ) - 3 ’ -  
n i t r o ta r t r a n i l ic  acid (2.17g) in  methanol (50ml), and the mixture 
heated on a steam bath fo r  5 m inutes. The s o lu t io n  was f i l t e r e d  
and the f i l t r a t e  evaporated in  vacuo. The residue was d isso lved  in  
a minimum amount o f warm methanol and the s o lu tio n  allowed to  cool 
to  room tem perature be fo re  r e f r ig e r a t io n  a t -5°C o v e rn ig h t.  A 
s o l id  (w t. 1.9g) w ith  [a ] p3 -  55.0° (C=0.5, MeOH) formed. A fte r  
four a d d itio n a l c ry s ta ll is a t io n s ,  800mg o f reso lved m a te ria l (no 
improvement o f r o ta t io n  on repeated re c ry s ta l l is a t io n )  w ith m.p. 
196°C and [ a ] p 3 -60 .0° (C=0.5, MeOH) was ob ta ine d . The (+ ) - fre e
base was generated by add ition  o f Nh^ OH to  the s a l t  and ex trac tio n  
w ith  dichloromethane (3 x 50ml). The dichloromethane extrac ts  were 
d r ie d  (MgSO,,), evaporated and the remaining s o lid  re c ry s ta ll is e d  
from petroleum s p i r i t  (b.p. 40-60°C) to  g ive  (+ )-a -l,2 -d im e th y l-4 - 
p h e n y lp ip e r id in -4 -o l,  (0.22g) [ a ]p 3 + 1.0° (0=1.0, MeOH) m.p. 
119°C.
P a r t ia l ly  re s o lv e d  ( - ) -a - l,2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l was 
recovered from the re so lu tio n  mother liq u o rs  by add ition  o f base 
(10% NaOH) and ex tra c tion  w ith chloroform  (3 x 30ml). Solvent was 
removed from the ex trac t in  vacuo to  g ive  crude ( - ) - a - l , 2 -d im e th y l- 
4 -p he n y lp ip e rid in -4 -o l (0.8g). This base was combined w ith (+)-3*- 
n i t r o t a r t r a n i l i c  ac id  (1.45g) and tre a te d  as described  above to  
a f f o r d  ( - ) - a - l ,2 - d im e th y 1 - 4 - p h e n y 1p ip e r  i d i n - 4 - o l - ( + ) - 3 ’ -  
n i t r o t a r t r a n i l a t e  m.p. 201°C [< * ]p 3 + 60 .0 ° (C =0.5 , MeOH). 
I s o la t io n  o f the fre e  base, as described  fo r  the a n tipo d e , gave
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( - ) - a - l ,2 - d im e th y l- 4 -p h e n y lp ip e r id in - 4 - o l ( 0 .3 2 g ) [a ]Q 3 -1 .0 °  
(C=1.0,Me0H) m.p. 120°C.
{see ta b le  23 fo r  f u l l  range o f o p t ic a l  ro ta t io n  
readings}
3.4.6(a) (+)-o-4-Acetyloxy-l,2-dimethyl-4-phenylpiperidine
The procedure described in  section 3.4.4 was employed using (+)-a-
1 .2 -d im e th y l-4 -p h e n y lp ip e r id in -4 -o l(0 .2 g )  and a c e ty l c h lo r id e  
( 0 .8 g ) .  T h is  g a ve  ( + ) - a _ -4 -a c e ty  lo x y - 1 , 2 - d im e t h y 1 - 4 -  
phenylp iperid ine hydrochloride (0.13g; 46%) m.p. 196°C.
v max : 1763cm"1 (C=0 s t r ) ,  770, 710cm"1 (monosub, benzene)
Found : C, 63.49; H, 7.88; N, 4.64%
C i5 H2 2 N02 C1 requ ires : C, 63.49; H, 7.76; N, 4.94%
(b) (-)-a-4-Acetyloxy-1,2-dimethyl-4-phenylpiperidine
The procedure described in  section 3.4.4 was employed using ( - ) -a -
1 .2 -d im e th y l-4 -p h e n y lp ip e r id in - 4 - o l  (0 .3g) and a c e ty l c h lo r id e  
C1 .2  g ) .  T h is  g a ve  ( - ) - c ^ - 4 - a c e ty  1 o x y -1 ,2 - d im e th y  1 - 4 -
phenylp iperid ine hydrochloride (0.16g*, 40%) m.p. 200°C.
v max : 1765cm"1 (C=0str), 775 710cm"1 (monosub, benzene)
Found : C, 63.43; H, 7.94; N, 4.78%
C i5 H2 2 NO2 CI requ ires: C, 63.49; H, 7.76; N, 4.94%
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Table 23 SPECIFIC ROTATION ( [a ] )  OF (+)-a-l,2-DIMETHYL-4-PHENYLPIPERIDIN- 







i p i_i NJ (0
(+ )-a -l,2 -a im e th y l-4 -p he ny l- 589 -60°
p ip e r id in -4 -o l- ( - )-3  *- 578 -64°
n it r o ta r t ra n ila te 546 -74°
436 -118°
(_ ) - a - l , 2-d im ethyl-4-phenyl- 589 +60°
p ip e r id in -4 -o l- (+ ) -3 , “ 578 +64°
n it r o ta r t ra n ila te 546 +72°
436 +1 2 0 °
a. Concentration = 0.5% w/v, solvent = methanol.
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3.4.7 4-C 3-Methoxypheny1)-l-methylpiperidin-4-ol (149)
N-Methylpiperidone (lOg) was added to  the Grignard reagent prepared 
from  m -b ro m o a n is o le  (28g) and magnesium (3 .8 g ) in  d ry  
te trahydrofuran (150ml). The s o lu tio n  was re fluxed  fo r 1 hour and 
then s t ir re d  overn igh t a t room temperature. The cooled product was 
poured onto a m ix tu re  o f crushed ice  and a c e tic  ac id  (50m l) and 
e x tra c te d  w ith  e th e r (2 x 50m l). The aqueous la y e r was b a s if ie d  
w ith saturated K2 C0 3 s o lu tio n  and extracted w ith  ether (3 x 1 0 0 m l). 
The combined e th e r la y e r  was washed w ith  water (2 x 30m l), d r ie d  
(MgSOj and evaporated in  vacuo to  g ive  a ye llow  o i l .  This o i l  was 
d i lu te d  w ith  pe tro leum  s p i r i t  (b .p . 30-40°C; 100ml) and the
re s u lta n t s o lid  re c ry s ta ll is e d  from the same so lven t to  g ive 4-(3- 
m e th o x y p h e n y l) - l-m e th y lp ip e r id in -4 -o l as a w h ite  s o l id  (6 .1g; 
31%), m.p. U0°C ( L i t . , 5 6  H2-113°C).
v max : 3300-3100cm” 1 (OH s t r )
5h (CDC13; free base):
1.65 (2H; d, 2J 13.5Hz; eq C3-H and C5-H), 2.08 (2H; t  x d,
2J 13.5, 3J 13.5, 4Hz; ax C3-H and C5-H), 2.18 (3H; s; N-CH3), 
2.45 (2H‘, t  x d, 2J 10.7, 3J 10.7, 1.7Hz; ax C2-H and C6 -H ), 
2.60 (2H; d, 2J 10.7Hz; eq C2-H and C6 -H ), 3.70 (1H; broad s; 
0-H), 3.72 (3H; s; 0-CH3), 6 .72-7 .22 (4H; m-, A ry l-H ).
: see tab le  24, No.l 
: see tab le  25
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3 .4 .8  4 - (3 -H ydroxypheny l)-l-m ethy lp ipe rid in -4 -o l (1£5)
To a s o lu tio n  o f 4-(3-methoxyphenyl)-l-methy lp ip e r id in - 4 - o l  (1&9; 
5g) and NaH (1.66g) in  anhydrous DMF (60m l), under N2 a t 25°C, was 
added n -p ro p a n e th io l (3.77g) dropw ise, and the re a c tio n  m ix tu re  
re fluxed  fo r 3 hours. The product was then cooled to  0°C, quenched 
w ith  ic e d -w a te r, and a c id if ie d  w ith  HC1 (6 M). A fte r  e x tra c t io n  
w ith  e th e r (3 x 50m l), the aqueous phase was b a s if ie d  w ith  NaHC03 
and e x tra c te d  w ith  e th y l a ce ta te  (3 x 100ml). The e th y l ace ta te  
e x tra c t  was d r ie d  (MgS0,J and evaporated in  vacuo to  g iv e  4 -(3 - 
hyd roxyp heny l)-l-m e thy lp ipe rid in -4 -o l as an o i l .  Treatment o f th is  
o i l  w ith  e th e re a l-H C l gave the h y d ro c h lo r id e  (0.45g; 8 %), m.p.
231°C ( L i t . , 5 6  237°C).
v max : 3150-3300, 3400-3450 cm- 1  (2 x OH s t r )
6 C j  see tab le  24, No.2
Found : C, 59.59; H 7.37; N, 5.99%
C1 2 H1 8 N02 C1 requires : C, 59.13; H, 7.39; N, 5.75%.
m/z  : see tab le  25
3 .4 .9  4-Acetyloxy-4-(3-m ethoxyphenyl)-l-m ethylp iperid ine (150) 
A c e ty l c h lo r id e  (3 .5g) was added to  4 -(3 -m e th o x y p h e n y 1 ) - l -  
m e th y lp ip e rid in -4 -o l (149; l.Og) in  to luene (50ml) and the m ixture 
heated under r e f lu x  fo r  3 hours. The coo led  p roduct was d i lu te d  
w ith  e th e r (100m l) and a s o l id  was de pos ite d . This s o l id  was 
c o lle c te d  by f i l t r a t i o n  and re c ry s ta ll is e d  from isopropanol to  g ive  
4 -a ce ty lo xy -4 -(3 -m e th o xyp h e n y l)- l-m e th y lp ip e rid in e  hydroch loride
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(0.85g; 63%), m.p. 201°C.
max s 1760 cm” 1 (c=0 s t r )
6 |_| (CDC13; free base) :
2.05 (3H; s; C0CH3), 2.15 (2H; d x d, 2J 13.5, 3J 4Hz; eq C3-H
and C5-H), 2.29-2.50 (4H; m; ax C2-H and C6 -H, ax C3-H and C5-H),
2.33 (3H; s; N-CH3), 2.77 (2H; d, 2J 10.7Hz; eq C2-H and C6 -H ),
3.78 (3H ; s; 0-CH3), 6 .77-7 .27 (4H; m; A r-H ).
5q : see table 24, No.3
Found : C, 60.01; H, 7.55; N, 4.46%
C1 5 H2 2 NO3 CI requires : C, 60.10; H, 7.34; N, 4.67%.
m/z  : see tab le  25
3.4.10 4-A ce ty loxy-4 -(3 -hyd roxypheny l)-l-m e thy lp ipe rid ine  (139* 
R=C0CH3)
n-B u ty l l ith iu m  (1.3g) in  hexane was added to 3-(2-tetrahydropyran- 
yloxy)bromobenzene(4.5g) in  anhydrous te tra h y d ro fu ra n  (50m l) under 
N2 a t -55°C. The mixture was s t ir re d  a t -50°C fo r 2 hours and then 
hJ-m ethylp iperidone (2g) in  dry te tra h y d ro fu ra n  (30m l) was added, 
w ith s t i r r in g  at -45°C, over 20 minutes. The mixture was s t ir re d  
a t  25°C fo r  30 m in u te s . A c e t ic  a n h y d r id e  (2 .5 g ) in  d ry  
te trahydrofuran (30ml) was added to the m ixture, which, a fte r  being 
s t i r r e d  fo r  3 hours, was poured onto ice-ammonium c h lo r id e  and 
e x tra c te d  w ith  ch lo ro fo rm  (3 x 1 0 0 m l). The combined c h lo ro fo rm  
e x tra c ts  were d r ie d  (MgS0,J and evaporated _in vacuo to  g iv e  the
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t i t l e  compound as the 2-te trahydropyranyl ether. On conversion o f 
the crude base to the hydrochloride s a l t  the p ro tec ting  group was 
cleaved to  y ie ld  4 -ace ty loxy-4 -(3 -hydroxypheny l)-l-m ethy lp iperid ine  
hydrochloride (2.6g; 51%), m.p. 203°C (e thano l).
v max : 3100-3300cm“ l (OH s t r ) ,  1755 (C=0 s t r )
<S|_I (CDC13; free  base) :
2.06 (3H; s; C0CH3), 2.10 (2H; t  x d, 2J 13.5, 3J 13.5, 2.2Hz; 
eq C3-H and C5-H), 2.36 (3H; s; N-CH3), 2 .38-2 .52 (4H; m; ax 
C2-H and C6 -H, ax C3-H and C5-H), 2.81 (2H; d, 2J 12.3Hz; eq C2-H 
and C6 -H ), 6 .71-7 .26 (4H; m; A ry l-H ) .
6 q j see tab le  24, No.4
Found : C, 58.80; H, 7.09; N, 5.02%
CllfH2 0 N03Cl requires : C, 58.84; H, 7.00; N, 4.90%
m/z  : see tab le  25
3•4.11 4-(3-Hydroxyphenyl)-l-methyl-4-propionyloxypiperidine
(159; R=C0C2 H5)
The r e a c t io n  m ix tu re  from  n - b u t y l  l i t h iu m  (1 .3 g ) , 3 - (2 -
tetrahydropyranyloxy)brom obenzene (4 .5g) and N -m e thy lp ip e rid one  
(2 g) in  dry te trahydrofuran ( 1 0 0 ml) was decomposed w ith a s o lu tio n  
o f p ro p io n ic  anhydride (2 .5g) in  dry te tra h y d ro fu ra n  (30m l) as 
o u t l in e d  in  s e c tio n  3 .4 .10 . The m ix tu re  was poured onto ic e -  
ammonium ch lo rid e  and extracted w ith chloroform  (3 x 100ml). The
- 226 -
combined chloroform  extrac ts  were dried (MgSOj and evaporated in  
vacuo to  g ive  the t i t l e  compound as the 2 -te trahydropyrany l ether. 
On con ve rs io n  o f  the  crude base to  the h y d ro c h lo r id e  s a l t  the  
p ro tec ting  group was cleaved to  y ie ld  4-(3-hydroxyphenyl)-l-m ethy l- 
4 -p ro p io n y lo x y p ip e r id in e  h y d ro c h lo r id e  (3 .2g; 60%), m.p. 204°C
( L i t . , 5 7  205-206°).
v max : 3200-3330 cm” 1 (OH s t r ) ,  1760 cm” 1 (C=0 s t r )
6 j_| (C0C13; free  base) :
1.11 (3H; t ,  3J 7.2Hz; CH2 CH3), 2.10 (2H, t ,  2J 12.4Hz, eq C3-H
and C5-H), 2 .30-2 .50  ( 6 H; m; QCOCH,, ax C2-H and C6 -H, ax C3-H
and C5-H), 2.34 (3H; s; N-CH3), 2.80 (2H; d, 2J 11.2Hz; eq C2-H
and C6 -H ), 6 .60-7 .14  (4H; m; A ry l-H ) .
s see tab le  24, No.5
m/z  : see tab le  25
3.4.12 a- and 8_-1,2-Dime thy 1 -4-prop iony loxy-4-{3-
tetrahydropyran-2-yloxy)phenyl}piperidine (160 and 161) 
n - B u t y l  l i t h i u m  (6 .5 g )  in  hexane  was added to  3 - ( 2 -
te trahydropyranyloxy)b rom obenzene ( 2 0 g) in  dry te tra h y d ro fu ra n  
(100ml) under N2 a t -55°C over a period o f 20 minutes. The m ixture 
was s t ir re d  a t -50°C fo r 2 hours and then l,2 -d im e thy l-4 -p ipe ridon e  
(1^ 8 *, lOg) in  te trahydro furan was added dropwise w ith s t i r r in g  at 
-45°C. The m ix tu re  was s t i r r e d  a t 25°C fo r  1 hour. P ro p io n ic  
anhydride (15g) in  te trahydro furan (30ml) was added to the m ixture,
la h l e  24 1 *C-CHEMICAL SHIFTS OF PHENOLIC ANALOGUES OF REVERSED ESTERS OF PETHIDINE AND RELATED COMPOUNDS a
c h 3
M C Chem ical S h i f t s  (ppm; TMS In t e r n a l  S ta n d a rd )
No. Compound R R’ N -C H j C -2 C -3 C -4
R
R'
A ro m atic  C
- 6 - 5
C=0 c h 2 c h s 1* 2 ’ 3 ' 4 ’ 5 ’ 6*
1 149 H Me 4 6 .2 5 5 1 .6 3 3 0 .2 7 6 9 .9 7 - - - 5 5 .0 1 1 5 0 .9 1 1 0 .0 1 5 9 .6 1 1 2 .1 1 2 9 .2 117 .1
2 155 H H 4 5 .4 1 5 0 .7 9 3 7 .3 7 6 0 .9 2 - - - - 1 5 0 .4 1 1 1 .6 1 1 2 .0 1 2 0 .2 1 1 5 .0
3 150 COCHj Me 4 6 .0 2 5 1 .4 6 3 5 .6 3 7 9 .7 0 1 6 9 .4 - 2 2 .1 0 5 3 .1 0 1 4 6 .1 111.1 1 5 9 .6 1 1 1 .9 1 2 9 .4 1 1 6 .9
4
159
R=cncn, COCHj H 4 5 .7 7 5 1 .2 5 3 5 .1 0 7 9 .7 3 1 6 9 .9 - 2 2 .1 2 - 1 4 5 .6 1 1 2 .1 1 5 6 .9 1 1 4 .0 1 2 9 .7 1 1 5 .7
5
159
r=c0 c 2h 5 c o c h 2c h , H 4 5 .7 0 5 1 .2 1 3 4 .9 9 7 9 .3 0 1 7 3 .1 2 0 .6 1 9 .2 1 - 1 4 5 .6 1 1 2 .1 157 .1 1 1 4 .0 1 2 9 .5 1 1 5 .6
a .  S p e c tra  reco rd ed  as base in  C D C lj.
-  2 2 8  -
Table 25 PERCENT ABUNDANCE OF DIAGNOSTIC FRAGMENT IONS OF PHENOLIC 





No. Compound R R’ M+ A B C D E Other
1 149 H Me 52 1 2 1 0 15 1 0 0 61





















which, a fte r  being s t ir re d  fo r 3 hours, was flooded w ith ether. A 
s o l id  was p re c ip ita te d  which was c o l le c te d  by f i l t r a t i o n .  Th is 
s o lid  was d isso lved  in  absolute ethanol and anhydrous ether added 
u n t i l  s o l id  ceased to  be de pos ited . Th is s o l id  was f i l t e r e d  o f f  
(shown to  be mainly inorganic m a te ria l) and the ethanol removed to 
y ie ld  a l i g h t  brown s o l id .  Th is s o l id  was r e c r y s ta l l is e d  from 
ace tone  to  y ie ld  pu re  § _ - l ,2 -d im e th y l-4 -p ro p io n y lo x y -4 - {3 -  
( te tra h y d ro p y ra n - 2 -y lo xy )p h e n y l}p ip e rid in e  as the propionate s a lt  
(6.4g; 19%), m.p. 270°C.
v max s 1740 cm" 1 (C=0 s t r )
<SH (CDC13; free base) :
1.12 ( 6 H; m; CH2 CH3, C2-CH3), 2.32 (3H; s; N-CH3), 1.63-2.56 
(14H; m* C2-H, C3-H, C5-H, eq C6 -H, COCI^ CHa, 0CH2 CH^ CH 2 -CH), 
2.77 (2H; d; ax 6 -H ), 3.60 (1H; m; 0-CH2 -CH2), 3.90 (1H; m; 
0-CH2 -CH2), 5.38 (1H; m; O-CH-O), 6.93-7.27 (4H; m; A ry l-H ).
6 q : see fig u re  11, N o .ii
Found : C, 66.29; H, 8.30; N, 2.89%
C2 ifH3 7 N06 requires : C, 66.21; H, 8.51; N, 3.22%
m/z  : see tab le  27
The o r ig in a l  mother l iq u o rs  were reduced in  volume in  vacuo and 
then poured onto a m ix tu re  o f ice  and ammonia. This m ix tu re  was 
e x tra c te d  w ith  e th e r (3 x 100ml), the  e th e r d r ie d  (MgSO^) and
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evaporated in  vacuo to  y ie ld  crude a -l,2 -d im e th y l-4 -p ro p io n y lo xy -4 - 
{3 -(te trahyd ropyran -2 -y loxy)pheny l}p ipe rid ine  w ith  some tra ce s  o f 
the  £ -  base. F ra c t io n a l r e c r y s ta l l is a t io n  from petroleum s p i r i t  
(b .p . 60-80°C) afforded the pure a-isomer (4 . 1 g; 15%), m.p. 128°C.
v max : 1750 cm" 1 (C=0 s t r )
5h CCDC13; free base) :
1.00 (3H; t ,  3J 7Hz; CH3-CH2 ) ,1 .11 (3H; d, 3J 6 Hz; C2-CH3), 
2.17 (2H; q, 3J 7Hz; CH2 C0), 1.49-2.29 (10H; m; 0-CH2 -CH2-  
CH2 -CH2 -CH; C3-H, C5-H), 2.81 (3H; m; C2-H, C6 -H ), 3.58 (1H; m; 
0-CH2 -CH2), 3.81 (1H; m; 0-CH2 -CH2), 5.37 ClH; m; O-CH-O),
6.96-7.28 (4H; m; A ry l-H ) .
6 C : see fig u re  11, No.i
Found s C, 69.63; H, 8.79.N, 4.20%
C2 i H3 iN0  ^ requires s C, 69.80; H, 8.58; N, 3.87%
m/z  : see tab le  27
3.4.13 a-1,2-Dimethyl-4-(3-hydroxyphenyl)-4-propionyloxy-
piperidine (126)
To an e th a n o lic  s o lu t io n  o f a - l,2 -d im e th y l-4 -p ro p io n y lo x y -4 -{3 - 
(te trahydropyran-2 -y loxy)phenyl}p iperid ine  (l&O; 4g) was added an
excess o f e thano lic-H C l. The ethanol was removed in  vacuo and the 
residue re c ry s ta llis e d  from acetone to  y ie ld  a - l,2 -d im e th y l-4 -(3 - 
hydroxyphenyl)-4-prop ionyloxyp iperid ine h y d ro c h lo r id e  as a w h ite
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hygroscopic s o lid  (0.62g; 18%), m.p. 163°C.
6 ^ : see tab le  26
: see fig u re  11, N o . i i i
Found : C, 38.37; H, 7.42; N, 3.98%.
Ci6 H2<*N03C1. H2° s q u ire s  : C, 57.92; H, 7.84; N, 4.22%.
m/z  s see tab le  27
3.4.14 £-1,2-Dimethyl-4-(3-hydroxyphenyl)-4-propionyloxy-
piperidine (127)
To an e th a n o lic  s o lu t io n  o f 3 ^ -l,2 -d im e th y l-4 -p ro p io n y lo xy -4 -{3 - 
Ctetrahydropyran-2 -y loxy )pheny l}p ipe rid ine  ( l& l ;  4g) was added an
excess o f e thano lic-H C l. The ethanol was removed in  vacuo and the 
residue re c ry s ta llis e d  from acetone to  y ie ld  8 - l,2 -d im e th y l-4 -(3 - 
hydroxyphenyl)-4-prop ionyloxyp iperid ine h y d ro c h lo r id e  as a w h ite  
c ry s ta l l in e  m ateria l (0.8g*, 23%), m.p. 264°C.
5|_l : see tab le  26
<SC : see fig u re  11, No.iv
Found : C, 61.02; H, 7.72; N, 4.18%
C i6 H2 „N03C1 requires : C, 61.24; H, 7.66; N, 4.46%
see tab le  27
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Table 26 l H-N.M.R. CHARACTERISTICS OF a- AND 3-2-METHYL PHENOLIC ANALOGUES 
OF THE REVERSED ESTER OF PETHIDINE 3
(136) in CDC13 (136) HC1 in D20 d (137) in CDCI3 (137) HC1 in  D20
N-qh3 62.28, s 52.77, S 
(62.81, s)
62.29, s 62.89, s
C2-qi3 61.16, d 
J6.4















eq 3H 62.76 ° g h 52.72 
2J17, 3J2




eq 5H b g h j
ax 6 H b g h 63.40
2 J1 2 . 8 , 3J1 2 . 8 , 2
eq 6 H b g 52.78
2 O il.4, 3J2
53.50
2 J1 2 .8 , 3J2
0 C0 CH_2 62.19, q 
J7.1
62.24, q, J7.1 
(62.37, q, 07.1)
62.30, q, J7 62.41, q 
J7.3
ch2ch3 61.00, t  
J7.1
60.89, t ,  07.1 
(60.98, t ,  07.1)
61.05, t ,  J7 61.01, t  
J7.3









Notes for Table 26
a. S p e c tra  re c o rd e d  on a JEOL GX400MHz FT N.M.R.
Spectrometer.
b. Signals part o f complex unresolved m u lt ip le ts .
c. Eq 3H s ig n a l a t approx 62.76 as i r r a d ia t io n  o f  ax 3H
(62.03) caused broad doublet to  reduce to  broad s in g le t.
d. Values in  parentheses re fe r to  minor epimer.
e. Each s igna l o f 1 proton in te n s ity .
f .  I r r a d ia t io n  o f these s ig n a ls  caused C2-Me d o u b le t to
reduce to  s in g le t.
g. Signals part o f complex unresolved m u lt ip le ts .
h. Unresolved s igna ls .
i .  Signal poorly resolved, overlapped by eq 6 H.
j .  Poorly resolved, pa rt o f s igna l a t 62.72.
k. P oo rly  re s o lv e d , i r r a d ia t io n  o f C2-Me d o u b le t (61.16),
62.29 a ffected .
Table 27 PERCENT ABUNDANCE OF DIAGNOSTIC FRAGMENT IONS OF PHENOLIC 2-METHYL ANALOGUES OF REVERSED ESTERS








A B C D E F Other
1 160 a a Not Seen 23 10 48 35 100 60
2 JL61 3 a 2 3° 25 100 70 58 86
3 136 a H Not Seen 27 63 31 22 C2H5C0+ (100)
lx 137 3 H Not Seen 33 69 33 18 C2H5CO+ (100)
a. Ion Types
A B C D E F
234
Figure 11
13C-n.m.r. data for 
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